Back grey_arrow_rt.gif
 
NATAP Aging & HIV Resource Center
 
null.gif
 
  "Caring for Older Adults with HIV in the 21st Century: It's Time for a Geriatric Approach"
Speakers: Angela Condo, M.D. - Assistant Professor of Geriatrics at the Icahn Schhool of Medicine Mount Sinai & Alexander Lee - PharmD, JD, AAHIVP
Click to View Webinar: Friday, April 22nd, 2022
Download the Joint Presentation Slide Set Here 04/22
 
  • Screening Tests for Older PWH Including Recommendations from IAS-USA & NYS Clinical Guidelines - (10/06/23)
     
  • Kidney Disease & HIV - (09/08/21)
     
  • Treating the Whole Patient - "Paitent-Centered" Care: Social Determinants of Health, Mental Health - (09/02/21)
     
    • Heart Disease & HIV
  • Heart Disease & HIV: statement from American Heart Association - (08/31/21)
     
  • What is Frailty ? Burden of frailty in the elderly population: perspectives for a public health challenge - (09/04/19)
     
    • Polypharmacy, What is it?
  • The challenge of HIV treatment in an era of polypharmacy - (08/31/21)
     
  • Aging, Comorbidities Screening Tests PWH Should Be Doing - (08/31/21)
     
  • HIV and the Bones - NATAP webinar, Todd Brown, MD - (08/30/21)
     
  • HIV & Aging Geriatric Clinics
     
  • Accelerated or Premature Aging & Comorbidities for PLWH & The Need To Fix Healthcare
     
  • Recorded Webinar and Slides- Taking Global Action Toward Improved Care, Quality of Life, and Empowerment for Older People with HIV - A Webinar
     
  • IAS: What is HIV-Associated Neurocognitive Disorder (HAND) & Its Symptoms - (08/12/24)
     
  • HIVMA-IDSA Guidance on Screening for Frailty, Neurocognitive Decline, Bone
    Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America     - (11/05/24)
     
    1. Ageism: the -ism affecting the lives of older people living with HIV - (12/21/24)
       
    2. Safety of Kidney Transplantation from Donors with HIV - (12/20/24)
       
    3. New HHS ART Guidelines discuss & Provide Guidance: Immunologc Aging, Bone Screening, Frailty, Cognitive Evaluations, Polypharmacy, DDIs in Older PWH - (12/19/24)
       
    4. Fostering healthy cognitive ageing in people living with HIV, New Position Paper - (12/06/24)
       
    5. ID Week: Adherence to Bone Mineral Density Screening Recommendations in Older Adults with HIV - (11/26/24)
       
    6. ID Week: Anal Pap Smear Trends in Patients Living with HIV and a History of Malignancy in a Single-Center: Retrospective Observational Study - (11/25/24)
       
    7. ID Week: Clinical Complications and Quality of Life in People Living with HIV and Other Comorbidities - (11/25/24)
       
    8. ID Week: The Silver Tsunami is Upon Us: Over Half of Persons with HIV in the United States Are Aged ≥50 Years and Almost Half Have Been Living with HIV >15 Years - (11/25/24)
       
    9. ID Week: An Analysis of an Evolving Malignancy Profile in an Urban Population of People Living with HIV - (11/25/24)
       
    10. Glasgow: PREVALENCE OF METABOLIC SYNDROME IN PEOPLE LIVING WITH HIV AND ITS RELATIONSHIP WITH FATTY LIVER AND CARDIOVASCULAR RISK - (11/24/24)
       
    11. Glasgow: Evaluation of T-cell immunosenescence markers in virologically suppressed people living with HIV aged over 60 years on BIC/FTC/TAF or DTG/3TC: the Collateral study - (11/18/24)
       
    12. Glasgow: Kidney Transplant HIV+ Donor to Positive Recipient - Should be SOC - (11/17/24)
       
    13. Glasgow: Comparison of 4 Frailty scores to predict adverse health outcomes and mortalit yin people living with HIV aged 70 years and more (ANRS EP66 SEPTAVIH study) - (11/17/24)
       
    14. Glasgow: Acceptability and feasibility of digital assessment of falls risk, frailty and mobility impairment using wearable sensors in PLWH as part of HIV care - (11/17/24)
       
    15. Glasgow: Antiretroviral therapy, comorbidities and concomitant medication in people with HIV aged over 75 years in one centre in London, UK - (11/17/24)
       
    16. Glasgow: Long-term change of renal function among people with HIV who received tenofovir alafenamide (TAF)-containing ART - (11/17/24)
       
    17. Glasgow: poster - Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study - (11/17/24)
       
    18. Glasgow: Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real- world OncoVIHAC ANRS CO24 cohort study - (11/17/24)
       
    19. Glasgow: Randomized, multicenter, double-blind clinical trial designed to evaluate the safety and convenience of switching from dolutegravir/lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV, good virologic control and neuropsychiatric comorbidities: Week 24 results from the GESIDA 11920 - MIND Study. - (11/17/24)
       
    20. Glasgow: Depression (20%) and anxiety (15%) symptoms among people with HIV in the UK: prevalence, correlates and treatment. Results from the Positive Voices 2022 study - (11/17/24)
       
    21. Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America - (11/05/24)
       
    22. AGE: Incorporating Clinical Geriatrics into HIV care: The Silver Clinic Experience; 'PWH frail 10 years earlier" - (11/01/24)
       
    23. AGE: Integrating geriatrics expertise into HIV primary care: The HIV-Endurance (HIVE) Clinic at Boston Medical Center - (10/31/24)
       
    24. AGE: Polypharmacy & Deprescribing PWH; Polypharmacy Impact - (10/31/24)
       
    25. AGE: Older PWH Loneliness & Facial Emotional Perception Related/Factors; Epigenetic Clock Reflects Coginitve Impairment; Model of Geriatric/Aging Care - (10/31/24)
       
    26. AGE: Detecting Brain Structural Changes with Portable Low-Field MRI Among Older People with HIV; Patterns of Brain Atrophy HIV vs without HIV - (10/31/24)
       
    27. AGE: Depressive Symptoms are Associated with Cortical Thickness, Regional Brain Volumes, and Cerebral Blood Flow Across Younger and Aging Persons with HIV - (10/31/24)
       
    28. AGE: Undiagnosed Sleep Disorders & HIV; Detecting Brain Changes Older PWH with Portable MRI; Depression & Brain Changes; Men with HIV have 42% higher odds of sleep apnea - (10/31/24)
       
    29. AGE: Undiagnosed PWH Dementia & Cognitive Impairment Older PWH & Higher Rates - (10/31/24)
       
    30. AGE: Clinical & Immunologic Features of People Living with Perinatally Acquired HIV - (10/31/24)
       
    31. AGE: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV Aged ≥ 50 Years: 48-Week Follow-Up From Four Phase 3 Studies - (10/30/24)
       
    32. AGE: Interim demographics, clinical characteristics, and effectiveness in the REGAL cohort: A REtrospective real-world study of the effectiveness and tolerability of the antiretroviral treatment reGimens DTG/3TC compAred to BIC/FTC/TAF in older persons Living with HIV - (10/30/24)
       
    33. AGE: Switching to B/F/TAF in a Real-World Cohort of Older People With HIV and a High Burden of Non-AIDS-Related Comorbidities - (10/30/24)
       
    34. AGE: Unraveling the Intricate Triangle: HIV, Frailty, and Inflammation - (10/30/24)
       
    35. AGE: Prevention and Treatment of Frailty in PLWH - (10/30/24)
       
    36. ID Week: Efficacy and Safety of B/F/TAF in Treatment-Naïve People With HIV Aged  50 Years: 5-Year Follow-Up From Two Phase 3 Studies - (10/22/24)
       
    37. ID Week: Breast Cancer (BC) and Colorectal Cancer (CRC) Screenings among Persons with HIV (PWH): The Role of Individual and System-Level Factors on Screening Completion - (10/22/24)
       
    38. ID Week: Comorbidities and Healthcare Resource Utilization Among People With HIV: Real-World Data From a Large Israeli Healthcare Provider - (10/22/24)
       
    39. ID Week: T-cell Immune Exhaustion and the Atherogenic Index of Plasma in People Living with HIV on Antiretroviral Therapy - (10/22/24)
       
    40. Flavonoid-Rich Foods, Dementia Risk, and Interactions With Genetic Risk, Hypertension, and Depression - (09/25/24)
       
    41. Loneliness & Diseases Risk - (09/25/24)
       
    42. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients; Gut Microbiota & CD4 Recovery - (09/25/24)
       
    43. Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era - (09/25/24)
       
    44. HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis - (09/25/24)
       
    45. Role of the gut-brain axis in HIV and drug abuse-mediated neuroinflammation - (09/25/24)
       
    46. Incident Proteinuria by HIV Serostatus Among Men With Pre¬Diabetes Mellitus: The Multicenter AIDS Cohort Study - (09/09/24)
       
    47. The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study - (09/09/24)
       
    48. HRSA Issues Aging/HIV Letter on Older HIV; Long-Term Survivors in Ryan White HIV/AIDS Program - (09/05/24)
       
    49. HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis - (09/03/24)
       
    50. IAS: Peripheral blood and cerebrospinal fluid viremia of 24-weeks MONOtherapy of DOlutegravir in HIV-1 virologically suppressed patients: MONODO study - (08/10/17)
       
    51. Aging with HIV - An Epidemiological Profile of Persons with Diagnosed HIV Aged 50 Years and Older in New York State, 2012-2021, new HIV more likely to have late diagnosis/stage 3 HIV, female white, heterosexual sex, IDU....heart disease/cancers leading cause of death NYC - (08/26/24)
       
    52. Prevalence and correlates of frailty among older people with and without HIV in rural Uganda - (08/26/24)
       
    53. THE ASSOCIATION OF ANEMIA WITH SURVIVAL AMONG PEOPLE WITH HIV FOLLOWING ANTIRETROVIRAL INITIATION IN THE NA-ACCORD 2007-2016 - (08/26/24)
       
    54. IAS: Negative Perception of Self & Stigma & Depression associated with Worse Expectations of Aging in Brazil - (08/26/24)
       
    55. FRAX assessment in people ageing with HIV - (08/19/24)
       
    56. Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk, plus Editorial Comment - (08/19/24)
       
    57. Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV - (08/19/24)
       
    58. IAS: Differences between integrase strand transfer inhibitors on glucose tolerance: a role for mitochondrial stress - (08/19/24)
       
    59. IAS: Aging & HIV Studies at IAS 2024 - (08/12/24)
       
    60. IAS: Bone health in Malaysian women living with HIV: uncovering the pores in osteoporosis screening and management in a high-risk population - (08/05/24)
       
    61. Low Compliance (10%) with Bone Mineral Density Screening Recommendations for People with HIV Despite High Fracture Rates...."critical to prioritize health screenings"
       
    62. IAS: Time is of the essence: clinical frailty among a cohort of Indigenous peoples aging with HIV in Ontario, Canada - (08/03/24)
       
    63. IAS: An assessment of clinical frailty and early aging among a cohort of people living with HIV in Ontario, Canada....41% prefrailty (age 44), 6% frailty (age 55): indicators of frailty & prefrailty; IDU history increased risk, previous AIDS increased risk - (08/03/24)
       
    64. IAS: Geriatric syndromes and quality of life in older adults living with HIV in Brazil....50% Pre-frail, 6% frail....age 62, CD4 700+, 90% undetectable viral load....greater services needed ! - (08/03/24)
       
    65. IAS: Unruly Natural Killer Cells May Figure in CVD Risk in HIV+ Adolescents - Mark Mascolini (08/02/24)
       
    66. IAS: An assessment of clinical frailty and early aging among a cohort of people living with HIV in Ontario, Canada - (08/01/24)
       
    67. IAS: Comprehensive geriatric assessment for people living with HIV and frailty: a feasibility randomized controlled trial - (08/01/24)
       
    68. IAS: Perceptions on frailty and frailty screening of people living with HIV and their healthcare professionals in Ethiopia: a qualitative study - (08/01/24)
       
    69. IAS: Frailty and multimorbidity in mid-aged and older adults living with HIV: a cross-sectional study in Zimbabwe - (08/01/24)
       
    70. IAS: What drives Comorbidities in PWH ? Highlights From Aging Pre-Conference Talks, at AIDS 2024 - (07/31/24)
       
    71. IAS: Assessing Comorbid Conditions in HIV/AIDS Patients: Insights from the CHAO (Comorbidities of HIV/AIDS Outpatients) Study in Meru County, Kenya and Their Role in Shaping Integrated Health Care Approaches - (07/31/24)
       
    72. IAS: What is HIV-Associated Neurocognitive Disorder (HAND) & Its Symptoms - (08/12/24)
       
    73. IAS: Prevalence and associated factors of chronic kidney disease in young people living with HIV in Uganda - (07/31/24)
       
    74. IAS: Increased cardiovascular risk in perinatally HIV-acquired adolescents (PHIV) may linked to proinflammatory NK cells - (07/31/24)
       
    75. IAS: Randomised placebo-controlled trial of high-dose vitamin D and low-dose calcium supplementation to improve bone density in adolescents with perinatally-acquired HIV in Southern Africa - (07/28/24)
       
    76. IAS: Neurocognitive trajectories among a young adult cohort from four African countries: associations with HIV and food insecurity - (07/28/24)
       
    77. IAS: Increased biomarkers of cardiovascular disease in a long-term survivor cohort of young adults living with perinatal HIV with virologic non-suppression or metabolic syndrome - (07/28/24)
       
    78. IAS: Vitamin D Plus Calcium Improves Bone Density in HIV Youth Who Start With Low Density - Mark Mascolini (07/28/24)
       
    79. IAS: Three CVD Markers High in 347 Young Adults With HIV in Thailand - Mark Mascolini (07/28/24)
       
    80. IAS: Multimorbidity by sex at birth among ageing (65 years and older) persons with HIV (PWH) in the Southern United States (US) - (07/28/24)
       
    81. IAS: Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa - (07/28/24)
       
    82. IAS: Detailed modelling of viremia exposure does not independently predict cardiovascular disease in people with HIV - (07/28/24)
       
    83. IAS: Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa - (07/28/24)
       
    84. IAS: Integrating non-communicable disease screening and treatment in antiretroviral clinics: insights from Malawi - (07/28/24)
       
    85. IAS: A pilot study assessing changes in cerebral function parameters in persons with insomnia switching integrase inhibitors - (07/28/24)
       
    86. IAS: Dolutegravir-containing antiretroviral therapy and incident hypertension: findings from a prospective cohort in Kenya, Nigeria, Tanzania, and Uganda - (07/27/24)
       
    87. Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America - (07/05/24)
       
    88. Food Is Medicine for Human Immunodeficiency Virus: Improved Health and Hospitalizations in the Changing Health Through Food Support (CHEFS-HIV) Pragmatic Randomized Trial - (06/21/24)
       
    89. Dasatinib + Quercetin Drugs Reduced Senescent-Associated Secretory Phenotype (SASP) in PLWH PBMCs - (06/21/24)
       
    90. Age-associated dementia (30%) among older people aging with HIV in the United States: a modeling study - (05/24/24)
       
    91. Comparison of dementia risk after age 50 between individuals with and without HIV infection: 58% Higher Risk, 10 years Earlier - (05/24/24)
       
    92. Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection - (05/08/24)
       
    93. CROI: HIV Transcription Persists in the Brain of People With HIV and Viral Suppression - (05/01/24)
       
    94. CROI: Infected T-Cell Clones Are Shared Across CSF and Blood Compartments in PWH - (05/01/24)
       
    95. CROI: Low Levels of HIV-1 in CSF During ART Are Associated With Neurocognitive Impairment and Inflammation - (05/01/24)
       
    96. CROI: Carotid Inflammation on FDG-PET Is Associated With Lower Cognitive Function in Treated HIV Infection - (05/01/24)
       
    97. CROI: Mini-Lecture on HIV Persistence in the CNS: Considerations for Current Cure Strategies - (05/01/24)
       
    98. 3 New Papers on Integrase Inhibitors & TAF and Weight Changes, Metabolics - (05/01/24)
       
    99. 3 New Papers on Integrase Inhibitors & TAF and Weight Changes, Metabolics - (04/17/24)
       
    100. CROI: EPIGENETIC IMPACT IN CSF CELLS FROM 48 WEEKS OF ADJUNCTIVE TELMISARTAN IN ACUTE HIV - (04/15/24)
       
    101. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV - (04/15/24)
       
    102. CROI: EPIGENETIC IMPACT IN CSF CELLS FROM 48 WEEKS OF ADJUNCTIVE TELMISARTAN IN ACUTE HIV - (04/12/24)
       
    103. CROI: Epigenetic Age Advancement Is Associated With Cognition, Frailty, and Mortality in Older PWH - (04/12/24)
       
    104. CROI: Differential Expression Analysis Reveals Pervasive Transcriptional Changes in the Brains of PWH - (04/12/24)
       
    105. CROI: ANTIRETROVIRAL REGIMENS ARE ASSOCIATED WITH COGNITIVE FUNCTION IN PEOPLE WITH HIV - (04/12/24)
       
    106. CROI: CD4 Count Predicts Longitudinal Trajectories of Central Executive Network Connectivity in PLWH - (04/12/24)
       
    107. CROI: Pro-Inflammatory Glycomic Dysregulations Define HIV-Associated Neurocognitive Impairments - (04/12/24)
       
    108. CROI: Predictors of CD4/CD8 T-cell Inversion After 96 Weeks of ART Initiated During Acute HIV - (04/12/24)
       
    109. CROI: Immune Checkpoint Signatures Associated With Impaired Cognition in People Living With HIV - (04/12/24)
       
    110. CROI: A New Measure of ART Activity in CSF and Association with Persistence and Cognitive Function - (04/12/24)
       
    111. CROI: Cumulative exposure to CVD risk factors more adversely affects cognition in women than men with and without HIV - (04/12/24)
       
    112. CROI: ASCVD Risk score Predicts Lower Cognitive Function, Bigger Affect in Women- Atherosclerotic Cardiovascular Disease Risk Score and Cognition by HIV Serostatus and Sex - (04/11/24)
       
    113. CROI: Brain White Matter Hyperintensity Accumulation in an Acute HIV Cohort over Two Years - (04/11/24)
       
    114. CROI: HIV-1 Infection and Alzheimer's Disease Pathobiology in a Novel Humanized APP-Knock in Mouse Model - (04/11/24)
       
    115. CROI: Effects of Recent Air Pollution Exposure on Cognition, Inflammation, and Neurodegeneration in HIV - (04/11/24)
       
    116. CROI: ASYMPTOMATIC CSF HIV-1 ESCAPE: INCIDENCE AND EFFECTS ON CNS BIOMARKERS - (04/11/24)
       
    117. CROI: Anti-47 antibody facilitates improved renal function during SIV infection in macaques - (04/11/24)
       
    118. CROI: Pattern of Age-Related Cognitive Decline in People With HIV Depends on Viral Suppression - (04/11/24)
       
    119. CROI: Clonal Hematopoiesis in HIV and Atherosclerosis, Arterial Inflammation, and Hematopoietic Activity - (04/11/24)
       
    120. CROI: Description of clonal hematopoiesis in a hospital-based cohort of people living with HIV - (04/11/24)
       
    121. CROI: Clonal Hematopoiesis and HIV Infection are Associated with Geriatric Outcomes: the ARCHIVE Study - (04/11/24)
       
    122. CROI: PWH 50% Unknown Causes of Death Latin America: Registered Causes of Death Remain Largely Unknown Among People with HIV in Latin America - (04/08/24)
       
    123. CROI: Older/Poor PWH Have Worse Hospital Readmission Rates vs PWoH: Trends in Hospital Readmissions Among Adults With (two-thirds higher) and Without HIV in the US, 2010-2020: indicates poor quality-of-care; women had higher rates - (04/08/24)
       
    124. Targeting Inflammation and Cardiovascular Disease in People with HIV: 2024 and onward, Priscilla Hsue MD - (04/03/24)
       
    125. CROI: Met and unmet health and welfare services needs amongst people with HIV in the UK: mental health, physical health, welfare - (04/02/24)
       
    126. CROI: Routine Collection of Patient-Reported Outcomes in HIV Clinics: Findings After >100,000 Assessments.....rates of depression, binge drinking, drug use, intimate partner violence CNICS Cohort - (04/02/24)
       
    127. CROI: Effect of Obesity on Response to Antiretroviral Therapy in SIV-infected Rhesus Macaques - (04/02/24)
       
    128. CROI: DOLUTEGRAVIR TARGETS THE HYPOTHALAMUS TO SUPPRESS ENERGY EXPENDITURE VIA ESTROGEN RECEPTOR - (04/02/24)
       
    129. CROI: Biomarkers Influence Kidney Function Estimates More So Than Race Among Persons with HIV - (04/02/24)
       
    130. CROI: Markers of Macrophage Activation and Kidney Function in People With and Without HIV - (04/02/24)
       
    131. CROI: Inflammatory profile of B/F/TAF, DTG/ABC/3TC, and DTG+F/TAF over 5-years and effects of viral blips: 'transient viral blips may contribute to inflammation in Art-treated' - (03/27/24)
       
    132. CROI: The (no) Effect of Dolutegravir on Whole-Body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers - (03/27/24)
       
    133. CROI: Temporal Trends of Cardiovascular Disease Incidence in People with HIV from 2001-2021: high prevalence of risk factors - (03/27/24)
       
    134. CROI: Global Trends in CD4 Count Measurement and Prevalence of CD4 <200 cells/μL at ART Initiation: high prevalence remains for <200 cd4 at ART start (30%) - (03/27/24)
       
    135. CROI: Pregnancy History Affects Age-Related Comorbidity Burden in U.S. Women With and Without HIV - (03/27/24)
       
    136. CROI: Consequences of Low-Level Viremia by Sex Among People With HIV in the United States - (03/27/24)
       
    137. CROI: InSTI Switch During Menopause Is Associated With Accelerated Body Composition Change: 'early accelerated increases in waist circumference & BMI' - (03/27/24)
       
    138. CROI: Age Modifies the Association Between Sex and the Plasma Inflammatory Proteome in Treated HIV: HIV+ women have more inflammation at older ages in particular, mortality associated - (03/27/24)
       
    139. CROI: Modifiable Factors Associated With Cardiovascular Disease Risk Among Women With and Without HIV - (03/27/24)
       
    140. CROI: Markers of Macrophage Activation and Kidney Function in People With and Without HIV - (03/27/24)
       
    141. CROI: Markers of Macrophage Activation and Kidney Function in People With and Without HIV - (03/27/24)
       
    142. CROI: Biomarkers Influence Kidney Function Estimates More So Than Race Among Persons with HIV - (03/27/24)
       
    143. CROI: Safety of Tenofovir Alafenamide in individuals with a history of Proximal Renal Tubulopathy on TDF - (03/27/24)
       
    144. CROI: PREGNANCY INFLAMMATORY MARKERS PREDICT POSTPARTUM WEIGHT IN SOUTH AFRICAN PEOPLE LIVING WITH HIV - (03/27/24)
       
    145. CROI: INCREASED CANCER RISK WITH LOW CD4 COUNTS PERSISTS DESPITE OVER 2 YEARS OF VIROLOGICAL SUPPRESSION - (03/27/24)
       
    146. CROI: Lipidome composition and weight changes at 48week 3TC-DTG and FTC/TAF/BIC: data of the ICONA cohort - (03/25/24)
       
    147. CROI: Switching to Integrase Strand Transfer Inhibitors and the Risk of Diabetes in Persons with HIV - (03/25/24)
       
    148. CROI: Weight Gain in People With HIV (PWH) vs People Without HIV (PWoH) Over a 3-Year Period - (03/25/24)
       
    149. CROI: Dolutegravir, Body Mass Index, and Metabolic Syndrome in the IeDEA Sentinel Research Network - (03/25/24)
       
    150. CROI: Weight Gain After Initiating ART Close to HIV Seroconversion: Is There a Return to Health Effect? - (03/25/24)
       
    151. CROI: Weight Change After Starting Doravirine Among ART-Experienced Individuals in the US - (03/25/24)
       
    152. CROI: Effect of TDF and TAF on Duodenal Enterocytes - a Hypothesis on Different Effect on Body Weight - (03/25/24)
       
    153. CROI: Hypertension in a randomized trial of DTG- vs EFV-based ART in pregnant and postpartum women - (03/19/24)
       
    154. CROI: Activated and exhausted CD8+ T Cell subsets associate with carotid atherosclerotic plaques in PLHIV - (03/19/24)
       
    155. CROI: Low Levels of HIV-1 in CSF During ART Are Associated With Neurocognitive Impairment and Inflammation - (03/19/24)
       
    156. CROI: Suppressing Asymptomatic CMV with Letermovir Reshapes Cardiometabolic Proteome in Treated HIV - (03/19/24)
       
    157. CROI: Plasma Proteome Signature of Immune Inhibition is Associated with CMV Coinfection in People with HIV - (03/19/24)
       
    158. CROI: Latent Viral Infections Are Associated With Veterans Aging Cohort Study Index in People With HIV - (03/19/24)
       
    159. CROI: Clinical Profiles Predicting Cognitive Decline (24%) over 10 years Among Older Adults with HIV in Canada - (03/19/24)
       
    160. CROI: High Plasma GFAP in older PWH with Low Nadir CD4 Support Legacy Brain Injury and Reactive Gliosis - (03/19/24)
       
    161. CROI: Application of STOPP Criteria in an Urban Cohort of People Aging with HIV, 50%+ PWH Taking Inappropriate Prescriptions - (03/19/24)
       
    162. CROI: Endothelial Dysfunction in HIV: Exploring Cytokine and Chemokine Dynamics - (03/19/24)
       
    163. CROI: ELEVATED TRIGLYCERIDES AND ENDOTHELIAL VASODILATOR DYSFUNCTION IN ADULTS LIVING WITH HIV-1 - (03/19/24)
       
    164. CROI: Biomarkers of Microbial Translocation and Inflammation Associated with Frailty among People with HIV 58% Frail/Prefrail - (03/19/24)
       
    165. CROI: OPTIMIZING LONG-TERM EXERCISE BENEFITS FOR OLDER ADULTS WITH HIV THE MOVIHNG STUDY - (03/19/24)
       
    166. CROI: Frailty and Health-Related Quality of Life (QOL 24% Lower) in an Aging Cohort of People with HIV 2012-2022 - (03/19/24)
       
    167. CROI: Neighborhood Vulnerability Predicts Non-Communicable Disease Risk Among People With HIV - (03/19/24)
       
    168. CROI: Semaglutide Trims Muscle Volume but Physical Function Not Lost - Mark Mascolini (03/19/24)
       
    169. CROI: Pitavastatin Has No Effect on Long-Term, Objective Physical Function in REPRIEVE - Mark Mascolini - (03/19/24)
       
    170. CROI: Pitavastatin Reduces Non-Calcified Plaque via Pro-Collagen PCOLCE Independently of LDL in REPRIEVE - (03/19/24)
       
    171. CROI: A Skewed NK Cell Repertoire Persists in People with HIV-1 Despite Long-Term ART - (03/19/24)
       
    172. CROI: Immunological Non-Responders have CD4+ Immunosenescence and Impaired Lymphocyte Cytokine production - (03/19/24)
       
    173. CROI: DNA Methylation-Based Telomere Length Is Associated with HIV Infection and Cancer in Relation to HIV Frailty and All-Cause Mortality - (03/19/24)
       
    174. CROI: Ultra-Low Level HIV p24 Production as a Driver of Immune Activation in Individuals Treated with ART - (03/19/24)
       
    175. CROI: CSF ART Exposure, Population Pharmacokinetic Approaches to Standardize Antiviral Exposure in the Cerebrospinal Fluid - (03/19/24)
       
    176. CROI: MRI With T2 Maps and Spectroscopy Show Chronic Progressive Brain Damage Despite HIV Suppression - (03/19/24)
       
    177. CROI: Community Health Worker-Facilitated Telehealth for Severe Hypertension Care in Kenya and Uganda - (03/18/24)
       
    178. CROI: Low Levels of HIV-1 in CSF During ART Are Associated With Neurocognitive Impairment and Inflammation - (03/18/24)
       
    179. CROI: CSF ART Exposure, Population Pharmacokinetic Approaches to Standardize Antiviral Exposure in the Cerebrospinal Fluid - (03/16/24)
       
    180. CROI: No neurocognitive benefit of immediate vs delayed tesamorelin in virally suppressed people with HIV - (03/16/24)
       
    181. CROI: Socio-Demographics Were Stronger Classifiers of Cognitive Profiles Than Neuroimaging in HIV - (03/16/24)
       
    182. CROI: EXTRA-CVD: A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention - (03/16/24)
       
    183. CROI: Treatment of Prehypertension in People Living With HIV: A Randomized Controlled Trial - (03/16/24)
       
    184. CROI: Pitavastatin Has No Effect on Long-Term, Objective Physical Function in REPRIEVE - (03/16/24)
       
    185. CROI: Performance of the ACC/AHA Pooled Cohort Equations or Risk Prediction in the Global REPRIEVE Trial - (03/16/24)
       
    186. CROI: Factors Contributing to Risk of Major Adverse Cardiovascular Events among People with HIV in REPRIEVE - (03/16/24)
       
    187. CROI: Pitavastatin Reduces Non-Calcified Plaque via Pro-Collagen PCOLCE Independently of LDL in REPRIEVE - (03/16/24)
       
    188. CROI: Aging at CROI 2024 - (03/16/24)
       
    189. CROI: Semaglutide at CROI 2024 - (03/16/24)
       
    190. CROI: Relating Pitavastatin Effects on Inflammatory Biomarkers to Plaque Changes in REPRIEVE - (03/16/24)
       
    191. CROI: Carotid Inflammation on FDG-PET Is Associated With Lower Cognitive Function in Treated HIV Infection - (03/16/24)
       
    192. CROI: Leading Causes of Death Among People With HIV in the US, 2001-2019...4x greater death risk than gen. pop., cancer & heart disease, HIV leading causes of death, Blacks have higher death rates - (03/13/24)
       
    193. CROI: Amyloid-β PET Positivity Among Cognitively Impaired People with HIV Over Age 60 - (03/13/24)
       
    194. CROI: Plasma Inflammatory Biomarkers Link to Worse Cognition Among Africans Living With HIV - (03/13/24)
       
    195. CROI: Age-Adjusted Mortality Rates Among Persons With HIV, by Race and Ethnicity and Cause of Death....22% due to comorbidities - (03/13/24)
       
    196. CROI: Leading Causes of Death Among People With HIV in the US, 2001-20194x greater death risk than gen. pop., cancer & heart disease, HIV leading causes of death, Blacks have higher death rates - (03/13/24)
       
    197. CROI: Progress Toward Achieving National Goals for Improved Quality-of-Life Among Black Women With HIV.....worse unmet mental health needs, self-rated good or better health worsened - (03/13/24)
       
    198. CROI: Immunoregulatory Pathways Predict Mortality More Strongly in People With Versus Without HIV - (03/13/24)
       
    199. CROI: Prostate cancer characteristics and outcomes for veterans: Higher Advanced Prostate Cancer Risk in Veterans With Than Without HIV, 67% Blacks in Study - Mark Mascolini (03/13/24)
       
    200. CROI: Low-Level HIV Viremia Affects T-Cell Activation and Senescence in InSTI Era - (03/13/24)
       
    201. CROI: Excess Inflammation Associated with AIDS and Non-AIDS Complications in Adults on ART...deferring ART increased inflammation, complications & Death Rates - (03/13/24)
       
    202. CROI: Sleep Deprivation Contributes to Immune Activation in People With HIV Control - Mark Mascolini (03/13/24)
       
    203. CROI: Association Between Depressive Symptom Severity and Incident Stroke among People with HIV - (03/13/24)
       
    204. CROI: HIV Clinical Factors and Cardiovascular Disease Risk Predict White Matter Hyperintensity Burden (brain) - (03/13/24)
       
    205. CROI: Assessing Blood-Based Biomarkers as Predictors of Cognitive Decline in PWH: ACTG A5322 (HAILO) - (03/13/24)
       
    206. CROI: Associations between Nadir CD4 and Subsequent Immune Measures with Long-Term Cognitive Function in HAILO (ACTG 5322) - (03/13/24)
       
    207. Latent Profile Analysis of Cognitive Performance and Depressive Symptoms Among People with HIV - (02/26/24)
       
    208. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial - (02/12/24)
       
    209. PTSD is also a common mental disorder among individuals living with HIV/AIDS, 7 Times Greater. HIV itself can be a Traumatic PTSD Event - (02/12/24)
       
    210. Polypharmacy Is Associated With Slow Gait Speed and Recurrent Falls in Older People With HIV- in ACTG HAILO Cohort where average age is only 51 - (02/12/24)
       
    211. Estimating the Use of Potentially Inappropriate Medications Among Older Adults in the United States - (02/05/24)
       
    212. Life expectancy of people with HIV on antiretroviral therapy in Spain: gap of 8.3 & 13.9 years persists in men & women compared to general population - (02/02/24)
       
    213. Real-world use of antiretroviral therapy and risk of cancer among people with HIV in Texas, Commentary - (02/02/24)
       
    214. Sleep Duration & Quality & Cognitive Function (MCI, Alzheimers, Dementia) - (02/02/24)
       
    215. Accelerated Health Declines among African Americans in the USA - (01/28/24)
       
    216. Associations between social determinants of health and co- and multi-morbidity in people of Black ethnicities with HIV - (01/28/24)
       
    217. Higher HbA1c is Associated with Greater Two-Year Progression of White Matter Hyperintensities - (01/28/24)
       
    218. Steps Reduce Belly Fat; couch time increases belly fat - (01/28/24)
       
    219. Sitting Increased CVD, Mortality; 15 Minutes Exercise reduced CVD & Mortality - (01/28/24)
       
    220. Cognitive criteria in HIV: greater consensus is needed - (01/28/24)
       
    221. Unmet needs for HIV ancillary services among persons with diagnosed HIV aged 55 years and older - (01/19/24)
       
    222. Tablet-Based Cognitive Impairment Screening for Adults With HIV Seeking Clinical Care: Observational Study - (01/15/24)
       
    223. Prenatal Social Disadvantage Affects Brain - (01/15/24)
       
    224. Non-AIDS Deaths/Comorbidities Lead Causes of Death for PWH - (01/15/24)
       
    225. PWH Internalizing HIV Stigma, Depression - (01/15/24)
       
    226. Hypertension and one-year risk of all-cause mortality among women (WIHS) with treated HIV in the United States - (01/15/24)
       
    227. Diet & Hypertension/High Blood Pressure for PWH - (01/15/24)
       
    228. Selection of cognitive impairment screening tools for longitudinal implementation in an HIV clinical care setting - (01/15/24)
       
    229. Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013 - (01/15/24)
       
    230. Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure - (01/15/24)
       
    231. Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study - (01/15/24)
       
    232. The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living With HIV - (01/15/24)
       
    233. Cocaine Eats Up Brain Twice as Fast as Normal Aging - (01/08/24)
       
    234. Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019 - (01/08/24)
       
    235. Management and Prevention of CVD in HIV: Where are we in 2023? - (01/02/24)
       
    236. Psychological Trauma and PTSD in HIV-Positive Women: A Meta-Analysis - (12/27/23)
       
    237. High Trauma Rates in PWH-MSM, Women, Drug Users - (12/27/23)
       
    238. High Trauma Rates African-American HIV+ MSM - (12/27/23)
       
    239. HIV Stigma and Health Care Discrimination Experienced by Hispanic or Latino Persons with HIV - United States, 2018-2020 - (12/27/23)
       
    240. Accelerated Health Declines among African Americans in the USA: "weathering" or traumas as we say in HIV - (12/27/23)
       
    241. "6-fold increase in PWH >75 Projected" The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030 - (12/21/23)
       
    242. Frailty screening is Feasible & Recommended by EACS. Implementation of frailty screening for older people living with HIV in Brighton, UK - (12/18/23)
       
    243. Ageism: the -ism affecting the lives of older people living with HIV - (11/29/23)
       
    244. AASLD: MUSCLE FAT INFILTRATION IS ELEVATED IN PREFRAIL AND MODERATELY PHYSICALLY IMPAIRED PATIENTS - INTERIM RESULTS FROM THE PROSPECTIVE MULTI-CENTER CIRRHOSIS COHORT STUDY ACCESS-ESLD - (11/21/23)
       
    245. AGE: High Rate of Metabolic Comorbidities in Young Adults With HIV Acquired Around Birth - (11/16/23)
       
    246. EACS: Despite Very Early ART Inflammation is Reduced But Persists - (11/06/23)
       
    247. EACS: Mental health disorders in people living with HIV - (11/06/23)
       
    248. EACS: Easy Onset Frailty in PWH at UK Silver Clinic; Implementation of Frailty Screening - (11/06/23)
       
    249. EACS: HIV in the elderly is becoming an easily manageable pathology: reality is contradictory. Much More Complex - (11/06/23)
       
    250. AGE: Epigenetic Age Advancement [5.4 years] is Associated with Lower CD4 T-cell Count, Increased Mortality Risk, and Frailty in Older Adults with HIV - (11/03/23)
       
    251. AGE: Immunogenicity of High Dose Flu Vaccine in Aging PWH, Premature Senesence - (11/03/23)
       
    252. AGE: The CD38-NAD+ Axis: A Key Mediator of Inflammaging in HIV Infection: immune exhaustion, age-associated comorbiditied - (11/03/23)
       
    253. AGE: Aging with HIV: social Isolation & Loneliness, Animal Therapy Intervention - (11/02/23)
       
    254. AGE: CNS complications in people aging with HIV - (11/02/23)
       
    255. AGE: Session 5: Lightning Poster Presentations - (11/02/23)
       
    256. AGE: Plasma proteomic signatures capture unique cardiovascular risk phenotypes among persons living with and without HIV in the United States: Plasma Proteome [biomarkers] Offers Insights Beyond Traditional CVD Risk Factors - Reported by Mark Mascolini for NATAP and Academic Medical Education(11/02/23)
       
    257. AGE: Clustering Frailty Components May Enable Sharper Comorbidity Insights - (11/02/23)
       
    258. AGE: Multifactorial Risk Factors for Cognitive Impairment - (11/02/23)
       
    259. AGE: Cognitive Frailty in People Living With HIV and Its Association With Geriatric Syndromes - (11/02/23)
       
    260. AGE: Session 2: Sarcopenia and Frailty Prevention & Treatment - (11/02/23)
       
    261. AGE: Underlying Mechanisms of Asymptomatic Neurocognitive Impairment - (11/01/23)
       
    262. AGE: Emotional, Not Social, Loneliness Is Related to Objective Cognitive Function in Older People With HIV - (11/01/23)
       
    263. AGE: 2 Oral Talks - PLWH: Sarcopenia, Mitochondrial Function - (11/01/23)
       
    264. AGE: Underlying Mechanisms of Asymptomatic Neurocognitive Impairment - (11/01/23)
       
    265. AGE: Emotional, Not Social, Loneliness Is Related to Objective Cognitive Function in Older People With HIV - (11/01/23)
       
    266. AGE: HIV Smoking Quitters Older and Have More Comorbidities Than Current Smokers - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/31/23)
       
    267. AGE: Switching to a Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed, Treatment-Experienced People with HIV (PWH) ≥ 65 Years Old - (10/31/23)
       
    268. AGE: Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV - (10/31/23)
       
    269. AGE: An integrated HIV-Geriatric Clinic Model: Lessons from Newlands Clinic, Harare Zimbabwe - (10/31/23)
       
    270. AGE: PWH Have Higher depression Rates Than People without HIV: Some Depressive Symptoms Wane With Age in HIV Group-Some Do Not - (10/31/23)
       
    271. AGE: Emotional (but not Social) Loneliness Tied to Cognition in Older People With HIV - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    272. AGE: Implementation of a multidisciplinary approach to care for people living with HIV aged over 80 years - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    273. AGE: Global Survey: "62% in low and middle income & 29% in high income countries are mostly unaware for developing health complications as they get older" - (10/30/23)
       
    274. AGE: Cognitive Function Fell in 25% of Canadian HIV Group Over 10 Years - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    275. AGE: Long-term effect of dolutegravir use on more depressive symptoms among older people with HIV - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    276. AGE: Cognitive Frailty Threatens People With HIV at a Younger Age - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    277. AGE: Older Age, More Comorbidities Mean Lower Chance of ART With Medicare - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    278. AGE: Prefrail or frail older people with HIV live in more disadvantaged areas than older HIV-positive nonfrail people - Reported by Mark Mascolini for Academic Medical Education and NATAP (10/30/23)
       
    279. AGE: High Rate of Metabolic Comorbidities in Young Adults With HIV Acquired Around Birth - Reported by Mark Mascolini for Academic Medical Education and NATAP (10/30/23)
       
    280. AGE: Aging, Comorbidities, Frailty, Polypharmacy for PLWH > 80 Years at Chelsea Westminster London HIV Clinic - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
       
    281. AGE: HIV in the Brain & Cognitive Impairment: Despite Viral Suppression [blood brain permeability] women with HIV have double stroke risk & non-Hispanic African-Americans have 3.5 higher stroke incidence - the 6Ms for managing PLWH in the clinic; neurotoxicity of ARTs - (10/30/23)
       
    282. EACS: In 70 and Older HIV Group, Frailty Worsens in Some, Improves in Others - Mark Mascolini (10/26/23)
       
    283. EACS: Classic Fracture Risk Factors May Need Replacing in Older People With HIV - Mark Mascolini (10/26/23)
       
    284. EACS: Weight gain and loss and stable weight in relation to fat and lean mass in PWH - (10/26/23)
       
    285. EACS: Early and Durable Reductions in Soluble CD14 Concentrations Among Treatment-Experienced Persons With HIV-1 Through 96 Weeks of Fostemsavir Treatment in a Phase 2b Clinical Trial - (10/26/23)
       
    286. EACS: Bictegravir alters glucose tolerance and metabolism - (10/26/23)
       
    287. EACS: Persistent Low-Level Viremia May Increase Risk of Cardiovascular Disorders in PWH - (10/26/23)
       
    288. EACS: Lessons from the Swiss Cohort study: Metabolic and cardiovascular co-morbidities among people living with HIV - (10/26/23)
       
    289. EACS Estimated risk of all-cause mortality [higher] and cardiovascular events in a cohort of women living with HIV and socio-demographically similar HIV-negative controls ≥40 years old - (10/22/23)
       
    290. EACS Evolution of cancers risk in PWH over 20 years and risks when immunity is restored and viral load is controlled Results from the ANRS CO4 FHDH cohort - (10/22/23)
       
    291. EACS Frailty and Quality of Life for People with HIV in Cyprus: re-visiting the cascade of care: 70% Prefrail/frail at median age 41; 44% anxiety/depression - (10/22/23)
       
    292. EACS Cognitive frailty in people living with HIV and its association with geriatric syndromes - (10/22/23)
       
    293. EACS PREDICTORS OF QUALITY OF LIFE AMONG OLDER PEOPLE LIVING WITH HIV IN KAMPALA, UGANDA: assessmemt & mgt of frailty, low physical function, malnutrition & depression could improve QOL - (10/22/23)
       
    294. EACS Uganda Elderly HIV+ Women Needs - (10/22/23)
       
    295. BMI vs body composition changes to predict metabolic outcomes in people with HIV - (10/22/23)
       
    296. EACS LDL-c target achievement in people living with HIV according to individual cardiovascular risk: a retrospective single center observational study - (10/22/23)
       
    297. EACS Suicide Mortality Trends and Predictors in the PISICS Cohort of People Living with HIV in Catalonia and the Balearic Islands, Spain; PWH >50 have highest rates - (10/22/23)
       
    298. EACS Evolving trends in mortality patterns and predictors among people living with HIV in Catalonia and the Balearic Islands (Spain), 1998-2020: a multisite cohort study - Comorbidities ! - (10/22/23)
       
    299. EACS Evolution of causes of death in people living with HIV: a retrospective single center observational study - CVD & Lung Cancer leading causes of death; 80% due to Comoridites - (10/22/23)
       
    300. EACS Immunological and inflammatory profile of cerebrospinal fluid (CSF) and plasma of people living with HIV (PLWH) with or without Central Nervous System (CNS) involvement - (10/22/23)
       
    301. EACS Subclinical coronary artery disease in persons living with HIV and uninfected controls: PWH at 2-3 fold higher risk - (10/22/23)
       
    302. EACS NEW RISK FACTORS FOR FRAGILITY FRACTURES MUST BE CONSIDERED IN OLDER ADULTS WITH HIV - (10/22/23)
       
    303. EACS Neurocognitve impairment & Anxiety Symptoms May Influence The Development of Prefrailty/Frailty in Japanese PLW Aged Over 40 Years 70% PreFrailty - (10/22/23)
       
    304. Exploring implementation considerations for geriatric-HIV clinics: A secondary analysis from a scoping review on HIV models of geriatric care - (10/09/23)
       
    305. Integrating HIV, hypertension, and diabetes primary care in Africa - (10/09/23)
       
    306. Diabetes, Lipids, Heart Disease: Weight gain after antiretroviral therapy initiation and subsequent risk of metabolic and cardiovascular disease - (10/04/23)
       
    307. Weight gain after antiretroviral therapy initiation and subsequent risk of metabolic and cardiovascular disease - (10/02/23)
       
    308. Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer - (09/28/23)
       
    309. Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers - (09/28/23)
       
    310. Updated mortality and causes of death in 2020-2021 in people with HIV: a multicenter study in France - (09/28/23)
       
    311. NIH OAR Aging/HIV Virtual Meeting: HIV and Aging Research: Current Landscape and Opportunities, Sept 5 2023 - (09/24/23)
       
    312. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection - (09/24/23)
       
    313. Reversal of epigenetic aging and immunosenescent trends in humans - (09/19/23)
       
    314. Aging Begins at Time of HIV Infection, Frailty in PWH - (09/13/23)
       
    315. Age Exacerbates HIV-Associated White Matter Abnormalities - (09/12/23)
       
    316. The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030 - (09/12/23)
       
    317. Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages - (09/12/23)
       
    318. White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy - (09/12/23)
       
    319. The importance of exercise and physical activity in older adults with HIV, editorial to 'prevent accelerated aging' - (09/12/23)
       
    320. Physical activity [steps] is associated with adiposity in older adults with HIV in the modern HIV era - (09/12/23)
       
    321. The incidence and dynamic risk factors of chronic kidney disease among people with HIV - (09/12/23)
       
    322. Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study - (08/29/23)
       
    323. FDA: Colchicine (marketed as Colcrys) Information - (08/27/23)
       
    324. Colchicine in Patients with Chronic Coronary Disease - (08/27/23)
       
    325. FDA Product Insert LODOCO (colchicine) tablets, for oral use - (08/27/23)
       
    326. IAS: Fostering cognitive and mental health in people aging and living with HIV while prioritizing the community and lived experience perspectives - (08/18/23)
       
    327. IAS: 6 Key Aging/ HIV Messages at IAS 2023 - (08/08/23)
       
    328. IAS: Integrating hepatitis C services into ART clinics in low and middle income countries (LMICs) as an approach toward hepatitis C micro-elimination: pilot experience in Nigeria - (08/07/23)
       
    329. IAS: Prevalence and risk factors for renal insufficiency among adults living with HIV in Tanzania: results from a cross-sectional study - (08/04/23)
       
    330. IAS: Sleep Disorder 25% More Likely With Than Without HIV - Mark Mascolini (08/03/23)
       
    331. IAS: Under 2% of San Franciscans With HIV Have All 5 CVD Risk Factors Controlled - Mark Mascolini (08/03/23)
       
    332. IAS: Frailty Worsens in 25% of 50-and-Older Thai HIV Group-But Improves in Many-Through 5 Years - Mark Mascolini (08/03/23)
       
    333. IAS: AGEING WITH HIV (IAS Plenary): Prioritizing person-centred care - (08/02/23)
       
    334. IAS: Gut dysfunction as an independent driver of neuroinflammation in ART-suppressed SIV - (08/02/23)
       
    335. IAS: Aging of brain network connectivity corresponds to cognitive impairment in persons with HIV - (08/02/23)
       
    336. IAS: Selected comorbidities and the risk of ART switch in the context of HIV-RNA suppressed to ≤50 copies/mL - (08/02/23)
       
    337. IAS: Vitamin D and calcium intake are associated with bone deficits among adolescents living with HIV in Zambia and Zimbabwe: low bone density higher among HIV+ (10% v 6%) - (08/02/23)
       
    338. IAS: Stigma and poor mental wellbeing: A global community approach to identifying and addressing common barriers to living well with HIV - Gilead Community Board Selects Barriers to Living Well with HIV - (08/02/23)
       
    339. IAS: Disability in people living with HIV (PLWH) in Asia: a prospective multi-centre case-control study: PWH had higher rates of frailty (6.8% v 1.3%), anxiety, stress, polypharmacy (14.7% v 7%), worse mood - men avg age 53+/-10 - (08/02/23)
       
    340. IAS: Frailty Worsens in 25% of 50-and-Older Thai HIV Group-But Improves in Many-Through 5 Years - Mark Mascolini (08/02/23)
       
    341. IAS: Sedative drug burden is associated with concurrent physical frailty in people aging with HIV in Canada: findings from the Positive Brain Health Now Study (+BHN) - (08/02/23)
       
    342. IAS: Association between non-alcohol steatohepatitis with significant activity and fibrosis and neurocognitive impairment in people with HIV - (08/02/23)
       
    343. IAS: Impact of GLP-1 receptor agonists on body weight in patients with type 2 diabetes and HIV - (07/29/23)
       
    344. IAS: Integrase strand inhibitors (INSTI) related changes in BMI and risk of diabetes - (07/29/23)
       
    345. IAS: Lifestyle Program Yields Modest CVD Benefits in HIV+ South African Women - Mark Mascolini (07/29/23)
       
    346. IAS: Persistent accelerated epigenetic aging is associated with altered neuroimaging and immune biomarkers in a longitudinal cohort of vertically-acquired HIV-positive adolescents - (07/26/23)
       
    347. IAS: Each Higher Sedative Burden Unit Boosts Odds of Physical Frailty With HIV 35% - Mark Mascolini - (07/24/23)
       
    348. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020 - (07/19/23)
       
    349. U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease - Colchicine 0.5 mg: Efficacy in Chronic Coronary Disease; Kidney Progression Risk Studies - (07/18/23)
       
    350. Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients - (07/10/23)
       
    351. Study Links viral infections to Alzheimer, Parkinsons - with many caveats - (06/14/23)
       
    352. Does shingles vaccination cut dementia risk? Large study hints at a link - (06/14/23)
       
    353. PWH had a higher prevalence of AD (alzheimers)/ADRD. PWH had a higher burden of dementia - (06/05/23)
       
    354. Impact of Multiple Social Determinants of Health on Incident Stroke - (06/05/23)
       
    355. Stroke Incidence among White, Black, and Hispanic Residents of an Urban Community - (06/05/23)
       
    356. Daily statin medication was found to reduce the risk of cardiovascular disease by 35% among people living with HIV; substantial CVD risk in Young PWH - REPRIEVE Study - (06/05/23)
       
    357. Antiretroviral Therapy Intensification for Neurocognitive Impairment in HIV - (05/25/23)
       
    358. CVD After Switch to DTG Reassuring Editorial Comment - Reassuring data for cardiovascular health after switching a boosted protease inhibitor to dolutegravir - (05/25/23)
       
    359. Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank - (05/25/23)
       
    360. New NYS Clinical Guidance: Addressing the Needs of Older Patients in HIV Care - (05/11/23)
       
    361. Association of Perceived Social Support with Viral Suppression Among Young Adults with Perinatally-Acquired HIV in the US-based Pediatric HIV/AIDS Cohort Study (PHACS) - (05/09/23)
       
    362. Results of a Multi-Disciplinary Approach Involving Geriatricians of a Clinic for Older People Living with HIV - (05/09/23)
       
    363. Evaluation of a Clinic Dedicated to People Aging with HIV at Chelsea and Westminster Hospital: Results of a 10-Year Experience - (05/09/23)
       
    364. Evaluation of a Combined HIV and Geriatrics Clinic
      for Older People Living with HIV: The Silver Clinic in Brighton, UK       - (05/09/23)
       
    365. - (05/09/23)
       
    366. New NYS HIV Aging Assessment Guidelines - (05/08/23)
       
    367. R.S.V. Vaccine Approved for Older Adults - (05/05/23)
       
    368. PWH Suffer Increasing Depression & Anxiety with Age/Disease Duration - (05/02/23)
       
    369. Dementias among older males and females in the U.S. Medicare system with and without HIV - (04/29/23)
       
    370. AGING DOES NOT IMPACT DRUG-DRUG INTERACTION MAGNITUDES INVOLVING ANTIRETROVIRAL DRUGS - (04/26/23)
       
    371. GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV - (04/26/23)
       
    372. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients - (04/21/23)
       
    373. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients - (04/21/23)
       
    374. Why we need to re-define long-term success for people living with HIV - (04/21/23)
       
    375. Cancer Treatment in Patients With HIV Infection and Non-AIDS-Defining Cancers: A Survey of US Oncologists - (04/21/23)
       
    376. Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIV - (04/19/23)
       
    377. Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV - (04/19/23)
       
    378. People living with HIV at substantially higher risk of depression and suicide, especially in first 2 years after diagnosis - (04/18/23)
       
    379. Rates and risk factors for suicidal ideation, suicide attempts and suicide deaths in persons with HIV: a systematic review and meta-analysis - (04/18/23)
       
    380. Birth of HIV & Aging Clinics in SF by Meredith Greene, MD Started in 2012 with 1st Geriatric Assessment Study at UCSF Ward 86. - (04/14/23)
       
    381. PLWH and Nursing Homes Report 5 Publications on Nursing Homes & PLWH - (04/13/23)
       
    382. Premature Menopause & HRT, Alzheimers - Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography - (04/10/23)
       
    383. Trends in mortality in people living with HIV in an
      international cohort (RESPOND): comorbidities, cancer, CD4/viral load       - (04/10/23)
       
    384. Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV - (04/09/23)
       
    385. SPATIAL PROFILING OF CORONARY PLAQUE SUGGESTS UNIQUE IMMUNE PATHWAYS IN HIV, HIV Found in Coronary Arteries of Deceased PWH - (04/03/23)
       
    386. CROI: SARCOPENIA, FRAILTY, NUTRITION AND HCV INFECTION AMONG OLDER PEOPLE WITH HIV - (03/29/23)
       
    387. CROI: Psychiatric Symptoms In PLHIV: Prevalences, Interactions And Consequences - here are slides in Themed Discussion & poster. - (03/27/23)
       
    388. CROI: THE SCIENCE OF AGING: LESSONS FOR HIV AT THE INTERFACE OF COMMONALITY AND HETEROGENEITY, George Kuchel - (03/27/23)
       
    389. CROI: COMPLICATIONS Oral Abstract Session-06 at CROI 2023 - (03/27/23)
       
    390. CROI: Weight Gain: Does what Goes Up Come Down ? Themed Discussion - (03/27/23)
       
    391. CROI: Any Level of Detectable Viremia is Associated with Serious Non-AIDS Events - (03/20/23)
       
    392. CROI: Changes in Body Mass Index with Longer-Term Integrase Inhibitor Use in REPRIEVE - (03/20/23)
       
    393. CROI: PSYCHIATRIC DISORDERS IN HIV EXPOSED UNINFECTED - VERSUS NON-HIV EXPOSED CHILDREN - (03/20/23)
       
    394. CROI: HIV EXPOSED UNINFECTED (HEU) INFANTS DISPLAY UNIQUE PRO-INFLAMMATORY BIOPROFILES - (03/20/23)
       
    395. CROI: Any Level of Detectable Viremia is Associated with Serious Non-AIDS Events - (03/20/23)
       
    396. CROI: Academic Performance Among Children with Perinatal HIV Exposure in Botswana - (03/20/23)
       
    397. CROI: PREGNANCY HORMONAL DYSREGULATION CORRELATES WITH HIV-EXPOSED INFANT GROWTH OUTCOMES - (03/20/23)
       
    398. CROI: Effect of in-utero HIV and ART exposure on growth during infancy - (03/20/23)
       
    399. CROI: CMV IgG is Associated with Muscle Function but not Quality or Mass in People with HIV - (03/20/23)
       
    400. CROI: Risk factors for liver fibrosis progression in HIV: a multi-center longitudinal study - (03/16/23)
       
    401. CROI: SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC-FATTY LIVER DISEASE - (03/16/23)
       
    402. CROI: A 12-WEEK MULTICOMPONENT EXERCISE PROGRAM REVERSES FRAILTY IN OLDER ADULTS WITH HIV - (03/16/23)
       
    403. CROI: Any level of detectable viremia is associated with serious non-AIDS events Even Low-Level Viral Load Inflates Risk of Serious Non-AIDS Illness - Mark Mascolini (03/16/23)
       
    404. CROI: Brain Aging Gap was significantly elevated in PWH compared to PWoH (p=0.001). - (03/16/23)
       
    405. CROI: RACIAL AND HIV DISPARITIES IN HYPERTENSION CASCADE AMONG WOMEN - (03/14/23)
       
    406. CROI: The BONDY Study: Bone density in youth living with perinatally acquired HIV - (03/14/23)
       
    407. CROI: Metabolic Health and bone density in youth living with perinatal HIV - (03/14/23)
       
    408. Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial - (03/13/23)
       
    409. CROI: Telomere Length in Aviremic PWH: How Different is it from Persons Without HIV? - (03/07/23)
       
    410. CROI: PWH Had Worse Depression Scores than PWoH & IL-r in Men Associated with Depression - (03/07/23)
       
    411. CROI: Worse Brain Aging in PWH: factors - CVD, Social Determinants, HCV, Viral Load, Unemployment - (03/07/23)
       
    412. CROI: Merck's MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study - (03/07/23)
       
    413. CROI: PERICORONARY ADIPOSE TISSUE DENSITY AND SUBCLINICAL CORONARY ARTERY DISEASE IN HIV - (03/07/23)
       
    414. CROI: INFUSION OF CCR5 GENE-MODIFIED T CELLS PROVIDES LONG-TERM HIV CONTROL - (03/07/23)
       
    415. CROI: VASCULAR AGE AND COGNITIVE OUTCOMES IN AN ACUTE HIV COHORT AFTER 5.5 YEARS OF ART - (03/05/23)
       
    416. CROI: Non-AIDS Defining Malignancy Mortality In People Living With HIV; CD4 is biggest risk factor, next is smoking - (03/05/23)
       
    417. CROI: Incidence of cancer among Medicaid beneficiaries with and without HIV: 2001-2015, PLWH have higher risks for certain cancers - (03/05/23)
       
    418. CROI: Effects of eplerenone on myocardial perfusion and function: the Miracle HIV study: May Stall Worsening Subclinical Heart Disease With HIV - Mark Mascolini (03/05/23)
       
    419. CROI: Non-AIDS Cancer Risk Varies by Age in Medicaid Group With vs Without HIV - Mark Mascolini (03/03/23)
       
    420. CROI: Screening approaches and clinical description of the anticholinergic burden & Symptoms in people with HIV - (03/02/23)
       
    421. CROI: MUSCLE QUALITY IS ASSOCIATED WITH CORONARY ARTERY PLAQUE AND PHYSICAL FUNCTION IN PEOPLE WITH HIV - (03/02/23)
       
    422. CROI: CMV IgG is Associated with Muscle Function but not Quality or Mass in People with HIV - (03/02/23)
       
    423. CROI: EFFECT OF COMMON ANTIRETROVIRAL COMBINATIONS ON DEPRESSIVE SYMPTOMS IN WOMEN WITH HIV 2nd report - (03/02/23)
       
    424. CROI: (NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION BETWEEN HIV AND DEPRESSION - (03/02/23)
       
    425. CROI: Screening approaches and clinical description of the anticholinergic burden & Symptoms in people with HIV, Polypharmacy - (03/02/23)
       
    426. CROI: Screening approaches and clinical description of the anticholinergic burden in people with HIV - (03/02/23)
       
    427. CROI: Sleep disturbances are associated with cognitive function in women living with HIV - (03/01/23)
       
    428. CROI: VISCERAL FAT REDUCTION WITH TESAMORELIN ASSOCIATED WITH METABOLIC SYNDROME REVERSAL - (03/01/23)
       
    429. CROI: Subcutaneous Adipose Tissue Cell Composition is Associated with Visceral Fat Volume - (03/01/23)
       
    430. CROI: Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in HIV - (03/01/23)
       
    431. CROI: Four Distinct Biopsychosocial Phenotypes in HIV in the CHARTER Cohort-and Why They Matter - Mark Mascolini (03/01/23)
       
    432. CROI: Cocaine Tied to White Matter Lesions With HIV, a Factor in Poor Cognitive Function - Mark Mascolini (02/25/23)
       
    433. CROI: Rates of Key Death Causes With HIV Falling in Europe/America. Deaths Due to Comorbidities - Mark Mascolini - (02/25/23)
       
    434. CROI: Depression or Anxiety Linked to Type 1 or 2 MI in US People With HIV - Mark Mascolini - (02/25/23)
       
    435. CROI: Effects of eplerenone on myocardial perfusion and function [subclinical heart disease]: the Miracle HIV study....."may prevent worsening of subclinical heart disease in HIV" - Mark Mascolini - (02/25/23)
       
    436. CROI: New Heart Disease Rate Similar With Integrase Inhibitors and Other First ART - Mark Mascolini (02/25/23)
       
    437. CROI: Good Rectal TAF/EVG Levels With Rectal Inserts in HIV-Negative Men and Women - Mark Mascolini (02/25/23)
       
    438. CROI: Long-Acting CAB for PrEP Acceptable, Safe in Adolescent Female Africans - Mark Mascolini- (02/25/23)
       
    439. CROI: Long-Acting Lenacapavir in a Combination Regimen for Treatment Naïve PWH: Week 80 - (02/25/23)
       
    440. CROI: Comparison of Telomere Length Changes Over 48 Weeks in SALSA Study: DTG/3TC vs CAR - (02/21/23)
       
    441. CROI: Mortality 1 Year After ICU Admission Falls Over 20 Years in HIV Group - Mark Mascolini (02/20/23)
       
    442. CROI: Trends in mortality in people living with HIV in an international cohort (RESPOND). - Mark Mascolini (02/20/23)
       
    443. Aging & Disproportionate disability in people with HIV - (02/20/23)
       
    444. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study - (02/19/23)
       
    445. Alzheimers Blood Markers - Plasma Aβ42/Aβ40 Ratios in Older People Living With Human Immunodeficiency Virus - (02/19/23)
       
    446. IAS Recorded Feb 7 webinar - Growing older with HIV in the Treat-All Era - (02/09/23)
       
    447. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US - (02/03/23)
       
    448. Only 36% (1507 of 4171) received any ART regimen during an average of 11.6months in Nursing Homes in USA - (02/02/23)
       
    449. US FDA accepts supplemental New Drug Application for Jardiance® for adults with chronic kidney disease - (02/02/23)
       
    450. Sex and Race Disparities in Mortality and Years of Potential Life Lost Among People With HIV: A 21-Year Observational Cohort Study - (02/02/23)
       
    451. "no safe amount of alcohol consumption for cancers and health can be established" - (01/30/23)
       
    452. No level of alcohol consumption is safe for our health - (01/30/23)
       
    453. Antisense Reduced LPa by 35% to 72% - (01/30/23)
       
    454. The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging - (01/25/23)
       
    455. Atazanavir Induced Senesence in Mice But Not Darunavir - (01/25/23)
       
    456. Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study - (01/25/23)
       
    457. Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial - (01/25/23)
       
    458. Diabetic Kidney Disease, HIV, Women - (01/24/23)
       
    459. Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated metaanalysis - (01/24/23)
       
    460. NYS Aging HIV RFP May 2022 - People Aging with HIV (PAWH) - (01/24/23)
       
    461. Exercise Reduced Heart Attacks & All-Cause Mortality - (01/24/23)
       
    462. kidney disease increases 4-fold in NYC Clinic from <50 to > 75 from 7% to 31%; high Rates Mental & physical of Comorbidities at large NYC HIV clinic - (01/23/23)
       
    463. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020: doubling & tripling - (01/23/23)
       
    464. Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort - (01/23/23)
       
    465. The prevalence of mental health disorders (55% and increasing) in people with HIV and the effects on the HIV care continuun - (01/23/23)
       
    466. New Anti-Aging Drugs Senolytics & Mitochondria/Aging HIV, Brain/diabetes, Muscles - (01/13/23)
       
    467. Lecanemab in Early Alzheimer's Disease - (01/07/23)
       
    468. FDA Grants Accelerated Approval for Alzheimer's Disease Treatment FDA NEWS RELEASE - (01/07/23)
       
    469.  "We can hardly even do it nowadays. So, what's going to happen in 5 years from now, 10 years from now?" The health and community care and support needs and preferences of older people living with HIV in Ontario, Canada: a qualitative study - (01/02/23)
       
    470.  Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - (01/02/23)
       
    471. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - (01/02/23)
       
    472.  SGLT2 Reduced Death, Improved Kidney In Patients with Kidney Disease - Dapagliflozin in Patients with Chronic Kidney Disease - (01/02/23)
       
    473. SGLT2 Improve Kidney Function - Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials - (01/02/23)
       
    474. Empagliflozin in Patients with Chronic Kidney Disease - SGLT2 Empagliflozin Slows Kidney Disease - (01/02/23)
       
    475.  Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications   - (01/02/23)
       
    476. SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review   - (01/02/23)
       
    477. NYS AIDS Institute Aging & HIV 2022 - (12/14/22)
       
    478. My Brain Fog; What is Brain Fog ? - (12/14/22)
       
    479. Depression and Sexual Stigma Are Associated With Cardiometabolic Risk Among Sexual and Gender Minorities Living With HIV in Nigeria - (12/12/22)
       
    480. Physician Reimbursement and Retention in HIV Care: Racial Disparities in the US South - (12/12/22)
       
    481. CROI-2016 - Neurotoxicity Screening of Antiretroviral Drugs With Human iPSC-Derived Neurons - (12/12/22)
       
    482. 20 Minutes Daily exercise at age 70 may reduce heart disease risk - (12/12/22)
       
    483. New HIV Guidelines IAS-USA Panel; Aging, Weight - (12/01/22)
       
    484. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens - (12/01/22)
       
    485. Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks - (12/01/22)
       
    486. Elderly & Older PLWH Need New Standard of Care in Clinic & Support Social Services - (11/28/22)
       
    487. The HIV healthcare system has ignored Aging Issues That Are Coming Back to Haunt Elderly PLWH Who Have Been Abandoned - (11/28/22)
       
    488. NYS People Aging with HIV (PAWH) Pilot (NYC too) - (11/21/22)
       
    489. Food Insecurity Is Associated with Key Functional Limitations and Depressive Symptoms in Older People Living with HIV - (11/15/22)
       
    490. Press Release: Older people living with HIV cannot be ignored and must NOT be left behind - (11/14/22)
       
    491. Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease - (11/10/22)
       
    492. ID Week: Screening for Hepatitis C as Part of an Opioid Stewardship Initiative: Identifying Infected Patients and Analyzing Linkage to Care - (10/26/22)
       
    493. ID Week: 76% >50 PLWH Report Suboptimal Mental, Physical Health- Clinical and Sociodemographic Characteristics Associated With Poor Self-rated Health Across Multiple Domains Among Older North American Adults Living With HIV - (10/23/22)
       
    494. AGE: Brief Summary, Highlights- 13th Intl Aging & HIV Workshop - (10/20/22)
       
    495. AGE: Brief Evaluation of Cognitive Impairment and IADL Among Art-Treated People With HIV in a Primary Care Setting - (10/19/22)
       
    496. AGE: Frontostriatal white matter microstructure alterations in HIV and aging - (10/19/22)
       
    497. AGE: TENOFOVIR ALAFENAMIDE IS ASSOCIATED WITH SHORTER TELOMERE LENGTH IN PEOPLE WITH HIV - (10/18/22)
       
    498. AGE: "CD38 is a potential therapeutic target for mitigating chronic inflammation that likely drives cellular aging, comorbidities, and end organ disease in PWH." - (10/18/22)
       
    499. AGE: Persistent CD38 expression on CD8+ T lymphocytes contributes to chronic inflammation in people with HIV, despite ART - (10/18/22)
       
    500. AGE: Glucose Changes Among Aging Female PWH in Southeast United States - (10/18/22)
       
    501. AGE: Aging Accelerates Brain Metabolic Abnormalities in HIV Clade-C Infected Young Adults - (10/18/22)
       
    502. AGE: DTI and DKI Markers of Brain Microstructural Integrity Show Similar Aging Between HIV Clade-C Infected and Healthy Young Adults - (10/18/22)
       
    503. AGE: Prevalence of Anal Human Papillomavirus and High-Grade Squamous Intraepithelial Lesions Among Men Who Have Sex With Men Ages 50+ - (10/18/22)
       
    504. AGE: Non-White & Low Income HIV+ Women Take Less Vitamin D: Rates of Vitamin D Supplementation and Barriers to Uptake Among Women Living with and Without HIV In Canada - (10/18/22)
       
    505. AGE: Comparing a Novel Virtual Reality Assessment Device, DETECT, to Best-Practices in Assessing HIV-Associated Cognitive Impairment and Mild Cognitive Impairment - (10/18/22)
       
    506. AGE: Post COVID Frailty Reversible: Frailty transitions in people with post-acute COVID syndrome - (10/18/22)
       
    507. AGE: Mortality among adult PLHIV in all PEPFAR-supported countries and regions-, October 2019-June 2022 - (10/17/22)
       
    508. AGE: Aging/HIV: Early interruptions in treatment among PLHIV over 50 years of age starting antiretroviral therapy in PEPFAR-supported low and middle-income countries - (10/17/22)
       
    509. AGE: Social support network factors linked to neuropsychological-verbal performance among disadvantaged persons living with HIV who use drugs - (10/17/22)
       
    510. AGE: Aging and HIV: What Is the Gap Between Clinical Practice and Guideline Recommendations? In Europe - (10/17/22)
       
    511. AGE: Prevalence of Geriatric Syndromes, Frailty and Comorbidities and their Association with Quality of Life in Older Adults with HIV in the Spanish FUNCFRAIL Cohort. - (10/17/22)
       
    512. AGE: Needs and Involvement of HIV Specialists and Geriatricians in the Care of Older Adults with HIV - A National Survey - (10/17/22)
       
    513. AGE: e-SMART/EST Telehealth Intervention to Reduce Depression in Older Women with HIV - (10/17/22)
       
    514. AGE: An Exploration of the Role of Intersectional Stigma and Discrimination on Cardiovascular Risk, among Aging Women with HIV - (10/17/22)
       
    515. AGE: New York State AIDS Institute Initiatives to Improve Care For Older People With HIV and Long-Term Survivors: An Example of a Government-Academic-Community Partnership - (10/17/22)
       
    516. AGE: Exploring Experiences Engaging in Exercise from the Perspectives of Women Living with HIV: a Qualitative Study - Barriers, Challenges - (10/17/22)
       
    517. AGE: Hormonal Intervention Combined with Allopregnanolone Alleviates Premature Age-Related Comorbidities in Female Mice Exposed to Ovarian Failure and HIV-1 Tat - (10/17/22)
       
    518. AGE: Physical frailty among older HIV-positive and HIV-negative women in Mombasa, Kenya: A cross-sectional study - (10/17/22)
       
    519. AGE: 50% Frail or Pre-Frail in Uganda: Risk Factors for Frailty in a Geriatric Cohort on Long Term Antiretroviral Treatment in Uganda - (10/17/22)
       
    520. AGE: Frailty & Hospitalization Associated at Kaiser - Evaluation of an electronic health record-based frailty index in people with and without HIV in a primary care setting - (10/17/22)
       
    521. AGE: Frailty and physical performance assessments as part of a comprehensive geriatric care model in an urban HIV clinic: 73% Pre-frail or Frail 50% Weak - (10/17/22)
       
    522. AGE: Physical Functioning in Older Adults with HIV - 80% Impaired Physical Function in Baltimore Clinic SPBB & IADL Measured - (10/17/22)
       
    523. AGE: Gaps in HIV Care Cascade for Older South Africans Raise Concern - Mark Mascolini - (10/15/22)
       
    524. AGE: Clinical Care Priorities and Service Needs Among People Aging with HIV in the Bronx, NY - (10/15/22)
       
    525. AGE: Assessing the Impact of HIV Status and Menstrual Abnormalities on Longitudinal Bone Density Loss in Women Living With and Without HIV - (10/15/22)
       
    526. AGE: Overlap Between Cognitive and Physical Frailty in Persons with HIV - (10/15/22)
       
    527. AGE: Aging, HAND & Alzheimers -Alzheimers pathology?? - (10/15/22)
       
    528. AGE: Increasing Neuroinflammation in People With HIV Tied to Worse Neurodegeneration - Mark Mascolini - (10/15/22)
       
    529. AGE: More Than Half of Kampala ART Responders Are Prefrail or Frail - Mark Mascolini - (10/15/22)
       
    530. AGE: Use of Senolytics: Anti-Aging Drugs; in PLWH Study - (10/14/22)
       
    531. AGE: Three Quarters of Spanish Geriatricians Uncomfortable With HIV Patients - Mark Mascolini - (10/14/22)
       
    532. AGE: Survey in Italy Finds Lack of Special Care for Elderly With HIV - Mark Mascolini - (10/14/22)
       
    533. AGE: Polypharmacy, Anxiety, Low Cognitive Score Tied to Frailty With HIV - Mark Mascolini - (10/14/22)
       
    534. AGE: NRTIs Do Not Protect Against Alzheimer-Type Amyloidosis - Mark Mascolini - (10/14/22)
       
    535. AGE: Critical Physical Function Loss in Three Quarters of Over-50 HIV Group - Mark Mascolini - (10/14/22)
       
    536. AGE: Lower Verbal Fluency Tied to Poor Social Support in HIV+ Drug Users - Mark Mascolini - (10/13/22)
       
    537. AGE: Standard Integrase Regimens Have Minimal Glucose Impact in Older Black Women - Mark Mascolini - (10/13/22)
       
    538. AGE: Frailty Rate Falls Over Time During Postacute COVID Syndrome - Mark Mascolini - (10/13/22)
       
    539. AGE: Heart Disease, HCV, Poverty, Early-Life Stress Tied to Brain Aging With HIV - Mark Mascolini - (10/13/22)
       
    540. AGE: Depression Tied to Noncommunicable Disease Rate in People With HIV - Mark Mascolini - (10/13/22)
       
    541. AGE: Hyperactivated CD8 Cells Higher With HIV and May Drive Chronic Inflammation - Mark Mascolini - (10/13/22)
       
    542. AGE: People Over 50 Face High Risk of ART Suspension in First Months: PEPFAR - Mark Mascolini - (10/13/22)
       
    543. Weightlifting & Aerobics Reduce Mortality Independently, Together Better - (10/11/22)
       
    544. What It Means to Age With HIV Infection Years Gained Are Not Comorbidity Free - (10/11/22)
       
    545. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study - (10/11/22)
       
    546. Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics - (10/06/22)
       
    547. Provision of HIV pre-exposure prophylaxis to female patients seeking family planning services in the United States - (10/06/22)
       
    548. HIV and Cardiac End-Organ Damage in Women: Findings from an Echocardiographic Study Across the United States - (10/06/22)
       
    549. Earlier menopause is associated with higher risk of incident frailty in community-dwelling older women in England - (10/03/22)
       
    550. Exciting New Alzheimer's Treatment Study Results - (09/28/22)
       
    551. Brain Decline & Frailty in PLWH - (09/28/22)
       
    552. Unraveling the mechanisms of HIV-induced hearing loss - (09/27/22)
       
    553. Dementia Care, Screening Awareness Needs Attention. PLWH are at Risk - World Alzheimers Report - (09/22/22)
       
    554. Aging in PLWH Increased Heart Attack Risk by 30% per Decade/BUT by 85% if HCV+ - (09/22/22)
       
    555. The Impact of Frailty on All-Cause Mortality in Patients with HIV Infection: A Systematic Review and Meta-Analysis - (09/14/22)
       
    556. Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus - (09/12/22)
       
    557. Hormone therapy and fractures [VMS] in postmenopausal women - (09/12/22)
       
    558. Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus - (09/12/22)
       
    559. Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia - (09/06/22)
       
    560. Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - an observational study - (09/06/22)
       
    561. Effects of alirocumab on carotid plaque lipid content and inflammation: a time course study using serial vessel wall imaging - (09/06/22)
       
    562. Emerging From the Shadows: Lp(a) - American College of Cardiology - (09/06/22)
       
    563. Antisense Drug Reduced LPa; in Phase 3 Study Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON) - (09/06/22)
       
    564. Lipoprotein(a) Testing Guidelines, at Cleveland Clinic - (09/06/22)
       
    565. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement  panel recommends testing at least once - (09/06/22)
       
    566. Prevalence and risk factors for falls and fall-related injuries in the 2018 National Post-acute and Long-term Care Study (25%) & for PLWH - (09/02/22)
       
    567. Nearly 40% of older adult brains studied showed signs of LATE pathology - (08/31/22)
       
    568. Failure to Address Aging in New NHAS Strategy Implementation Plan - (08/31/22)
       
    569. Social stress contributes to accelerated aging of the immune system, study finds - (08/31/22)
       
    570. Risk of premature death in adulthood influenced by patterns of early childhood adversity - (08/25/22)
       
    571. Lean NAFLD can range from 7% to 10% in the United States - (08/18/22)
       
    572. Non-Invasive Testing - Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis - (08/18/22)
       
    573. Non-AIDS-events in individuals with spontaneous control of HIV-1: a systematic review - (08/16/22)
       
    574. IAC: Arterial remodeling is associated with CD4 T cell count and plasma IL-10 in persons with HIV - (08/08/22)
       
    575. IAC: Age Associated with Comorbidites in Spain - Risk factors linked to age-related comorbidities among people living with HIV aged over 40 years - (08/08/22)
       
    576. IAC: Comorbidity Rate Rose 1% to 2% Yearly in 2008-2018 for HIV+ in Hospital Integrase Inhibitor in First ART Poses Some Cardio Risks in Big US Analysis - Mark Mascolini (08/08/22)
       
    577. IAC: An immunological signature for subclinical atherosclerosis in people living with HIV-1 receiving antiretroviral therapy - (08/03/22)
       
    578. IAC: Smaller Volumes of 2 Brain Regions in Children Exposed to HIV in Utero - Mark Mascolini - (08/02/22)
       
    579. Title: RFA 22-0003 People Aging with HIV - (07/21/22)
       
    580. Accelerated aging [by 5 years] with HIV begins at the time of initial HIV infection - (07/05/22)
       
    581. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial - (06/30/22)
       
    582. EASL: Health-related quality of life is impaired in people living with HIV and hepatic steatosis - (06/30/22)
       
    583. My Life Check | Life's Simple 7 - (06/17/22)
       
    584. Failing Fragmented HIV Care Continuum for Aging & Elderly PLWH & all PLWH - (06/13/22)
       
    585. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels A Meta-analysis - (06/08/22)
       
    586. Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events - (06/07/22)
       
    587. Disability Measured in PLWH in London: 39.5% Severe Disability; 70.5% Moderate Disability - (06/03/22)
       
    588. PLWH Had 3 X Worse Fatigue. Fatigue associated with Worse Cognition, Daily Functioning - (06/02/22)
       
    589. Brain Affects by Integrase Inhibitors & ARTs - Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors - (05/31/22)
       
    590. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease - (05/24/22)
       
    591. Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events - (05/24/22)
       
    592. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa - (05/23/22)
       
    593. Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study - cd4 nadir - (05/23/22)
       
    594. Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV - (05/23/22)
       
    595. Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events - (05/23/22)
       
    596. PCSK9 - A Journey to Cardiovascular Outcomes Editorial - (05/23/22)
       
    597. Heart Disease & HIV - (05/23/22)
       
    598. What is cholesterol? Managing Lipids - (05/23/22)
       
    599. Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease A Prespecified Analysis From the FOURIER Trial - (05/20/22)
       
    600. Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab - LDL response at week 4 - An Analysis of FOURIER Trial Data - (05/20/22)
       
    601. In treating DM, lifestyle changes are critical, as a 5%-10% weight loss can have important metabolic effects - Diagnosing and Managing Diabetes in HIV-Infected Patients: Current Concepts - (05/18/22)
       
    602. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010 - (05/18/22)
       
    603. Coronary Artery Calcium (CAC) Scoring - (05/18/22)
       
    604. Diabetes and Your Heart - (05/17/22)
       
    605. Lipid & Cholesterol Lowering Drugs: Pitavastatin May Be the Best Statin Option for PLWH - (05/17/22)
       
    606. Lipid-lowering therapy in HIV-infected patients: relationship with antiretroviral agents and impact of substance-related disorders - (05/17/22)
       
    607. LPa & Heart Disease Risk - (05/17/22)
       
    608. Antisense Drug Cuts Lp(a) in Midstage Study - Up next: phase III trial probing clinical outcomes - (05/16/22)
       
    609. Associations Between Central Obesity and Lifelong Antiviral Therapy in Adults Living With HIV Acquired From Early Childhood - (05/16/22)
       
    610. FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV - Press Release - (05/16/22)
       
    611. LPa Risk Factor For Heart Disease - New Antisense Drug for LPa in Studies - (05/16/22)
       
    612. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk - (05/16/22)
       
    613. PCSK9 Inhibitor & Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome - (05/16/22)
       
    614. Effect of PCSK9 Evolocumab on Non High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies - (05/16/22)
       
    615. The Effects on Plaque of Statins & PCSK9 Inhibitors - (05/16/22)
       
    616. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis [plaque] in Patients With Acute Myocardial Infarction - (05/16/22)
       
    617. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection - (05/13/22)
       
    618. Carotid Intima-Media Thickness and Midlife Cognitive Function- - (05/16/22)
       
    619. HIV Death Rates Almost Double in NYC Compared to General Population; Heart Disease is A Leading Increasing Cause of Death in NYC - (04/18/22)
       
    620. Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission. - (04/18/22)
       
    621. "clinicians must recognize that patients with HIV have a unique CVD risk profile that may dictate different approaches" - need for tailored cardiovascular prevention strategies in patients with HIV - (04/18/22)
       
    622. Brain Decline in Frail PLH Not Detectable By Standard Neuropsych Tests - (04/18/22)
       
    623. the need for tailored cardiovascular prevention strategies in patients with HIV - "clinicians must recognize that patients with HIV have a unique CVD risk profile that may dictate different approaches" - (04/14/22)
       
    624. Reduced Cardiac Strain Among Women with HIV Relates to Inflammatory Monocyte Activation - (04/13/22)
       
    625. SUBCLINICAL ATHEROSCLEROSIS AND IMMUNE ACTIVATION AMONG US FEMALES VS MALES WITH HIV women have more immune activation - (04/13/22)
       
    626. Aging & Immune System: Women-Specific Aspects (higher inflammation; estrogen; menopause; response to HIV by women) - (04/13/22)
       
    627. CV Risk Factors Common Among 50 Yr Old PLWH - "Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial" - (04/13/22)
       
    628. Among WWH in the REPRIEVE trial, more advanced reproductive age is associated with metabolic dysregulation and region of residence - (04/13/22)
       
    629. Health systems must adapt to the special needs of ageing people with HIV and comorbid diseases to improve both patient-centred and population-centred health outcomes - (04/13/22)
       
    630. Double the Relative Risk for HIV+ Women for Heart Attacks Highest rates at 65-74 Years Old - (04/12/22)
       
    631. Arc of Aging with HIV 1996-2022: from promise to disappointment & despair: a broken HIV healthcare system. Slide talk by Jules Levin - (04/11/22)
       
    632. Cognitive Impairment at Midlife in Long-Term Cannabis Users - (04/05/22)
       
    633. Quality of Life Worse for Long-Term Survivors; Frailty/Function worse for >65 - (04/01/22)
       
    634. CROI: CROI 2022 Key Aging & Comorbidities Highlights - (03/28/22)
       
    635. CROI: CROI 2022 Aging & HIV Symposium - (03/28/22)
       
    636. Gilead's Aging Positively 2nd Round Grantees Announced - (03/28/22)
       
    637. Excess cancer prevalence in men with HIV: A nationwide analysis of Medicaid data - (03/28/22)
       
    638. Mortality Is Greater For Some PLWH: African-Americans, Elderly, Frail, Comorbidities, Women - (03/28/22)
       
    639. Senolytics for Poets - (03/24/22)
       
    640. Jak-STAT Inhibition: Therapeutic Intervention for Inflammaging and Comorbidities in PWH - (03/24/22)
       
    641. Alzheimer's disease and related dementias among older U.S. Medicare beneficiaries with and without HIV - (03/21/22)
       
    642. Finding the 'Tipping Point' to Permanent Kidney Damage - (03/15/22)
       
    643. 210,000 PLWH in USA Over >60 years Old - (03/11/22)
       
    644. CROI: NON-OBESE NAFLD IS ASSOCIATED WITH HIGHER SCD14 CONCENTRATIONS IN ADULTS WITH HIV - (03/11/22)
       
    645. CROI: 11% - HIGH INCIDENCE RATE OF CT-MEASURED NAFLD IN MACS MEN WITH AND WITHOUT HIV INFECTION - (03/11/22)
       
    646. CROI: DETERMINANTS OF LIVER STEATOSIS IN PEOPLE LIVING WITH HIV ON ANTIRETROVIRAL THERAPY - ALT matters - (03/11/22)
       
    647. CROI: IMPACT OF NASH ON THE SURVIVAL OF PEOPLE LIVING WITH HIV - (03/11/22)
       
    648. CROI: PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE VERTICALLY HIV-INFECTED YOUTHS - (03/11/22)
       
    649. CROI: Effect of Tenofovir on T-cell Maturational Subsets in Long Term Aviraemic HIV Adults - (03/11/22)
       
    650. CROI: NEUROSYMPTOMATIC HIV-1 CSF ESCAPE ASSOCIATES WITH REPLICATION IN CNS CD4+ T CELLS - (03/11/22)
       
    651. CROI: Effect of Tenofovir on T-cell Maturational Subsets in Long Term Aviraemic HIV Adults - (03/08/22)
       
    652. More alcohol, less brain: Association begins with an average of just one drink a day - (03/07/22)
       
    653. Evaluation of Computerized Cognitive Training and Cognitive and Daily Function in Patients Living With HIVA Meta-analysis - (03/07/22)
       
    654. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment - (03/07/22)
       
    655. CROI: STATIN USE IN ART-TREATED HIV REVEALS AN ALTERED MACROPHAGE TRANSCRIPTOMIC PROFILE - (03/04/22)
       
    656. CROI: PREVALENCE OF ANEMIA AND RISK FACTORS IN PEOPLE WITH HIV IN THE MODERN ART ERA: aging, Blacks, women, Hispanics have higher risk - (03/04/22)
       
    657. CROI: Impaired response of memory Treg to HDL is associated with high cardiovascular disease risk in persons with HIV - (03/04/22)
       
    658. CROI: Carl Dieffenbach Highlights Aging & Comorbidities for PLWH, Frailty & Research & the Need for Better Care: "care of people living with HIV has NOT kept up with the reality of this aging population" - (03/04/22)
       
    659. Risk, resiliency in aging brain focus of $33 million grant - (03/01/22)
       
    660. CROI: Atrial Fibrillation Risk Factors Among Patients in HIV Care in the United States - (02/25/22)
       
    661. CROI: Sleep and Frailty Among Men with and Without HIV - poor sleep for PLWH - (02/25/22)
       
    662. CROI: POOR SLEEP IS LINKED TO CVD RISK IN PLWH IN A SOUTHWESTERN US CLINIC - 40% Have Sleeping Difficuties - (02/25/22)
       
    663. CROI: A novel comorbidity index predicts cognitive change in people with chronic HIV - (02/24/22)
       
    664. CROI: Aging Symposium 2022 - Jules Levin slides, talk - NATAP - National AIDS Treatment Advocacy Project (02/24/22)
       
    665. CROI: Impact of Rheumatologic Therapies on Cardiovascular Outcomes in People with HIV (02/24/22)
       
    666. CROI: Inflammatory clusters are associated with multimorbidity and Cardiovascular disease in People with HIV on effective treatment (02/24/22)
       
    667. CROI: Effects of Air Pollutants on Neuroimaging Measures Diverge by HIV Status: poverty-neighborhood area & HIV effect brain structure (02/24/22)
       
    668. CROI: HIV-INDUCED CELLULAR SENESCENCE IN PLWH IS DECREASED EX VIVO BY D+Q SENOLYTIC DRUGS (02/24/22)
       
    669. CROI: Associations Between Plasma Biomarkers and Neurocognition in ART-Treated PWH (02/24/22)
       
    670. CROI: ACTG A5351s: Effect of Immune-Modulatory Interventions on CMV Replication during ART - Mark Mascolini (02/22/22)
       
    671. CROI: From NAFLD to MAFLD: implications of change in terminology in PWH - (02/22/22)
       
    672. CROI: NAFLD IS COMMON AND ASSOCIATED WITH CARDIOVASCULAR RISK IN REPRIEVE PARTICIPANTS - (02/22/22)
       
    673. CROI: Proteinuria Is Common Among People with HIV With Controlled Viremia - (02/22/22)
       
    674. CROI: MUSCLE QUALITY AND PHYSICAL FUNCTION IN MEN WITH AND WITHOUT HIV - (02/22/22)
       
    675. CROI: IS THERE A ROLE OF NOVEL ART REGIMENS IN THE DECLINING PREVALENCE OF HAND? HAND 22% Today in Italy- Asymptomatic Remains Prevalent 10%-24% - (02/22/22)
       
    676. CROI: SERUM AND CSF ULTRA-SENSITIVE DETECTION OF NFL AND ALZHEIMER'S BIOMARKERS IN PLWH - (02/22/22)
       
    677. CROI: IMPROVING INTESTINAL BARRIER USING GLP-2 AGONIST REDUCES ARTERIAL INFLAMMATION IN PWH - (02/16/22)
       
    678. CROI: MI Risk Not Falling in HIV Group, as It Is in non-HIV Peers - Mark Mascolini (02/15/22)
       
    679. CROI: CROI Monday Feb 14: 5 Key Aging & Metabolic Oral Presentation Studies - (02/15/22)
       
    680. CROI: TENOFOVIR ALAFENAMIDE IS ASSOCIATED WITH SHORTER TELOMERE LENGTH IN PEOPLE WITH HIV - (02/15/22)
       
    681. CROI: Macrophage-specific arterial infiltration relates to plaque type and immune activation in HIV - (02/14/22)
       
    682. CROI: PLWH Have Higher levels of Fat Tissue Fibrosis - INFLAMMATION AND KYNURENINE PATHWAY LINKED TO TYPE 2 DIABETES AND FAT FIBROSIS IN HIV - (02/14/22)
       
    683. CROI: Trends in Myocardial Infarction Risk by HIV Status in Two US Healthcare Systems - (02/14/22)
       
    684. Effect of HIV and Interpersonal Trauma on Cortical Thickness, Cognition, and Daily Functioning - (02/14/22)
       
    685. CROI: Two or More Anticholinergics Tied to Falls, Frailty in People With HIV - Mark Mascolini (02/14/22)
       
    686. CROI: Geographical Differences in Functional Impairment of PLWH: Over One Third in Global HIV Analysis Have Impaired Physical Function - Mark Mascolini (02/14/22)
       
    687. CROI: PREVALENCE OF ANEMIA AND RISK FACTORS IN PEOPLE WITH HIV IN THE MODERN ART ERA - (02/14/22)
       
    688. CROI: Assessing health-related quality of life in people with HIV and cognitive issues - (02/13/22)
       
    689. Transitioning to Frailty for PLWH 2 fold higher, Risk Factors - (02/07/22)
       
    690. PCSK9 (Repatha) in HIV+, Affect on Plaque - (02/06/22)
       
    691. Mortality & Elderly PLWH - (02/05/22)
       
    692. Updated cholesterol guidelines offer more personalized risk assessment, additional treatment options for people at the highest risk - risk factors - (02/05/22)
       
    693. HIV CVD Guidelines - 2019 - Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association - (02/05/22)
       
    694. FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year - (02/05/22)
       
    695. NIA: Data shows racial disparities in Alzheimer's disease diagnosis between Black and white research study participants - (02/03/22)
       
    696. Merck readies oral, macrocyclic PCSK9 inhibitor for phase II test - (02/03/22)
       
    697. Evolocumab (PCSK9 Inhibitor for Heart Disease) in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study - (01/27/22)
       
    698. Peripheral artery disease and physical function in women with and without HIV - (01/27/22)
       
    699. PLWH Survival Declines with Comorbidities Danish Cohort - (01/25/22)
       
    700. Mutimorbidity Increases 50% in PLWH Over Past Several Years; 76% of HIV Have Polypharmacy. - (01/25/22)
       
    701. HIV Care Fragmentation - PLWH Did Not Receive Good Specialty Care for Hypertension & Hyperlipidemia - (01/25/22)
       
    702. HIV infection is associated with an increased risk of PAD, Peripheral Artery Disease - (01/25/22)
       
    703. Telomere Length, Traditional Risk Factors, HIV-related Factors and Coronary Artery Disease Events in Swiss Persons Living with HIV - (01/25/22)
       
    704. 26%, 10x HIGHer Prevalence of Peripheral Artery Disease in African-American Women with HIV in WIHS - (01/25/22)
       
    705. What is Frailty in PLWH ? 25% of HIV+ Men in MACS >65 Were Frail in 2013; 42% of HIV+ Women >60 in WIHS in 2019 were Frail/Pre-Frail. Frailty Increases Mortality - (01/25/22)
       
    706. No amount of alcohol is good for the heart, new report says, but critics disagree on science - (01/20/22)
       
    707. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001 2015 - (01/19/22)
       
    708. Menopause Is Associated With Immune Activation in Women With HIV - (01/19/22)
       
    709. Fall & Frailty Increase Mortality in Older PLWH Frailty Assessments In Routine Care - (01/18/22)
       
    710. Older adult opioid overdose death rates on the rise - 4 times higher for African-American Men - (01/16/22)
       
    711. San Francisco Dept of Public Health: 71% >50, 29% >65 PLWH - (01/16/22)
       
    712. 2 Recent study publications from Kaiser on Dementia & Heart Failure in PLWH - (01/15/22)
       
    713. Impact of Heroin and HIV on Gut Integrity and Immune Activation - (01/15/22)
       
    714. Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence - (01/15/22)
       
    715. Transgender Women and PrEP Care in NYC - (01/15/22)
       
    716. Impact of Heroin and HIV on Gut Integrity and Immune Activation - (01/15/22)
       
    717. Reduced Levels of NAD in Skeletal Muscle and Increased Physiologic Frailty Are Associated With Viral Coinfection in Asymptomatic Middle-Aged Adults - (01/13/22)
       
    718. Life Expectancy Decreases with Comorbidities - Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies - (01/12/22)
       
    719. Life expectancy estimates based on comorbidities and frailty to inform preventive care - (01/11/22)
       
    720. 60% in NYC >50 years old & 30% > 60 years old - (01/09/22)
       
    721. Sex Differences in People Aging With HIV - women have worse quality of life & physical function & suffer more exhaustion - (01/09/22)
       
    722. Women with HIV Have More Comorbidities, Worse Physical Function, & Inflammation - (01/07/22)
       
    723. Faces of Frailty [women] in Aging with HIV Infection - (01/07/22)
       
    724. Body Changes for Young Adults Acquiring HIV at Early Age & Perinatally - (01/06/22)
       
    725. Life Expectancy for PLWH: disparities for Blacks, Women; Frailty High Rates in MACS, Physical Impairments by Age Worsen; Cognitive Impairment in Older PLWH - (01/04/22)
       
    726. Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016 - (01/03/22)
       
    727. PLWH - Women; Life Expectancy-disparities; Social Determinants; Frailty; Physical & Cognitive Impairment - (12/28/21)
       
    728. FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year - (12/23/21)
       
    729. ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention - (12/23/21)
       
    730. PLWH who adhere to ART but smoke are substantially more likely to die from lung cancer than from AIDS-related causes - (12/23/21)
       
    731. Excess Black Deaths PLWH & Higher Morbidity - (12/23/21)
       
    732. Social Determinants of Health & African-Americans Associated with Chronic Comorbidities & Brain Aging - (12/23/21)
       
    733. The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030......23% >65y, 20% >70y (200,000+) and Impact - (12/23/21)
       
    734. "I'm Just Forgetting and I Don't Know Why": Exploring How People Living With HIV-Associated Neurocognitive Disorder View, Manage, and Obtain Support for Their Cognitive Difficulties - study interviewing 25 PLWH average age 51 diagnosed with HAND (HIV-associated neurocognitive disorder) - (12/13/21)
       
    735. New Aging/HIV Language in New US AIDS Strategy 2022-2026 - (12/02/21)
       
    736. Gender Inequity-Inappropriate Prescribing for Elderly PLWH in Swiss Cohort - (11/30/21)
       
    737. Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study - (11/30/21)
       
    738. The Clinical Safety, Pharmacokinetics, and LDL-Cholesterol Lowering Efficacy of MK-0616, an Oral PCSK9 Inhibitor - (11/30/21)
       
    739. The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030 - (11/09/21)
       
    740. EACS: More than half of well-treated persons living with HIV have angiography verified coronary artery disease Angiography Confirms Coronary Artery Disease in Over Half With HIV in Copenhagen - Mark Mascolini (11/06/21)
       
    741. EACS: Increased neurocognitive impairment and white matter damaged in young adults with perinatal HIV infection. A case-control study - (11/06/21)
       
    742. EACS: A fog that impacts everything: understanding quality of life in people living with HIV and cognitive impairment - poor mental & physical function - (11/06/21)
       
    743. EACS: Long-term HIV survivors and adults 65 or over with HIV: two separate profiles with different needs - (11/03/21)
       
    744. EACS: Comorbidities in women living with HIV: a systematic review - higher rates for kidney, bone, heart, neurocognitive diseases - (11/03/21)
       
    745. EACS: Themes of Aging from Older PLWH: A fog that impacts everything: understanding quality of life in people living with HIV and cognitive impairment - (11/03/21)
       
    746. EACS: Correlation between inflammatory biomarkers with four cardiovascular disease (CVD) risk models in aging patients living with HIV - (11/03/21)
       
    747. EACS: Incidence of diabetes mellitus in PLWHIV: impact of antiretroviral therapy - (11/03/21)
       
    748. EACS: Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors - (11/03/21)
       
    749. What problems associated with ageing are seen in a specialist service for older people living with HIV? at the SAGE Clinic in London - (11/02/21)
       
    750. EACS: New HRSA Funding Opportunities Focus on HIV and Aging Oct 28 published - (11/02/21)
       
    751. EACS: Insulin resistance in PWH is associated with abdominal obesity and prior exposure to thymidine analogues and/or didanosine - (11/01/21)
       
    752. EACS: Angiography Confirms Coronary Artery Disease in Over Half With HIV in Copenhagen - Mark Mascolini (11/01/21)
       
    753. EACS: Evaluating the relationship between inflammation biomarker interleukin-6 (IL-6) levels and residual, low-Level viraemia in HIV-1 suppressed participants in the TANGO study at week 96 (WK96) - (10/27/21)
       
    754. EACS: Durable efficacy and safety of DTG + 3TC in treatment-naive people with HIV-1 stratified by age: 144-week results from GEMINI-1 and -2 - (10/27/21)
       
    755. EACS: Incidence of hypertension in people living with HIV receiving InSTI versus other third-drug ART regimens in the RESPOND cohort - (10/27/21)
       
    756. EACS: High incidence of subclinical peripheral artery disease in people living with HIV in Denmark: a 2-year follow-up study - (10/27/21)
       
    757. Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease - (10/12/21)
       
    758. Cross-sectional study of correlates and prevalence [high rates] of functional and high-risk multimorbidity in an academic HIV practice in New York City at Cornell-Weill HIV Clinic - (10/05/21)
       
    759. AGE: Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV - (09/28/21)
       
    760. AGE: Rapid Aging of HIV Immune System Reported in 2011 and Earlier by Rita Effros & UCLA Researchers. - (09/28/21)
       
    761. AGE: Frailty and resilience in people living with HIV during the COVID era: two complementary constructs? Sarcopenia, frailty & % of adipose tissue worsened. 37% were Frail & Non-Resilient - (09/28/21)
       
    762. AGE: Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV - (09/27/21)
       
    763. AGE: Pain Linked to Depression, Worse Physical Function, Falls, Frailty and Inflammation in Older People With HIV - By Mark Mascolini - (09/27/21)
       
    764. AGE: Burden of age-associated chronic comorbidities among people living with and without HIV: Years of life lost to premature mortality in British Columbia, Canada - (09/27/21)
       
    765. AGE: COVID Vaccine Effectivity in Aging & HIV Populations - (09/27/21)
       
    766. AGE: NYC Ryan White Part A: Program Model of Care for HIV and Aging - (09/25/21)
       
    767. AGE: Black and Hispanic women in the United States are disproportionally affected by the HIV infection - (09/25/21)
       
    768. AGE: Preliminary Hearing Data in Older Adults Living with 1HIV from 2the DETECT Study - (09/25/21)
       
    769. AGE: Survey of Consumers, Clinicians and Service Providers about Needs of Long-Term Survivors and People Aging with HIV in New York State - (09/25/21)
       
    770. AGE: Cognitive Impairment in Aging PLWH - Bruce Brew, MD lecture - (09/25/21)
       
    771. AGE: NAFLD Independently Tied to Worse Physical Quality of Life With HIV - By Mark Mascolini - (09/25/21)
       
    772. AGE: NAFLD Independently Tied to Worse Physical Quality of Life With HIV - (09/24/21)
       
    773. AGE: Polypharmacy Halves Odds of Nonadherence to ART-Frailty Boosts Odds - (09/24/21)
       
    774. AGE: Life Years Lost Due to Comorbidities 2.5 Time Greater With HIV - (09/24/21)
       
    775. AGE: NAFLD Independently Tied to Worse Physical Quality of Life With HIV - (09/24/21)
       
    776. AGE: Polypharmacy Halves Odds of Nonadherence to ART-Frailty Boosts Odds - (09/24/21)
       
    777. AGE: Life Years Lost Due to Comorbidities 2.5 Time Greater With HIV - (09/24/21)
       
    778. AGE: Less Healthy Response to Skeletal Muscle Damage in Older Men With HIV - Mark Mascolini (09/23/21)
       
    779. AGE: Higher Viral Load Predicts Thromboembolism in People With HIV - Mark Mascolini (09/23/21)
       
    780. AGE: Rare Menopausal Hormone Therapy in HIV+ Women Tied to Lack of Clinician Discussion - Mark Mascolini (09/23/21)
       
    781. Effects of Growth Hormone Releasing Hormone on Cognitive Function in Adults With Mild Cognitive Impairment and Healthy Older Adults - Results of a Controlled Trial - (09/21/21)
       
    782. Congresswoman Barbara Lee and Jenniffer González continue to fight for those living with HIV Congressional HIV/AIDS Caucus Co-chairs introduce bipartisan bill (supporting aging/HIV & goals of HIV Awareness Ageing Day) - (09/21/21)
       
    783. Tablet-Based Cognitive Impairment Screening for Adults With HIV Seeking Clinical Care: Observational Study - (09/15/21)
       
    784. Coronary Aging in HIV-Infected Patients - (09/13/21)
       
    785. Evaluation of a Clinic Dedicated to People Aging with HIV at Chelsea and Westminster Hospital: Results of a 10-Year Experience - (09/10/21)
       
    786. Menopausal hormone therapy for women living with HIV - (09/10/21)
       
    787. Racial Discrimination & Inflammation/Comorbidities - Experienced discrimination and racial differences in leukocyte gene expression - (09/10/21)
       
    788. HIV & the Brain: ARTs, Mitochondria, Stress - (09/08/21)
       
    789. HRSA Aging/HIV Medicare Paper - "need for personalized care & maximizing functional status....training medical professionals....increased coordination & integration of services, geriatric services " - (09/08/21)
       
    790. HIV/AIDS and aging: the new frontier for HIV/AIDS research and care - Viewpoint - "Community Engagement Research" - (09/08/21)
       
    791. Kidney Disease & HIV - (09/08/21)
       
    792. Treating the Whole Patient - "Paitent-Centered" Care: Social Determinants of Health, Mental Health - (09/02/21)
       
    793. HIV and antiretroviral therapy-related fat alterations - (09/02/21)
       
    794. Fat & ART Effects in HIV, Comorbidities: Initiating ART Is Associated With Decreased Fat Density in People Living With HIV - (09/02/21)
       
    795. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials - (09/02/21)
       
    796. IAS: Anxiety and Alcohol Consumption in the Miami Adult Studies on HIV (MASH) Cohort During the COVID-19 Pandemic - (09/01/21)
       
    797. Food Insecurity Affects HIV+ Minorities & Associated with Comorbidities & Mortality - (09/01/21)
       
    798. Managing frailty in people living with HIV: establishing and reviewing a new clinical service at Royal Free HIV Clinic London UK - (09/01/21)
       
    799. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV - (09/01/21)
       
    800. Heart Disease & HIV: statement from American Heart Association Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association - (08/31/21)
       
    801. The challenge of HIV treatment in an era of polypharmacy - (08/31/21)
       
    802. Aging, Comorbidities Screening Tests PWH Should Be Doing - (08/31/21)
       
    803. Aging & HIV, Comorbidities, CROI Update - NATAP webinar, Todd Brown, MD - (08/30/21)
       
    804. Heart Disease & HIV Review & Update - NATAP webinar, Priscilla Hsue, MD - (08/30/21)
       
    805. HIV and the Bones - NATAP webinar, Todd Brown, MD - (08/30/21)
       
    806. Models of HIV & Aging Care - (08/30/21)
       
    807. Targeting visceral adiposity with pharmacotherapy - Effects of liraglutide on visceral and ectopic fat - (08/30/21)
       
    808. HIV & Aging Geriatric Clinics
       
    809. Implementation of an HIV and Aging Clinical Program
       
    810. Implementation of an HIV and Aging Clinical Program / A Geriatrician's Approach To Aging With HIV
       
    811. A Geriatrician s Approach To Aging With HIV
       
    812. Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in SanFrancisco
       
    813. Brighton UK Geriatric HV Clinic
       
    814. From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care
       
    815. HRSA New Resources Available on HIV and Aging: Care, Screening Tools & Staff Training
       
    816. Senescence & Exhaustion of T Cell Memory Subsets Increased in Aging Persons with HIV
       
    817. IAS: Metabolics, Comorbidities & Aging at IAS 2021 - (08/15/21)
       
    818. HIV mortality across the 30 largest U.S. cities: assessing overall trends and racial inequities. Black people were approximately 2-8 times more likely to die from HIV compared to White people at both time points. - (08/25/21)
       
    819. Age, Comorbidities, and AIDS Predict a Frailty Phenotype (FP) in Men Who Have Sex With Men - (08/25/21)
       
    820. Evaluation of a Clinic Dedicated to People Aging with HIV at Chelsea and Westminster Hospital: Results of a 10-Year Experience - (08/25/21)
       
    821. Advancing Age Past 65-70 & Comorbidities, Risk Factors - Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-De ning Cancer in HIV-Infected Versus Uninfected Adults - (08/25/21)
       
    822. IAS: Co-morbidity and HIV: What Matters to Patients ? - IAS Symposium - Growing old with HIV: Co-morbidities and ageing (CME) - (08/25/21)
       
    823. IAS: Food insecurity is associated with increased immune activation in people living with HIV - (08/24/21)
       
    824. IAS: HIV Immune Response to COVID - 2 studies: 1- Robust SARS-CoV-2-specific serological and functional t-cell immunity in PLWHIV, 2 - SARS-Cov-2 immunity in COVID-19 convalescent individuals living with HIV: bulk immune profiling and SARS-CoV-2 specific humoral and cellular immune responses - (08/24/21)
       
    825. IAS: Baricitinib reduces macrophage-mediated inflammation in HIV infection - (08/23/21)
       
    826. IAS: Ageing and renal insufficiency in persons living with and without HIV in AFRICOS - (08/23/21)
       
    827. IAS: Daily Variations- HIV & Immunity, T-Cell Exhaustion in Vertically Acquired HIV-children/adolescents/adults - (08/23/21)
       
    828. IAS: Circulating GDF15 levels [cellular stress] are associated with aging, risk of non-AIDS comorbidities and integrated HIV DNA in ART-treated people living with HIV - (08/23/21)
       
    829. IAS: Circulating GDF15 levels [cellular stress] are associated with aging, risk of non-AIDS comorbidities and integrated HIV DNA in ART-treated people living with HIV - (08/23/21)
       
    830. IAS: Stress & Aging, Sleep & Brain - (08/23/21)
       
    831. NYC Forum on Older People with HIV: Developing a Service Model for PWH Over 50 in NYC - (08/23/21)
       
    832. Working HAND in HAND: Central nervous system complications in people with HIV - (08/21/21)
       
    833. Advancing Age Past 65-70 with HIV will likely remain somewhat different from ageing without HIV - (08/19/21)
       
    834. IAS: Metabolics, Comorbidities & Aging at IAS 2021 - (08/15/21)
       
    835. Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project - (08/15/21)
       
    836. Increased brain-predicted aging in treated HIV disease in COBRA - (08/15/21)
       
    837. IAS: PSYCHOLOGICAL STRESS IS ASSOCIATED WITH CAROTID INFLAMMATION IN PERSONS WITH TREATED HIV INFECTION - (08/13/21)
       
    838. Life Expectancy & Comorbidities: mental & physical comorbidities, social determinants of health, lifestyle, trauma, social isolation - (08/15/21)
       
    839. HIV/Life Expectancy-Mental Health/Comorbidities- Psychosocial-Lifestyle-Social Determinants - (08/15/21)
       
    840. Cognitive Impairment in a Clinical Setting - in London - (08/15/21)
       
    841. Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV - (08/15/21)
       
    842. Differences in Cognitive Function Between Women and Men With HIV - (08/15/21)
       
    843. Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV - (08/15/21)
       
    844. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity - (08/12/21)
       
    845. Intranasal COVID-19 vaccine effective in animal studies - (08/12/21)
       
    846. Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers - (08/12/21)
       
    847. Muscle Function & Cognitive Decline; Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline - (08/12/21)
       
    848. The effect of mail order pharmacy outreach on older patients with diabetes - (08/12/21)
       
    849. Physical activity (36 minutes) moderates the effect of sedentary time on an older adult's physical independence - (08/12/21)
       
    850. Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living with HIV - (08/19/21)
       
    851. Neurocognitive Dysfunction; Premature Cognitive Aging in PLWH Adjusting for Comorbidities & Comorbidities Contribute - (08/12/21)
       
    852. Switch to INSTI more than offset negative effects of weight gain on incidence of insulin resistance in people living with HIV - (08/09/21)
       
    853. Combination of high liver and visceral fat predict diabetes in people living with HIV - (08/09/21)
       
    854. IAS: Immunoscenescence and HIV: mutual interactions? - (07/26/21)
       
    855. IAS: Aging PLWH & Higher Readmission Hospital Rates than the General Population Hospital Readmissions Fall in Big HIV Group But Still High vs Non-HIV Patients - Mark Mascolini (07/23/21)
       
    856. IAS: The association of cardiovascular risk factors and disease in people living with HIV in the UK: a retrospective matched cohort study - (07/21/21)
       
    857. IAS: The association of cardiovascular risk factors and disease in people living with HIV in the UK: a retrospective matched cohort study Higher CVD Risk With HIV, Especially in People Younger Than 40 - Mark Mascolini - (07/21/21)
       
    858. IAS: Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV - (07/21/21)
       
    859. IAS: Higher comorbidity and comedication burden in women and young people living with HIV More Comorbidities, Polypharmacy With HIV-But Subgroup Differences Abound - (07/21/21)
       
    860. IAS: Mitochondrial disorders in activated memory CD4+ T cells derived from HIV-infected immunological non-responders - (07/21/21)
       
    861. IAS: Higher CVD Risk With HIV, Especially in People Younger Than 40 - Mark Mascolini - (07/21/21)
       
    862. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging - (07/14/21)
       
    863. 2 New studies: Diabetes-Depression-Women & High Suicide Rates PLWH - (07/09/21)
       
    864. Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With HIV and a Proposed Way Forward - (07/09/21)
       
    865. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015 - (06/09/21)
       
    866. NYC Planning Council talk by Jules: Aging with HIV in the US & NYC-clinical & community care & services needs, unmet needs - (06/14/21)
       
    867. Medicare PLWH: Blacks & Latinos 4-Fold Greater Risk - (06/14/21)
       
    868. HHS-Older PLWH Reduced Survival by 3.6 times & More Comorbidities - (06/14/21)
       
    869. HHS-Older PLWH Reduced Survival by 3.6 times & More Comorbidities - (06/14/21)
       
    870. Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers - (06/09/21)
       
    871. Assessing the health status and mortality of older people over 65 with HIV - greater mortality, more comorbidities - (06/07/21)
       
    872. Organ Reserve, Excess Metabolic Capacity, and Aging - (05/18/21)
       
    873. HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition - (05/11/21)
       
    874. New Data on Colchicine Bring Conflicting Results - (05/10/21)
       
    875. Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity - (05/10/21)
       
    876. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus - undetectable HIV viral load reduced risk - (05/10/21)
       
    877. Accelerated Brain Aging and Cerebral Blood Flow Reduction in Persons With Human Immunodeficiency Virus - (04/29/21)
       
    878. CROI: BIOLOGICAL PROFILES PREDICT CORONARY ARTERY DISEASE IN PWH AND RISK-MATCHED CONTROLS - (03/08/21)
       
    879. CROI: COMORBIDITY BURDEN IN PEOPLE LIVING WITH HIV IN THE UNITED STATES - (03/06/21)
       
    880. CROI: Neurocognition & PLWH - CROI 2021 - (03/28/21)
       
    881. CROI: Aging & HIV Highlights at CROI 2021 - (03/25/21)
       
    882. CROI: EPIGENETIC AGING ASSOCIATED WITH COGNITIVE IMPAIRMENT IN OLDER BLACK ADULTS WITH HIV - (03/24/21)
       
    883. CROI: DEMENTIA INCIDENCE AMONG ART-TREATED PEOPLE WITH HIV IN A PRIMARY CARE SETTING - (03/24/21)
       
    884. CROI: NEUROCOGNITIVE DYSFUNCTION, INFLAMMATION, AND ADIPOSITY IN TREATED HIV PATIENTS - (03/24/21)
       
    885. CROI: PWH AND ALZHEIMER'S DISEASE RISK: CLARIFYING THE HAND PHENOTYPE OVER TIME - (03/24/21)
       
    886. CROI: NEURON DAMAGE AND RESERVOIR ARE SECONDARY TO HIV TRANSCRIPTS DESPITE SUPPRESSIVE ART - (03/17/21)
       
    887. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable - (02/26/21)
       
    888. CROI: SEX DIFFERENCES IN DIABETES PREVELANCE AMONG PERSONS WITH HIV IN THE UNITED STATES...40% of HIV+ Women >65 have diabetes. - (03/19/21)
       
    889. CROI: CROI 2021 - Complications: HIV, COVID - (03/19/21)
       
    890. Burden of Hypertension, Diabetes, Cardiovascular Disease, and Lung Disease Among Women Living With Human Immunodeficiency Virus (HIV) in the United States - (03/18/21)
       
    891. CROI: SECOND ANTIRETROVIRAL THERAPY REGIMEN IN VIREMIC PEOPLE WITH HIV IN THE US, 2008-2018 - (03/15/21)
       
    892. CROI: CHARACTERIZING FIRST VIRAL FAILURES AMONG ANTIRETROVIRAL THERAPY INITIATORS IN THE US - (03/15/21)
       
    893. CROI: T-CELL IMMUNE DYSREGULATION AND MORTALITY IN WOMEN WITH HIV - (03/15/21)
       
    894. CROI: URINE MITOCHONDRIAL DNA, WEIGHT LOSS, AND BODY COMPOSITION IN OLDER ADULTS WITH HIV - (03/14/21)
       
    895. CROI: ASSOCIATION BETWEEN INTEGRASE INHIBITORS (InSTIs) AND CARDIOVASCULAR DISEASE (CVD) - (03/14/21)
       
    896. CROI: INFLAMMATORY AND ATHEROGENESIS MARKERS 148 WEEKS POSTSWITCH TO DTG+RPV IN SWORD-1/ -2 - (03/14/21)
       
    897. CROI: RENAL/BONE OUTCOMES AFTER LONG-ACTING CABOTEGRAVIR + RILPIVIRINE IN ATLAS + ATLAS-2M - (03/14/21)
       
    898. CROI: BEYOND PAIN: PRESCRIPTION OPIOID USE IN THE WOMEN'S INTERAGENCY HIV STUDY - (03/12/21)
       
    899. CROI: Acute Kidney Injury Less Frequent With Remdesivir Than Standard of Care - Mark Mascolini (03/12/21)
       
    900. CROI: HIV REPLICATION IN THE CNS IS ASSOCIATED WITH NEUROCOGNITION AND DEPRESSION PRE-ART - (03/12/21)
       
    901. CROI: FACTORS ASSOCIATED WITH SYSTEMIC IMMUNE ACTIVATION IN A GLOBAL HIV COHORT - (03/12/21)
       
    902. CROI: INTRANASAL INSULIN IMPROVES ATTENTION AND MEMORY IN PEOPLE WITH HIV - (03/12/21)
       
    903. CROI: HIV-1, INSUFFICIENT SLEEP, AND ENDOTHELIAL VASODILATOR FUNCTION - (03/12/21)
       
    904. IAS: Higher comorbidity and comedication burden in women and young people living with HIV More Comorbidities, Polypharmacy With HIV-But Subgroup Differences Abound - (07/21/21)
       
    905. CROI: RCT OF AN ONLINE MENTAL HEALTH INTERVENTION AMONG OLDER PLWH DURING COVID-19 PANDEMIC - Improved Depression, Anxiety & Loneliness - (03/11/21)
       
    906. CROI: IDENTIFICATION OF UNIQUE PROTEINS PREDICTIVE OF MORTALITY AND MECHANISMS IN HIV - (03/08/21)
       
    907. CROI: Multimorbidity in people with HIV using ART in the US: Projections to 2030 - (03/08/21)
       
    908. CROI: BIOLOGICAL PROFILES PREDICT CORONARY ARTERY DISEASE IN PWH AND RISK-MATCHED CONTROLS - (03/08/21)
       
    909. CROI: Over One Third With HIV in US Will Suffer Multimorbidity by 2030.... researchers forecast a "silver tsunami" in multimorbidity, polypharmacy, and healthcare costs in US residents with HIV - (03/08/21)
       
    910. CROI: Female Sex Modifies Link Between Inflammation and Non-AIDS Vascular Events - Mark Mascolini (03/08/21)
       
    911. CROI: SEX MODIFIES THE ASSOCIATION BETWEEN INFLAMMATION AND VASCULAR EVENTS IN TREATED HIV - (03/08/21)
       
    912. CROI: INTEGRASE INHIBITORS TARGET MITOCHONDRIA IN BROWN ADIPOCYTES DISRUPTING THERMOGENESIS - (03/08/21)
       
    913. CROI: WEIGHT GAIN AMONG PWH WHO SWITCH TO ART-CONTAINING InSTIs OR TAF - (03/08/21)
       
    914. CROI: HIV WITH TRANSMITTED DRUG RESISTANCE IS DURABLY SUPPRESSED BY B/F/TAF AT WEEK 144 - (03/08/21)
       
    915. CROI: HIV DIFFERENTIALLY IMPACTS AGE-RELATED COMORBIDITY BURDEN AMONG US WOMEN AND MEN - (03/06/21)
       
    916. Non-Viral Liver Disease in HIV+ - Increased Prevalence of Liver Fibrosis in PLWH Increased Prevalence of Liver Fibrosis in People Living With Human Immunodeficiency Virus Without Viral Hepatitis Compared to Population Controls - (03/02/21)
       
    917. HIV+ Women Have Higher Burden of Comorbidities vs HIV- Women / Accelerated-Earlier by 10 Years - (03/02/21)
       
    918. ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Expanded Use of Cabenuva (cabotegravir, rilpivirine) as an HIV Treatment for Use Every 2-Months - (02/26/21)
       
    919. Cognitive ageing is premature among a community sample of optimally treated people living with HIV - (02/26/21)
       
    920. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable - (02/26/21)
       
    921. HIV+ Women & MSM: aging & other issues - (02/22/21)
       
    922. Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco - (02/21/21)
       
    923. Aging Guidelines Called For by HIV Researchers /Women with HIV... "What It Means to Age With HIV Infection, Years Gained Are Not Comorbidity Free" - (02/13/21)
       
    924. Incident Non-AIDS Comorbidity Burden among Women with or at-risk for HIV in the U.S - suggest high susceptibility to -premature aging - (02/13/21)
       
    925. COVID Impact on Older HIV+ / Quality of Life NOT Viral suppression Is Endpoint !!!! - (02/11/21)
       
    926. Impact of COVID on HIV & Aging in Era of ART - (02/11/21)
       
    927. Healthy aging 80% Non Resilient Now During COVID / Isolation - Resilience and frailty in people living with HIV during the COVID era: two complementary constructs? - (02/09/21)
       
    928. GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders - (02/08/21)
       
    929. NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research - (12/21/20)
       
    930. Inflammation Marker D-Dimer Associated with cell-associated HIV RNA in Virally Suppressed HIV+..... Aging is associated with inflammation and non-significantly higher ca-HIV RNA levels - (11/03/20)
       
    931. New NYC Funding for Care & Services for Black & Latino Older PLWH - Geriatric Clinic - Men & & Women, Transgender, Young - 5 Service Categories, including Hepatitis C - (11/03/20)
       
    932. CDC: HIV Mortality - HIV+ Dying Increasingly Consist of Women, Blacks/African-Americans, South residents, older HIV+ - cancer, heart disease, suicide among leading causes of death - (11/03/20)
       
    933. ID Week: Association of Aging, Frailty and Place of Residence with Skin, Oral and Gut Microbiome Characteristics and Pathogenicity Reservoirs - (11/02/20)
       
    934. HRSA New Resources Available on HIV and Aging: Care, Screening Tools & Staff Training - (10/20/20)
       
    935. AGE Wrkshp: HIV & Aging Geriatric Clinics - (10/02/20)
       
    936. AGE Wrkshp: Dozing or Napping Has Bigger Cognitive Impact in People With HIV - By Mark Mascolini - (10/05/20)
       
    937. AGE Wrkshp: A Study of Neurocognitive Performance in Women Living With and Without HIV in South Africa - (10/05/20)
       
    938. AGE Wrkshp: Polypharmacy in 94% of Older HIV Group, Inappropriate Meds Frequent - By Mark Mascolini - (10/05/20)
       
    939. AGE Wrkshp: Aging with HIV in Latin America and The Caribbean: a systematic review - (10/05/20)
       
    940. AGE Wrkshp: Urine mtDNA Signals Lower Muscle, Fat Mass, Weight in Older Group With HIV - By Mark Mascolini - (10/05/20)
       
    941. AGE Wrkshp: Effects of HIV and Aging on the brain - (10/05/20)
       
    942. AGE Wrkshp: Age-Related Trajectories of C-Reactive Protein Among Men With and Without HIV Infection in the Multicenter AIDS Cohort Study - (10/05/20)
       
    943. AGE Wrkshp: Bictegravir/FTC/TAF Effective at 48 Weeks in Elderly: 4-Trial Analysis - By Mark Mascolini (10/02/20)
       
    944. AGE Wrkshp: HIV & Aging Geriatric Clinics - (10/02/20)
       
    945. AGE Wrkshp: Increased Neuropathy in Older PLWH - (10/02/20)
       
    946. AGE Wrkshp: Should we still care about bone? Screening, treatment, TDF vs TAF - (10/02/20)
       
    947. AGE Wrkshp: Sex Hormone-Binding Globulin Tied to Frailty, Low BMD in Women, Not Men - By Mark Mascolini (10/02/20)
       
    948. AGE Wrkshp: Frailty Common in HIV+ Middle-Aged: Tied to Depression, HCV, Substance Use - By Mark Mascolini (10/02/20)
       
    949. AGE Wrkshp: Latent Class Analysis--Unique Predictor of Hospitalization, Death in Older HIV+ - (10/01/20)
       
    950. AGE Wrkshp: Getting HIV Infection Speeds Up Epigenetic Clock (and Biologic Aging) Right Away - By Mark Mascolini - (10/01/20)
       
    951. AGE Wrkshp: Heart Failure Diagnosed 6 to 16 Years Earlier in Veterans With vs Without HIV - By Mark Mascolini - (10/01/20)
       
    952. AGE Wrkshp: A Multidisciplinary Approach (Exercise Program) to Chronic Pain and Frailty Among Those Aging with HIV: Lessons Learned - (10/01/20)
       
    953. AGE Wrkshp: ART-Associated Issues, Fat & Muscle Density, The Significance of ART-associated Weight Gain in HIV - (10/01/20)
       
    954. AGE Wrkshp: Associations between Frailty and Clinical Characteristics, Comorbidities, and Substance Abuse Among PLWH.....12% frailty in CNICS Cohort (CAR).....past drug use associated with frailty....average age only 47 - (10/01/20)
       
    955. AGE Wrkshp: Lack of Transportation Tied to Array of Health Measures in Aging US HIV Group - By Mark Mascolini - (10/01/20)
       
    956. COVID in Elderly .......Can the science of aging move us forward - (09/23/20)
       
    957. Cost of Comorbidities/HIV: Mean costs of care increased from $30,312 for those without an identified comorbidity to over $46,000 for those with 2 comorbidities, and up to $219,000 for people with 11 or more. - (09/21/20)
       
    958. Gaps in Monitoring Older HIV+ in UK - (09/21/20)
       
    959. Structural and functional brain abnormalities in HIV disease revealed by multimodal MRI fusion: association with cognitive function - (09/21/20)
       
    960. Risk of Cataract Surgery in HIV-Infected Individuals: A Danish Nationwide Population-Based Cohort Study - (08/25/20)
       
    961. APLA Health Announces Statewide Strategic Planning Meeting to Address Urgent Needs of People Aging with HIV - (08/05/20)
       
    962. Aging/HIV AIDS United Policy/Advocacy Paper - (07/31/20)
       
    963. The changing HIV epidemic: a view from the front line in the United States -holistic care needed - (07/29/20)
       
    964. from the NIH Comorbidities Workshop held Sept 2019 at NIH - Report Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop - (07/27/20)
       
    965. Cognitive disorders in people living with HIV - (07/16/20)
       
    966. IAC 2020 Virtual: Almost Half of Older HIV+ Adults Report Poor Overall Health in 25-Country Survey - (07/15/20)
       
    967. Hypertension/79% in >65 HIV+ Causes-Risk Factors - (07/01/20)
       
    968. Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients - (07/01/20)
       
    969. Disparate Impact of HIV/Aging on women - (06/30/20)
       
    970. HIV Neuropathy: Women & Men/Prevalence-Risk Factors - (06/30/20)
       
    971. Combination of healthy lifestyle traits may substantially reduce Alzheimer's disease risk & Dietary flavonols too - (06/29/20)
       
    972. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir - (06/29/20)
       
    973. HIV-Aging/Senescence/CAR-T-Cells. Senolytic Agents or Senolytic Therapeutics - (06/25/20)
       
    974. Senolytic drugs reverse damage caused by senescent cells in mice - (06/25/20)
       
    975. Risk of Increased Physical Inactivity During COVID 19 Outbreak in Older People: A Call for Actions - Editorial - (06/22/20)
       
    976. Burden of Aging with HIV: "better Care Systems Needed" UCSF - (06/22/20)
       
    977. Older Adults on ART Have Double the Mortality Risk of Their HIV-Negative Counterparts.....Survival of people aged 50 years and older by HIV and HIV treatment status: findings from three waves of the SAGE-Wellbeing of Older People Study (SAGE-WOPS) in Uganda - (06/18/20)
       
    978. Senolytics improve physical function and increase lifespan in old age - (06/17/20)
       
    979. Senescent cells: an emerging target for diseases of ageing - Senotherapeutics for healthy ageing - (06/17/20)
       
    980. senolytics might become an entirely new path for alleviating currently untreatable chronic diseases and enhancing human health span. - (06/17/20)
       
    981. HIV and cardiovascular disease - Review - (06/16/20)
       
    982. Questioning statin therapy for older patients - (06/12/20)
       
    983. Metabolic Syndrome and Neurocognitive Deficits in HIV Infection - 'Metabolic syndrome most strongly associated with neurocognitive impairment......' - (06/11/20)
       
    984. Senotherapeutics and HIV-1 Persistence & Aging/Senescence - (06/09/20)
       
    985. Statin use is associated with insulin resistance in participants of the Canadian Multicentre Osteoporosis Study - (06/08/20)
       
    986. Frailty in People Living with HIV - new review following several CROI reports on frailty, mitochondrial damage & brain function & frailty - (06/01/20)
       
    987. Leaning on Community-Based Participatory Research to Respond During COVID-19 - Aging HIV+ - (05/18/20)
       
    988. COBRA/Europe-Aging Epidemic/ Increased Brain Aging in HIV+ - (05/13/20)
       
    989. Older HIV+ Women Have Worse Increasing Comorbidities / HOPS 95% >50 Years Old Have Increasing Numbers of Comorbidities - (05/13/20)
       
    990. Cognitive Impairment among HIV-Infected Men with Longitudinal Follow-ups - (05/11/20)
       
    991. Heart Disease in HIV - (05/11/20)
       
    992. New York City by Far has the Highest Rates of PLWH >55 in the USA, SF 2nd Rates by City - (04/29/20)
       
    993. Rates HIV+ Over 55/60 Mapped, NYC, USA, by County - (04/29/20)
       
    994. Rates by Race/Aging: Over 55 HIV+ - (04/29/20)
       
    995. Accelerated Aging - HIV+ Appear to be 5-17 Years Older Chronologic Age - (04/28/20)
       
    996. Depressive Disorders in HIV/AIDS:....older PLWH, social isolation, stigma, survivor guilt, shame & guilt, existential issues - (04/28/20)
       
    997. Rates HIV+ Over 55/60 Mapped - (04/28/20)
       
    998. NATAP: Rates by Race/Aging: Over 55 HIV+ - (04/28/20)
       
    999. CROI: Comorbidities at CROI - mortality, aging..... - (04/20/20)
       
    1000. CROI: Comorbidities at CROI - mortality, aging..... - (04/20/20)
       
    1001. CROI: TRICARBOXYLIC ACID METABOLITES PREDICT METABOLIC COMORBIDITIES AND DEATH IN AGING PWH (04/07/20)
       
    1002. CROI: TRICARBOXYLIC ACID METABOLITES PREDICT METABOLIC COMORBIDITIES AND DEATH IN AGING PWH (04/07/20)
       
    1003. CROI: Retinal Thinning in Well-Controlled HIV-infected Patients (03/30/20)
       
    1004. CROI: Retinal Thinning in Well-Controlled HIV-infected Patients (03/30/20)
       
    1005. CROI: EFFECTS OF HIV INFECTION AND IMMUNE REGULATION ON LONGITUDINAL LUNG FUNCTION DECLINE (03/30/20)
       
    1006. CROI: Modifiable Risk Factors for Kidney and Heart Disease Have Less Impact in HIV+ Than HIV- - Mark Mascolini (03/30/20)
       
    1007. CROI: EFFECT OF ANTICHOLINERGIC MEDICATIONS ON BRAIN INTEGRITY IN OLDER HIV-POSITIVE ADULTS (03/23/20)
       
    1008. CROI: SINGLE-CELL GENOMIC ANALYSIS OF BLOOD AND CSF T CELLS IN HIV+ AND HIV- ADULTS......T Cell Exhaustion in CNS HIV (03/17/20)
       
    1009. CROI: MITOCHONDRIAL DNA, COGNITIVE FUNCTION, AND FRAILTY IN OLDER ADULTS WITH HIV (03/17/20)
       
    1010. CROI: Less Coronary Intervention, Higher Mortality in HIV+ People With Acute Coronary Syndrome - Mark Mascolini (03/17/20)
       
    1011. CROI: Starting ART With a PI or an InSTI (Mainly Raltegravir) May Heighten Risk of Diabetes - Mark Mascolini (03/17/20)
       
    1012. CROI: METABOLIC COMPLICATIONS OF HIV AND ITS THERAPIES (03/17/20)
       
    1013. CROI: Predicted 10-year risks of diabetes and cardiovascular disease in the ADVANCE trial (03/17/20)
       
    1014. CROI: Testosterone Use Tied to Signals of Atherosclerosis Progression in Men With HIV (03/17/20)
       
    1015. CROI: VISCERAL FAT IS A PREDICTOR OF LIVER FIBROSIS AND FIBROSIS PROGRESSION IN PEOPLE LIVING WITH HIV (03/17/20)
       
    1016. CROI: Clinical Predictors of Liver Fibrosis Presence and Progression in HIV-Associated Nonalcoholic Fatty Liver Disease (03/17/20)
       
    1017. CROI: 144-Week Efficacy and Safety of B/F/TAF in Treatment-Naive Adults Age ≥50 Years - (03/11/20)
       
    1018. CROI: ViiV Healthcare presents positive long-term data from phase III study demonstrating efficacy and safety of cabotegravir and rilpivirine, its investigational, long-acting injectable treatment regimen in adults living with HIV-1 - (03/11/20)
       
    1019. CROI: Glucose Upsets Tied to Worse Physical Function in Men With or Without HIV - Mark Mascolini (03/11/20)
       
    1020. CROI: LONG-ACTING CABOTEGRAVIR + RILPIVIRINE FOR HIV TREATMENT: FLAIR WEEK 96 RESULTS - (03/11/20)
       
    1021. CROI: STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1 [Combinectin GSK3732394] - (03/11/20)
       
    1022. CROI: Mortality 4-Fold Higher With HIV in Canadian Group--in Sync With Comorbidity Tally - Mark Mascolini (03/11/20)
       
    1023. CROI: HIV Severity and Incident Heart Failure Among Adults in a Large Healthcare System - (03/11/20)
       
    1024. CROI: WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251 - (03/11/20)
       
    1025. CROI: New Data on Gilead's Biktarvy® Presented at CROI 2020, Including Data in Black Americans and Older Adults - (03/11/20)
       
    1026. CROI: HIV cure from bench to bedside.....and to community - (03/11/20)
       
    1027. Could Colchicine Be the New Aspirin? - (03/09/20)
       
    1028. HIV Itself Ages PLWH - Immunosenescence - (03/09/20)
       
    1029. HIV Causes Aging In HIV & Contributes to the Onset Prematurelly & in Greater Rates of Comorbidities - (03/09/20)
       
    1030. Bone Update: Is It Still an Issue Without Tenofovir Disoproxil Fumarate? - (03/09/20)
       
    1031. Geriatric model & screening assessments ALL HIV clinics should have - (02/28/20)
       
    1032. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study - (02/27/20)
       
    1033. CROI: Changes in markers of T-cell Senescence and Exhaustion With HIV Therapy - (02/21/20)
       
    1034. Aging of HIV+ in US.....an epidemic coming - (02/21/20)
       
    1035. Multiple roles for HIV broadly neutralizing antibodies - (02/21/20)
       
    1036. Aging in NYC: Black/Latino 25% >60 Yrs Old; 75% >40. 23,000 >60 - (01/23/20)
       
    1037. HIV/Aging in NYC 80%+ over 40 Yrs Old/IDUs 95%/HIGH Death Rates for Older HIV - (01/23/20)
       
    1038. Increased Healthcare Costs for Older HIV+ - (02/10/20)
       
    1039. Functional Interval Training for Veterans Exercising Through Telehealth. (FIT-VET) - (02/06/20)
       
    1040. Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV - (02/04/20)
       
    1041. Aging At CROI 2019 - (01/29/20)
       
    1042. Harvard HIV and Aging Workshop: Perspectives and Priorities from Claude D. Pepper Centers and Centers for AIDS Research - (01/28/20)
       
    1043. Gender & Racial Aging/HIV Disparities - (01/28/20)
       
    1044. AGE: Food Insecurity and Frailty among Women Living with or At-risk for HIV in the U.S. - (01/24/20)
       
    1045. AGE: Can Frailty Be Prevented or Reversed???? - (01/24/20)
       
    1046. Frailty & 5x Higher Mortality in HIV+ Women (WIHS) & Men (MACS) with HIV; frailty doubles fracture rate in older women with HIV; Ever opiate or cocaine use was also associated with increased risk - (01/24/20)
       
    1047. A Study of Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) to Maintain Viral Suppression in Adults Living with HIV-1 A Multicenter Trial of the AIDS Clinical Trials Group (ACTG) - A5357 - (01/24/20)
       
    1048. AGE: Frailty and Aging (worse mortality): The last 10 years of aging research, and next steps. - (01/23/20)
       
    1049. EACS: Aging with HIV (01/22/20)
       
    1050. AGE: Loneliness & Social Isolation in HIV: Reduces Mental & Physical Health. The "Village Model in HIV study: pilot in San Diego, app" - (01/22/20)
       
    1051. Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017 - (01/17/19)
       
    1052. Aging Successfully in WIHS...BUT. Prevalence and Correlates of Self-Rated Successful Aging Among Older Women Living With HIV - (01/17/19)
       
    1053. Alzheimers & Amyloid, Mild Cognitive Impairment in HIV - (01/17/19)
       
    1054. Fauci: Comorbidities in Persons With HIV - The Lingering Challenge - (12/18/19)
       
    1055. Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study....'40% diabetes, 10% cancers, 80% elevated cholesterol, 30% low kidney function eGFR <60, 20% osteoporosis, 80% high blood pressure - (12/13/19)
       
    1056. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study; Commentary: Thinking About Getting Older With Human Immunodeficiency Virus "HIV Clinics Need To Expand Services" - (12/13/19)
       
    1057. HIV and the Aging Brain - Miami CFAR Aging Conference - (12/12/19)
       
    1058. Ruth M. Rothstein CORE Center and Cook County Health HIV Integrated Program launch 'CORE Healthy Aging Initiative 2.0' - (12/12/19)
       
    1059. EACS: Integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in adipose tissue and adipocytes (12/12/19)
       
    1060. Inflammaging: Discover the Fountain of Youth - CFAR Miami Conference - (12/09/19)
       
    1061. People ageing with HIV face an uncertain future - (12/05/19)
       
    1062. New Survey of Young Adults Uncovers Low Levels of Accurate Knowledge About HIV Transmission Coupled with High-Risk Sexual Behaviors - (12/05/19)
       
    1063. CT Fat Density Accurately Reflects Histologic Fat Quality in Adults With HIV On and Off Antiretroviral Therapy - Adipose/Fat Density & Quality - (12/05/19)
       
    1064. Bisphosphonates and lower mortality risk, Heart Disease & Bone Disease Associated in HIV+ - (12/04/19)
       
    1065. EACS: Depression and kynurenine/tryptophan ratio in people living with HIV (12/04/19)
       
    1066. EACS: Pharmacokinetics of Cabotegravir and Rilpivirine Long-Acting Injectables in HIV-Infected Individuals Through 48 Weeks in the FLAIR and ATLAS Phase 3 Studies (12/02/19)
       
    1067. EACS: EACS New Aging/Screening Guidelines / HIV+ Case 69 Year Old Aging in Spain - Brighton UK Geriatric HV Clinic - (11/14/19)
       
    1068. EACS: Fibrosis, Steatosis, and NAFLD Boost Odds of Frailty in HIV Group - Mark Mascolini (11/13/19)
       
    1069. Aging with HIV in the US / Proposed Research Implementation Study: clinical & community care & services needs, unmet needs - Jules Levin (09/23/19)
       
    1070. Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women - (11/04/19)
       
    1071. Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations - (11/04/19)
       
    1072. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era - Results From the Veterans Aging Cohort Study - (11/04/19)
       
    1073. AGE: Aging Workshop Report : DNA Methylation : Heart Disease ; Kidney Disease - Christina K. Psomas MD - (11/01/19)
       
    1074. AGE: The Utility of Olfactory Function in Distinguishing Early Stage Alzheimer's Disease from HIV-associated Neurocognitive Disorder: A Pilot Study - (11/01/19)
       
    1075. AGE: Lipidome abnormalities and altered macrophage phenotype may contribute to cardiovascular disease risk in the aging HIV population - (11/01/19)
       
    1076. AGE: FRAILTY PHENOTYPE IN OLDER VIROLOGICALLY SUPPRESSED PLWH IS STRONGLY CORRELATED WITH SPECIFIC COMORBIDITIES AND TOBACCO USE - (11/01/19)
       
    1077. Time to change cardiovascular prevention in people with HIV - A more pragmatic approach is the direct measurement of cIMT to construct cIMT-based monitoring and prevention guidelines for HIV-positive people - comment - (10/25/19)
       
    1078. Brain Dysfunction/HIV-Neurologic Decline Shifting - (10/25/19)
       
    1079. AGE: PERCEPTIONS OF AND PREFERENCES FOR ORAL OR LONG-ACTING INJECTABLE ANTIRETROVIRAL TREATMENT REGIMENS IN THE UNITED STATES AND CANADA - (10/23/19)
       
    1080. AGE: Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment Among People Living With HIV - (10/23/19)
       
    1081. AGE: "I feel empowered": Women's perspectives on and experiences with long-acting injectable anti-retroviral therapy in the United States and Spain - (10/23/19)
       
    1082. AGE: Experiences and Emotional Challenges of Antiretroviral Treatment - Findings from the Positive Perspectives Study - (10/23/19)
       
    1083. AGE: LONG-TERM PRE-HAART SURVIVORS OF HIV: A SPECIFIC GROUP WITH SPECIFIC NEEDS - 'high rates of mental & physical impairments' - (10/23/19)
       
    1084. AGE: Food Insecurity and Frailty among Women Living with or At-risk for HIV in the U.S. - 40% WIHS Women Have Food Insecurity - where us Ryan White Care Act? - No Safety Net - (10/23/19)
       
    1085. AGE: What is the lived experience of loneliness in older men living with HIV? A qualitative analysis to guide service development - (10/23/19)
       
    1086. AGE: Magnetic Resonance Spectroscopy Evidence of Accelerated Aging in Virally-Suppressed HIV - (10/23/19)
       
    1087. Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base - (06/18/19)
       
    1088. HIV and Aging - Primary and secondary prevention of coronary artery disease among People living with HIV - HIV+ higher death risk after stroke or MI - (09/25/19)
       
    1089. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy insights from coronary computed tomography-angiography - (09/24/19)
       
    1090. Excess heart age in adult outpatients in routine HIV care (HOPS) - excess heart age by 10-13 Years in HIV+ - (09/24/19)
       
    1091. Aging with HIV in the US / Proposed Research Implementation Study: clinical & community care & services needs, unmet needs - (09/23/19)
       
    1092. Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity - (06/14/19)
       
    1093. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in HIV-Infected Adults - (06/14/19)
       
    1094. Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation A Randomized Clinical Trial - (06/14/19)
       
    1095. Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States - (06/14/19)
       
    1096. Aging Grant - NIH Grant Funds $23 Million Study of Diseases Affecting People Living with HIV - (06/12/19)
       
    1097. The Changing Face of HIV-Associated Malignancies: Advances, Opportunities, and Future Directions / Treatment Access Denied to HIV+ - (06/10/19)
       
    1098. HIV/Safe PD-1 Cancer Treatment / Studies Should Include HIV+ - (06/10/19)
       
    1099. New PrEP Long-Acting MK-8591, for HIV Treatment Too - (06/10/19)
       
    1100. Excess Vitamin D Linked to Kidney Damage - (06/10/19)
       
    1101. Short-term outcomes for lung cancer resection surgery in HIV infection - (06/05/19)
       
    1102. Cardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence - (06/05/19)
       
    1103. Aging of HIV-Infected: a explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too - Commentary by Jules Levin - (04/04/17)
       
    1104. Aging in US - Worse Still To Come - polypharmacy, multiple comorbidities, decreased survival, impaired daily activities functioning - (12/21/16)
       
    1105. Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures: 'HIV Atrophies Brain Despite HAART/HIV Aged Brain 17 Yrs Faster/Evaluation Tests' - (12/07/16)
       
    1106. HIV & Aging - Mental Needs: Policy, Mental Health Services Program, Comorbidities, Services for Aging/Older HIV+ - (09/29/14)
       
    1107. AGE: Poorer Muscle Quality and Quantity with ART Initiation is Associated with Greater Inflammation and Immune Activation - (10/21/19)
       
    1108. AGE: Blunted Increase in Muscle Mass After Exercise Training in People Aging with HIV - (10/21/19)
       
    1109. AGE: Frailty But Not HIV Tied to Falls in Large Group of Older US Women - Mark Mascolini (10/21/19)
       
    1110. AGE: Blunted Increase in Muscle Mass After Exercise Training in People Aging with HIV - (10/17/19)
       
    1111. AGE: Frailty phenotype is associated with antiretroviral exposure among older persons living with HIV. - (10/17/19)
       
    1112. AGE: Comorbidities Are Key Frailty Risk Factors in Older French Group With HIV - Mark Mascolini (10/17/19)
       
    1113. AGE: Real-World Use of Ibalizumab in Physician Office infusion Centers (POICs) - (10/17/19)
       
    1114. AGE: The association between mitochondrial DNA copy number and longitudinal lung function decline among people with or at risk of HIV - Mark Mascolini (10/17/19)
       
    1115. AGE: Supplemental Testosterone Contributes to Strength Differences in Men With vs Without HIV - Mark Mascolini (10/17/19)
       
    1116. AGE: Characteristics Associated with Exercise Adherence in the Setting of a Supervised Intervention - (10/17/19)
       
    1117. AGE: HIV+ People Who Need Exercise More Are Less Likely to Adhere to Program - Mark Mascolini (10/17/19)
       
    1118. AGE: Physical Function, Falls, Comorbidity > Predict Death in Middle-Aged With HIV - Mark Mascolini (10/17/19)
       
    1119. AGE: Elevated Cardiac Risk Score by ASCVD Calculation is Associated with Albuminuria in Older People Living with HIV - (10/17/19)
       
    1120. AGE: Elevated Cardiac Risk Score by ASCVD Calculation is Associated with Albuminuria in Older People Living with HIV - (10/17/19)
       
    1121. AGE: Elevated Albuminuria Tied to ASCVD Risk in Older People With HIV - (10/17/19)
       
    1122. AGE: Physical Function, Falls, Comorbidity Predict Death in Middle-Aged With HIV - Mark Mascolini - (10/15/19)
       
    1123. IDWeek 2019: Household Income and its Relationship with Patient-reported Outcomes among Older People Living with HIV - (10/15/19)
       
    1124. IDWeek 2019: Characteristics Associated with Pre-Frailty in Older People Living with HIV (47% Pre-Frailty) - (10/15/19)
       
    1125. IDWeek 2019: Poor Mental Health & Quality of Life in Virally Suppressed HIV+ - (10/15/19)
       
    1126. IDWeek 2019: Household Income and its Relationship with Patient-reported Outcomes among Older People Living with HIV - (10/15/19)
       
    1127. IDWeek 2019: Characteristics Associated with Pre-Frailty in Older People Living with HIV (47% Pre-Frailty) - (10/15/19)
       
    1128. Ageing with and without HIV: will advanced age bring equity or greater disparity? Perspective by Amy Justice - (10/03/19)
       
    1129. Reversal of epigenetic aging and immunosenescent trends in humans - (09/25/19)
       
    1130. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy insights from coronary computed tomography-angiography - (09/24/19)
       
    1131. Excess heart age in adult outpatients in routine HIV care (HOPS) - excess heart age by 10-13 Years in HIV+ - (09/24/19)
       
    1132. Aging with HIV in the US / Proposed Research Implementation Study: clinical & community care & services needs, unmet needs - Jules Levin (09/23/19)
       
    1133. Quality of Life in HIV+ in US & Globally: most unhappy - (09/13/19)
       
    1134. 75-85% in SF-NY-Florida-Boston with HIV Are Over 40 Years Old....25% over 60 in SF-Florida-NY - (09/04/19)
       
    1135. Inflammation in HIV+ Causes Mood Emotions Changes & Alters Social Interaction - (09/09/19)
       
    1136. New ways of developing treatment of chronic inflammation - (09/04/19)
       
    1137. People Living With HIV in New York City Still Dying From Infections, Not Just Old Age - (09/04/19)
       
    1138. What is Frailty ? Burden of frailty in the elderly population: perspectives for a public health challenge - (09/04/19)
       
    1139. HIV+ 70-74 Have Same # of Comorbidities as HIV-Neg >85, Similarly for polypharmacy. Medicare study Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis - (09/04/19)
       
    1140. HIV in Atlanta/Georgia-Aging - (09/04/19)
       
    1141. 75-85% in SF-NY-Florida-Boston with HIV Are Over 40 Years Old....25% over 60 in SF-Florida-NY - (09/04/19)
       
    1142. Cardiovascular risk of smoking may last up to 25 years, new study - (09/04/19)
       
    1143. Neurpoathy Predictors in HIV in CHARTER Group - (09/04/19)
       
    1144. IAS: Symptom Burden and Inflammatory Cytokines in PLWH in the US: an analysis by sex, menopause stage and menstrual cycle phase - (09/03/19)
       
    1145. IAS: Smoking and High HIV Viremia Damage Mitochondrial DNA and May Accelerate mtDNA Aging - (09/03/19)
       
    1146. A Novel Therapeutic (NTRX-07) Targeting Neuroinflammation in Alzheimer's disease is Undergoing Phase I trials - (08/14/19)
       
    1147. Dementia/Sleep Aids-Drugs/Women HIV+ More Vulnerable - "Sleep aids and dementia: Studies find both risks and benefits" - (08/14/19)
       
    1148. Increased Risk of Subjective Cognitive Decline in the LGBT Community - (08/14/19)
       
    1149. 18-Month Results (Open Label Extension) of a Phase 2/3 Trial of Inhaled Insulin in People With MCI or Mild Alzheimer's - (08/14/19)
       
    1150. Gilead $17 Million RFP & ViiV Aging Projects - (08/09/19)
       
    1151. What Aging With HIV Means in the Year 2019 - (08/06/19)
       
    1152. IAS: Comorbidities Canadians: >70 HIGH Rates - (08/05/19)
       
    1153. IAS: Perspectives from the Front Lines: Encouraging Community Engagement in the Performance of Research at the Intersection of HIV and Aging - (08/05/19)
       
    1154. IAS: "There's no retirement plans for us": Re-analysis from a qualitative study of HIV-positive MSM who use substances - (07/27/19)
       
    1155. Elderly HIV+ Physiologic Changes, Polypharmacy, Prescribing Issues Prescribing issues in elderly individuals living with HIV REVIEW - (07/17/19)
       
    1156. 2-3 Times Greater MI & Heart Failure Risk in HIV+ / "rates of CVD hospitalization were double in HIV infected" - "HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database" - (07/16/19)
       
    1157. Persistent HIV in central nervous system linked to cognitive impairment - (07/16/19)
       
    1158. CROI: TOCILIZUMAB (monoclonal antibody) ALTERS LIPIDS IN HIV+ INDIVIDUALS IN A RANDOMIZED, DOUBLE-BLIND STUDY - (07/10/19)
       
    1159. Aging/HIV & Senescence; NASH - (07/08/19)
       
    1160. Doubling of Rates of HIV in Nursing Homes - Nursing Home Residents by Human Immunodeficiency Virus Status: Characteristics, Dementia Diagnoses, and Antipsychotic Use - (07/08/19)
       
    1161. Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection - (07/02/19)
       
    1162. Women - greater weight gain than men associated with integrase inhibitors - all future ART studies should include looks at weight gain. - (07/02/19)
       
    1163. Increased Prevalence of Hepatic Steatosis in Young Adults With Lifelong HIV...33% hepatic steatosis >/= grade 1 vs 10% controls - > grade 2 28% vs 5% controls - belly, metabolics - (06/28/19)
       
    1164. When to use CT Angiography - Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data - (06/25/19)
       
    1165. Kidney Disease "Risk Factor for CVD" - (06/19/19)
       
    1166. Activation and Senescence Markers in HIV Patients with Chronic Kidney Disease - (06/17/19)
       
    1167. NEW DATA RELEASED BY THERATECHNOLOGIES DEMONSTRATE POSITIVE IMPACT OF TESAMORELIN IN PATIENTS WITH LIVER FIBROSIS - (06/17/19)
       
    1168. CROI: Lower bone strength by peripheral quantitative CT (pQCT) in children living with HIV - (06/05/19)
       
    1169. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association - (06/05/19)
       
    1170. Congestive Heart Failure and Chronic Kidney Disease The CardioRenal/NephroCardiology Connection - EDITORIAL COMMENT - (06/05/19)
       
    1171. Heart Disease Risk Factors in HIV+ This study just published: "Factors Associated With Excess Myocardial Infarction Risk in HIV-Infected Adults" But there are key crucial points NOT covered in this meta-analysis study...... - (06/05/19)
       
    1172. Arterial Stiffness in the Heart Disease of CKD - Kidney/Cardio Connection - (06/05/19)
       
    1173. Metabolic Bone Disease in Chronic Kidney Disease - Kidney-Bone-Cardio Connection - (06/03/19)
       
    1174. Impact of HIV/simian immunodeficiency virus infection and viral proteins on adipose tissue fibrosis and adipogenesis - (06/03/19)
       
    1175. Intranasal Insulin for Cognition / New study in HIV+ - (06/03/19)
       
    1176. Energy Drinks: Another Cause of QT Prolongation? - (06/03/19)
       
    1177. CROI: Mood Disorders & Increased Risk of Non-communicable Diseases in Adults Aging with HIV.....more HIV+ females had mood disorders 27% vs 22% - (05/31/19)
       
    1178. CROI: Bone, Frailty, and Aging at CROI 2019 - Todd Brown, MD, PhD Division of Endocrinology, Diabetes, & Metabolism Johns Hopkins University - (05/31/19)
       
    1179. Type 2 diabetes prevalence [doubled] and its risk factors in HIV: A cross-sectional study - (05/28/19)
       
    1180. "The absurdly high cost of insulin" - as high as $350 a bottle, often 2 bottles per month needed by diabetics - (05/28/19)
       
    1181. Diabetes Risk 39% Higher: BMI, Obesity, Old PIs and NRTIs Associated; Insulin Cost Tripled; Competition Limited - (05/28/19)
       
    1182. Ageing with HIV: Emerging importance of chronic comorbidities in patients over 75 - (05/24/19)
       
    1183. Chronic kidney disease is associated with < low BMD at the hip but not at the spine - (05/24/19)
       
    1184. HIV-infected patients aged above 75 years in France: - (05/21/19)
       
    1185. Mediterranean/Low Carb Diet Superior in Reducing Hepatic Fat for Fatty Liver/NAFLD & Non-NAFLD too - (05/17/19)
       
    1186. CROI: MECHANISMS OF WHITE-MATTER LOSS DUE TO HIV INFECTION AND ANTIRETROVIRAL THERAPY - (05/13/19)
       
    1187. CROI: RELAPSE OF SYMPTOMATIC CSF HIV ESCAPE UPON PREVIOUSLY OPTIMIZED cART REGIMEN CHANGES / CNS Eradication Reservoir - (05/13/19)
       
    1188. Increasing Cognitive Aging in HIV+ WIHS Women Despite Viral Suppression, MACS Men - (05/10/19)
       
    1189. HIV+ Women & Aging: worse for women with HIV - (05/10/19)
       
    1190. 35% of HIV+ Taking > 10 Comedications at Northwestern ID Clinic - (05/01/19)
       
    1191. 50% Polypharmacy Rates in HIV MACS >5 Comoedications / Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016 - (05/01/19)
       
    1192. Frailty phenotype in older people living with HIV: concepts, prevention and issues - (04/29/19)
       
    1193. CROI: HIV is Associated with Lung Function Impairment in the Multicenter AIDS Cohort Study - (04/28/19)
       
    1194. CROI: 2 Studies on Sudden Cardiac Death in HIV+ at CROI 2019 with surprising findings regarding causes of deaths - (04/28/19)
       
    1195. CROI: HIV is Associated with Lung Function Impairment in the Multicenter AIDS Cohort Study - (04/23/19)
       
    1196. CROI: 2 Studies on Sudden Cardiac Death in HIV+ at CROI 2019 with surprising findings regarding causes of deaths - (04/23/19)
       
    1197. PSYCHOLOGICAL BURDEN AND THE IMPACT ON ENGAGEMENT WITH CARE AMONG ETHNICALLY DIVERSE OLDER WOMEN WITH HIV - (04/23/19)
       
    1198. People living with HIV in the UK have a higher risk of progression to CNS disorders and other comorbidities than matched counterparts - (04/23/19)
       
    1199. FATTY LIVER in HIV+, alcohol, 50% have NAFLD, 27% Liver Fibrosis - The prevalence of liver fibrosis in HIV infected patients with abnormal liver function tests - (04/23/19)
       
    1200. Multimorbidity burden in an HIV population aged over 50 in South-East England - (04/23/19)
       
    1201. "I'm 51 but living in the body of a 65-year old":Exploring the experiences and needs of those living with HIV and multiple comorbidities - (04/23/19)
       
    1202. Comorbidities Prevalence & Clustering Together in 2 European Aging/HIV Cohorts - POPPY & AGEHIV - (04/18/19)
       
    1203. Expanded Access - Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection - (04/18/19)
       
    1204. Study Finds No Benefit for Dietary Supplements - (04/18/19)
       
    1205. Aging & HIV: Gilead Funds 30 Organizations with $17 Million; ViiV Project - "Aging/HIV has become the #1 issue from at least a clinical perspective" - (04/17/19)
       
    1206. HIV and aging: time to bridge the gap between clinical research and clinical care - Editorial "PLWH seem to be biologically older than their chronological age..... something has to be done to bridge the gap between clinical research and clinical care." - (04/17/19)
       
    1207. Why are people with HIV considered "older adults" in their fifties? "immunosenescence" - (04/17/19)
       
    1208. New VIDEO - Staying Golden: Aging With HIV - (04/05/19)
       
    1209. American Heart Association Recommends Depression Screening for Cardiovascular Disease Patients Cardiovascular Disease / 'Double the Concern in Older HIV+' - (04/10/19)
       
    1210. How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection? Dementia Risk in HIV+ is Higher - (04/09/19)
       
    1211. Working memory revived in older adults by synchronizing rhythmic brain circuits - (04/09/19)
       
    1212. CROI: Aging At CROI 2019 - (04/02/19)
       
    1213. CROI: I Keep Forgetting HIV, Aging, and Cognitive Disorders - (03/29/19)
       
    1214. CROI: THE PROJECTED AGE DISTRIBUTION OF WHITE, BLACK, AND HISPANIC MSM ON ART, 2009-2030 / 20% White MSM Projected to be over 70 by 2030 - (03/28/19)
       
    1215. CROI: THE PROJECTED AGE DISTRIBUTION OF WHITE, BLACK, AND HISPANIC MSM ON ART, 2009-2030 - (03/28/19)
       
    1216. CROI: Earlier Age of Onset and Higher Prevalence of Comorbidities in People Living with HIV: A Population-Based Cohort Study in British Columbia, Canada - (03/28/19)
       
    1217. CROI: PROJECTED GROWTH AND NEEDS OF AGING PLWH IN HRSA'S RYAN WHITE HIV/AIDS PROGRAM .....from 2010 through 2030 % > 50 years old doubles with curve sharply increasing-see graph below - (03/28/19)
       
    1218. Neurocognitive SuperAging (SA) in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates (CHARTER) - (03/25/19)
       
    1219. CROI: Integrase Strand Transfer Inhibitors are Associated With Weight Gain in Women - (03/25/19)
       
    1220. Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors - (03/22/19)
       
    1221. Aspirin Use Discourged / 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease - (03/22/19)
       
    1222. CROI: High endothelial dysfunction rate with recent HIV in young adults with low cardiovascular risk - Mark Mascolini (03/19/19)
       
    1223. CROI: ART IN EARLY INFECTION IMPROVES NEUROCOGNITION REGARDLESS OF INFECTION DURATION - (03/19/19)
       
    1224. CROI: Obesity & Weight Gain on Antiretroviral Therapy - (03/11/19)
       
    1225. CROI: RISK FACTORS FOR EXCESS WEIGHT GAIN FOLLOWING SWITCH TO INTEGRASE INHIBITOR-BASED ART - (03/11/19)
       
    1226. CROI: Dolutegravir and Insulin Resistance - (03/11/19)
       
    1227. CROI: MIDLIFE ADIPOSITY PREDICTS COGNITIVE DECLINE IN THE MULTICENTER AIDS COHORT STUDY (MACS) - (03/11/19)
       
    1228. CROI: Pharmacogenetics of Weight Gain after Switch from Efavirenz to Integrase Inhibitors - (03/11/19)
       
    1229. CROI: LONG-LASTING ALTERATIONS IN FAT DISTRIBUTION IN PLWH EXPOSED TO THYMIDINE ANALOGUES - (03/11/19)
       
    1230. CROI: Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV - (03/11/19)
       
    1231. CROI: GREATER WEIGHT GAIN AMONG TREATMENT-NAIVE PERSONS STARTING INTEGRASE INHIBITORS - (03/11/19)
       
    1232. CROI: Weight Gain among Virally Suppressed Persons who Switch to INSTI-Based ART, The HIV Outpatient Study - (03/11/19)
       
    1233. CROI: Two thirds of HIV group report pain and 14% endure "widespread" pain [50% to 80% report pain, average age only 53] - Mark Mascolini (03/11/19)
       
    1234. CROI: The Impact of Weight Gain and Sex on Immune Activation Following Initiation of ART - (03/11/19)
       
    1235. CROI: INTEGRASE STRAND TRANSFER INHIBITORS ARE ASSOCIATED WITH WEIGHT GAIN IN WOMEN - (03/11/19)
       
    1236. CROI: Higher cardiovascular risk in older HIV group tied to worse cognitive function - Mark Mascolini (03/08/19)
       
    1237. CROI: Changes in Lipids After a Direct Switch from TDF to TAF (03/08/19)
       
    1238. CROI: Memory and Learning Dysfunction with Integrase Strand Transfer Inhibitor Use (03/08/19)
       
    1239. CROI: HIV-Cognitive Impairment/Obesity-Overweight-Exercise-Efavirenz-Age "OBESITY IS INDEPENDENTLY ASSOCIATED WITH NEUROCOGNITIVE DECLINE IN HIV".....16% had neurocognitive impairment (NCI) & 6% frailty at baseline (03/08/19)
       
    1240. CROI: BREAKING BONES IS BAD: INCIDENT FRACTURE AND MORTALITY IN THE HIV OUTPATIENT STUDY - 45% Increased Mortality Associated with Fracture - (03/06/19)
       
    1241. ViiV ADHOC - Aging with Dignity, Health, Optimism, & Community Study /Registry - (03/01/19)
       
    1242. ViiV ADHOC Aging/HIV Study Registry / Database - "Loneliness Among Older Adults HIV+" - (03/01/19)
       
    1243. Gilead Sciences Launches Age Positively Initiative to Address Unique Challenges of Aging Population Living with HIV - (03/01/19)
       
    1244. 2 Very Recent Studies Linking Inflammation to Causing Cognitive Impairment / inflammation-telomerase connection - (02/27/19)
       
    1245. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials - (02/27/19)
       
    1246. Primary prevention with statins for older adults - Editorial / Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study - (02/27/19)
       
    1247. Primary prevention with statins for older adults - Editorial / Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study - (02/26/19)
       
    1248. ART - Lipodystrophy/Diabetes/Fat Tissue/Mitochondrial damage/Heart Disease: Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy - (02/26/19)
       
    1249. High-Fat Diets Linked With Changes in Gut - (02/26/19)
       
    1250. 2 Studies: Frailty Associated with 4 Times Increased Death Rates in HIV+, Associated with Comorbidities Onset, 2- Frailty and NCI (neurocognitive impairment) in study 2 Led to Increased disability, falls, in inability to Function Measuring by IADLs, independent living - (02/26/19)
       
    1251. OAR Advisory Council Meeting - Aging/HIV Discussion Slide Presentation by NIA HIV-Brain Researcher - Nov 15 2018 - (02/26/19)
       
    1252. Diagnosis and Treatment of Cognitive Impairment in HIV Patients - (02/25/19)
       
    1253. Cardiac dysfunction prevalent in patients with HIV. - Editorial - Myocardial Dysfunction With Contemporary Management of HIV Prevalence, Pathophysiology, and Opportunities for Prevention - Belly Fat-Lipodystrophy Connection - (01/30/19)
       
    1254. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? - (01/30/19)
       
    1255. Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study - (01/30/19)
       
    1256. MACS Fraikty - HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty - (01/30/19)
       
    1257. GLASGOW: Comorbidities, Comedication, and Polypharmacy Burden in Patients With HIV: Retrospective Claims Data in Germany - (01/28/19)
       
    1258. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm - (01/16/19)
       
    1259. Mild renal impairment is associated with calcified plaque parameters assessed by computed tomography angiography in people living with HIV - (01/14/19)
       
    1260. Not surprisingly this study reports fat belly * fat loss contributes to heart disease & inflammation, previous studies have found similarly. The other study I just emailed to you found mild kidney dysfunction, eGFR/creatinine- too can increase heart disease risk. Jules - (01/14/19)
       
    1261. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? Yes-Biological Age greater by 13 Years in HIV+ - (01/14/19)
       
    1262. Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis - (01/14/19)
       
    1263. Aging & the Brain - Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5 - (01/04/19)
       
    1264. Cognitive Impairment and 1-Year Outcome in Elderly Patients with Hip Fracture.....hip fracture death rates are 11% to 34% - (01/04/19)
       
    1265. Brain Atrophy in HIV+ > 60 is Progressive Despite Viral Suppression / ART Neurotoxicity /LIMC / Aging/ Mental & Substance Abuse Disorders - (01/02/19)
       
    1266. HIV-positive participants had worse complex motor performance than HIV-negative participants - (01/02/19)
       
    1267. HIV infection [slows brain activity] results in ventral-striatal reward system hypo-activation during cue processing - (01/02/19)
       
    1268. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure - (01/02/19)
       
    1269. The Challenges of Improving Treatments for Depression - (01/02/19)
       
    1270. ART Promise is Gone For Older Aging HIV+ - (12/19/18)
       
    1271. HIV Death Rates Will Increase Due To Aging/Comorbidities & Healthcare Costs Will Double Housing, This Must Get Close Attention - (12/19/18)
       
    1272. Beating Aging/HIV - How to Be More Resilient - (12/19/18)
       
    1273. Preclinical Biomarkers for Functional Decline in HIV and Aging - (12/19/18)
       
    1274. Cure: Little Progress & Disappointing thus far, Researchers say - (12/19/18)
       
    1275. The Demographic Shift in HIV: The Aging HIV Patient - (12/19/18)
       
    1276. AGE: Comprehensive Geriatric Assessment (CGA) - (11/08/18)
       
    1277. GLASGOW: Factors associated with HIV associated neurocognitive disorder in an unselected cohort in East and South London-The HAND study - (11/08/18)
       
    1278. GLASGOW: HIV and Ageing Challenges and Goals - Plenary Talk at Glasgow 2018 - (11/08/18)
       
    1279. GLASGOW: Two Thirds Reach Sub-50 Viral Load Through 48 Weeks With Ibalizumab - Mark Mascolini (11/07/18)
       
    1280. GLASGOW: HIV Linked to Higher Odds of Anemia, Neutropenia, and Thrombocytopenia - Mark Mascolini (11/07/18)
       
    1281. Non-Smokers Are At Risk for COPD & Marijuana May Add to Risk, Smokers Are At Greater Risk. Lung Cancer in HIV+ is one of the more frequent cancers among men - (11/06/18)
       
    1282. GLASGOW: Prevalence of mental health problems among people living with HIV: - (11/05/18)
       
    1283. AdverseReactComor: Switching tenofovir disoproxil fumarate to tenofovir alafenamide - not only bone and kidney - (11/01/18)
       
    1284. GLASGOW: The economic burden of comorbidities among people living with HIV in Germany; A cohort analysis using health insurance claims data - (10/29/18)
       
    1285. GLASGOW: Multimorbidity and risk of death differs by gender in people living with HIV in the Netherlands - the ATHENA cohort study - (10/29/18)
       
    1286. GLASGOW: Mixed Signals With Cardiovascular Markers in Dolutegravir Switch Study - Mark Mascolini - (10/29/18)
       
    1287. GLASGOW: Neuro Impairment in Over One Third of London HIV Group--Anxiety Doubles Risk - Mark Mascolini - (10/29/18)
       
    1288. SF Aging Survey: Lack of Service; older aging-loneliness-depression, feeling abandoned - (10/22/18)
       
    1289. Association of antiretroviral therapy with brain aging changes among HIV-infected adults - (10/17/18)
       
    1290. AGE: Aging and Falls & Fractures in HIV+ - (10/15/18)
       
    1291. 50% Have Pain, Neuropathy in HIV+: its implications & psychological affects- distress opioid abuse, depression, adherence - (10/15/18)
       
    1292. IDWeek: Characteristics of HIV+ Patients Prescribed Raltegravir QD in the United States - good picture of the aging generation - (10/13/18)
       
    1293. IDWeek: The aging epidemic: virologic control, immunologic recovery, treatment regimens, and clinical outcomes among older adults living with HIV in Washington, DC: Long-Term CD4 and Viral Rebound Trends Worse Over Age 59 Than at 18 to 35 - Mark Mascolini (10/12/18)
       
    1294. IDWeek: Hospitalization rates among persons with HIV who gained Medicaid or private insurance in 2014: Moving From Ryan White to Medicaid or Private Insurance Did Not Boost Hospital Use; BUT Older HIV+ 55-64 Had Double the Hospitalization Rate; Low CD4 & Detectable Viral load also had Higher Hospitalization Rates (10/12/18)
       
    1295. IDWeek: Hospital Rates Rise With Age for Cancer, Cardio, Other Diseases in US HIV Group - Mark Mascolini (10/10/18)
       
    1296. IDWeek: Mental Health Medications (Non-ARV meds) in Older HIV+ Appear to Cause Cognitive Impairment & Slow Gait Speed - Ethnicity, Insurance Differ in Older HIV Group Taking Mental Health Meds - Mark Mascolini - (10/09/18)
       
    1297. AGE: Cumulative Affects of Aging & HIV: mental & physical affects Reported at 2018 aging Workshop - 'mental & physical functional Disabilities' - (10/06/18)
       
    1298. IDWeek: Results of Patient-Reported Outcome Data from the Phase III BRIGHTE Study of Fostemsavir - (10/05/18)
       
    1299. IDWeek: Half of 50-Plus HIV Group Lonely, But Loneliness Declines in the 60s - Mark Mascolini - (10/05/18)
       
    1300. IDWeek: In 60-Year-Plus HIV Group With Viral Suppression, 70% Have Low CD4:CD8 Ratio - Mark Mascolini - (10/05/18)
       
    1301. IDWeek: Predictors of cardiovascular outcomes in older HIV-infected patients: CORE50 Cohort 10-year follow-up / Framingham Score, Depression, Aspirin Predict Cardiovascular Events in Older People With HIV - Mark Mascolini - (10/05/18)
       
    1302. AGE: CD4 effector memory T cells connected to death in veterans living with HIV..... "suggest an accelerated aging of the immune system, and an increase in this particular risk factor for death" - (09/26/18)
       
    1303. AGE: Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis - (09/26/18)
       
    1304. AGE: The Impact of Structured Exercise on Brain Health in Individuals with HIV: A Pilot Study from the Brain Positive Health Now Cohort (BHN).....Improved Physical Function - (09/26/18)
       
    1305. AGE: 75% Projected to Be Over 50. 85% of HIV+ projected to Have Cadiovascular Disease in USA, 30% malignancy, 23% diabetes. Care Costs Increase by 40% due to Comorbidities. - (09/25/18)
       
    1306. AGE: Frailty Phenotype in Canadian Men and Women with HIV. from Jules: Fried Frailty test is too simple in HIV - (09/25/18)
       
    1307. AGE: How Different Are Invisible and Visible Disabilities in HIV? Over 60 functioning Very Limited - Important Report: mental & physical limitations in Aging HIV+ - (09/25/18)
       
    1308. AGE: Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Treatment-experienced, Virologically Suppressed (EMERALD) and Treatment-naïve (AMBER) Patients: Week 48 Subgroup Analysis by Age - (09/25/18)
       
    1309. AGE: Acute Exercise-Induced Inflammatory Response among Older Adults with and without HIV - (09/25/18)
       
    1310. AGE: Exercise-Induced Inflammatory Changes among Older Adults with and without HIV.... from Jules: look at slides at end showing improved functioning due to exercise with high intensity exercise appearing to show more benefits, and decreased CRP with high intensity. - (09/25/18)
       
    1311. AGE: HIV and the "Geri-ome": Linking Gut Dysbiosis to Inflammation - (09/25/18)
       
    1312. AGE: 'Premature Muscle Aging In Middle-Aged HIV+ men & women' - (09/25/18)
       
    1313. AGE: Aging with HIV? I'm fine, thanks for asking! - 14% Age Well in Canada Cohort - (09/21/18)
       
    1314. AGE: Associations of loneliness with cognitive function and quality of life (QoL) among older adults living with HIV - (09/19/18)
       
    1315. AGE: Considerations for The HIV Positive Woman during menopause - (09/19/18)
       
    1316. AGE: Frailty and the Risk of Falls in HIV-Infected Older Adults in the ACTG A5322 Study - (09/19/18)
       
    1317. AGE: Advance Directives and Medical Power of Attorney Assignment in Individuals with HIV - low rates: only 30%-50% or less leave advance directives or power of attorney before death - (09/19/18)
       
    1318. AGE: Cognitive aging in the era of effective antiretrovirals - (09/19/18)
       
    1319. AGE: More than 40% of HIV group has hepatic steatosis, regardless of age - Mark Mascolini (09/19/18)
       
    1320. AGE: Associations of loneliness with cognitive function and quality of life (QoL) among older adults living with HIV - 18% lonely quite often - Mark Mascolini (09/19/18)
       
    1321. AGE: Aging HIV+ Brain - The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by age - (09/19/18)
       
    1322. AGE: Muscle mitochondrial function and contemporary anti-retroviral therapy - (09/19/18)
       
    1323. AGE: Physical function worse in older women than men with HIV, despite better CD4 recovery - Mark Mascolini (09/19/18)
       
    1324. AGE: Metabolic syndrome tied to neurocognitive deficit with (but not without) HIV - Mark Mascolini (09/19/18)
       
    1325. AGE: Older age raises odds of amnestic mild cognitive impairment (but not HAND) with HIV - by 5% per year of aging - Mark Mascolini (09/19/18)
       
    1326. AGE: 63% Frail at 65 Years Old-Itlalian Study/NEW HIV Index+Protective Index / HIV-related and social frailty predictors and protectors in 1612-person Italian cohort - (09/19/18)
       
    1327. AGE: HIV and frailty predict first fracture in middle-aged US women's cohort - doubled fracture rates - Mark Mascolini (09/19/18)
       
    1328. AGE: Frailty Phenotype: A Clinical Marker of Age Acceleration in the older HIV-Infected Population - (09/18/18)
       
    1329. AGE: Exhausted & Depleted T Cells in HIV+ Cause Premature Aging & Comorbidities & Frailty Memory loss: T cell subsets associated with mortality in HIV+ and HIV- veterans - (09/18/18)
       
    1330. AGE: Effects of Comorbidity Burden and Age on Brain Integrity in HIV - (09/17/18)
       
    1331. AGE: The Impact of Number of Medications on Falls in Aging Persons Living with HIV - every increase in 1 medication increased risk by 10% for a fall - "50, the new 65?" - (09/17/18)
       
    1332. AGE: The Impact of Number of Medications on Falls in Aging Persons Living with HIV - every increase in 1 medication increased risk by 10% for a fall - "50, the new 65?" - (09/17/18)
       
    1333. AGE: Frailty Predicts Fractures Among HIV-infected and Uninfected Women: Results from the Women's Interagency HIV Study - (09/17/18)
       
    1334. AGE: People taking more medications and women have higher fall risk in older HIV group - written by Mark Mascolini - (09/17/18)
       
    1335. AGE: Exercise-induced inflammatory changes among older adults with and without HIV Inflammation does not drop more with HIV after 24 weeks of exercise - written by Mark Mascolini - (09/17/18)
       
    1336. AGE: Only 42% in HIV group have an advance directive immediately before death - written by Mark Mascolini - (09/17/18)
       
    1337. AGE: "Aging well" more frequent than frailty in Canadian HIV group - written by Mark Mascolini - (09/17/18)
       
    1338. AGE: People taking more medications and women have higher fall risk in older HIV group - written by Mark Mascolini - (09/14/18)
       
    1339. AGE: Big HIV clinic sees more than 1000% jump in patients 65 and older - written by Mark Mascolini - (09/14/18)
       
    1340. AGE: Depression, bipolar disorder tied to noncommunicable disease risk with HIV - written by Mark Mascolini - (09/14/18)
       
    1341. AGE: People taking more medications and women have higher fall risk in older HIV group - written by Mark Mascolini - (09/14/18)
       
    1342. AGE: Big HIV clinic sees more than 1000% jump in patients 65 and older - written by Mark Mascolini - (09/14/18)
       
    1343. AGE: Depression, bipolar disorder tied to noncommunicable disease risk with HIV - written by Mark Mascolini - (09/14/18)
       
    1344. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV - Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor - (09/11/18)
       
    1345. The Aging HIV Brain - HIV Accelerates Brain Aging by 3 to 15 Years in Various Studies over the Past 9 years - (09/11/18)
       
    1346. Caring for Older Adults Living with HIV Infection: policy needed - (09/11/18)
       
    1347. What is Cognitive impairment ? - (09/11/18)
       
    1348. Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women (WIHS) - (09/11/18)
       
    1349. Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients - 'fatty liver & NASH in HIV mono-infected called non-viral hepatitis is a new aging comorbidty' - (09/05/18)
       
    1350. Met and unmet health, welfare and social needs of people living with HIV social isolation - (09/05/18)
       
    1351. Health-related quality of life of adults living with HIV in England and Wales: a utility analysis of EQ-5D-5L compared to the general population - (09/05/18)
       
    1352. The cost of comorbidities in treatment for HIV/AIDS in California - (09/05/18)
       
    1353. Does Social Isolation Predict Hospitalization and Mortality Among HIV+ and Uninfected Older Veterans? YES - (09/05/18)
       
    1354. HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition - (09/05/18)
       
    1355. Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection - (09/05/18)
       
    1356. IAC: Higher Prevalence NCI In Aging HIV-Infected Women Despite Lower Comorbidities Than Men (08/17/18)
       
    1357. IAC: Severe menopausal symptoms double odds of poor ART adherence in UK women - Mark Mascolini (08/08/18)
       
    1358. IAC: CD4 count and viral load tied to atherogenic cholesterol in people with HIV - Mark Mascolini (08/07/18)
       
    1359. IAC: Prevalence and immuno-metabolic associations of frailty in older Australian men living with HIV: a crosssectional analysis (08/08/18)
       
    1360. IAC: Vitamin D does not modulate immune-mediated bone loss during ART initiation: A5280 (08/07/18)
       
    1361. IAC: Liver enzyme spikes--then normalizes--when elderly start dolutegravir - Mark Mascolini (08/07/18)
       
    1362. IAC: Half of adults in HIV group have insomnia--fewer than half of them treated (08/02/18)
       
    1363. IAC: Trends in mortality among HIV-infected subjects; differences by HCV coinfection - 70% of Deaths Non-AIDS: liver-HCV, psychiatric, malignancies, cardiovascular & pulmonary diseases common causes of death (07/31/18)
       
    1364. IAC: "Increased risk of both mortality and incident comorbidity among frail HIV-positive and HIV-negative participants and increased risk of frailty progression in those with HIV." (07/31/18)
       
    1365. IAC: HIV infection independently increases the risk of developing heart failure: The HIV HEART study - Mark Mascolini (07/30/18)
       
    1366. IAC: Very high levels of inflammation marker CRP in young MSM with or without HIV - Mark Mascolini (07/30/18)
       
    1367. IAC: Higher depression and anxiety rates with HIV across ART and viral load categories - Mark Mascolini (07/30/18)
       
    1368. IAC: Beyond the 60s: Changing co-morbidities in people living with HIV aged over 60 attending clinic in 2010 and 2017 - (07/25/18)
       
    1369. EATG Aging / HIV Project - Europe Addressing HIV & Aging - there is no such project in the USA. - (07/19/18)
       
    1370. Aging/HIV - Gilead RFPs - (07/10/18)
       
    1371. Loneliness in Older Adults Living with HIV (58%) - (06/7/18)
       
    1372. Cancer risk among the HIV-infected elderly in the United States - (06/22/18)
       
    1373. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination - (05/15/18)
       
    1374. Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents - (05/14/18)
       
    1375. HIV-infected people are living for years, but age-related diseases set in early - (04/23/18)
       
    1376. Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood - (03/12/18)
       
    1377. How Exercise May Help Protect Your Brain From Cognitive Decline and Dementia - (03/12/18)
       
    1378. Aging in HIV-Infected Subjects: A New Scenario and a New View - (03/05/18)
       
    1379. HIV+ Women - Frailty / Falls / Fracture / Mortality - (03/02/18)
       
    1380. Bone Mineral Density and Parathyroid Hormone as Independent Risk Factors for Mortality in Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study in Brazil. The São Paulo Ageing & Health (SPAH) Study - (02/26/18)
       
    1381. Find drugs that delay many diseases of old age: class of drugs called geroprotectors / European Aging Researchers Unite for Aging Drug Development - (02/26/18)
       
    1382. HIV: ageing, cognition and neuroimaging at 4-year follow-up - 'Accelerated Brain Aging' - (02/15/18)
       
    1383. HIV Accelerates Brain Damage ; "Neurological Complications of HIV Infection" Review - (02/06/18)
       
    1384. MitoQ - An antioxidant to attenuate aortic aging / Mitochondria Treatment - (01/31/18)
       
    1385. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes - (01/31/18)
       
    1386. Changes in viral suppression status among US HIV-infected patients receiving care - (01/31/18)
       
    1387. Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications - (01/31/18)
       
    1388. Viral Suppression Patterns Among Persons in the United States With Diagnosed HIV Infection in 2014 - CDC - (01/31/18)
       
    1389. HIV & PTSD, Lifetime Trauma/Mental Health, Adherence - Aged HIV+ Deserve Better - (01/29/18)
       
    1390. WIHS HIV+ Women - More falls, comorbidities, cognitive impairment, isolation/loneliness, self-stigma, detectable viral load; CDC Viral Suppression is Over Estimated in the USA - (01/29/18)
       
    1391. Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression - (01/29/18)
       
    1392. Forgotten Aging HIV+ - An Explosive Devastating Problem Being Ignored - its scandalous - (01/24/18)
       
    1393. Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in MenThe Cooper Center Longitudinal Study - (01/24/18)
       
    1394. Ten Take-Home Lessons From Top HIV-Aging Articles in 2017 - (01/22/18)
       
    1395. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study - (01/11/18)
       
    1396. Accelerated Brain Aging: WHICH IS IT - No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project - OR - Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60 - (01/05/18)
       
    1397. Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? - (01/03/18)
       
    1398. Suicide in Aging Older HIV+ / Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey - France - (01/03/18)
       
    1399. Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers....[20% diabetes, 44% hypertension, 56% dyslipidemia, HPV, lymphoma & cancers were more prevalent in HIV+, so was stroke] - (12/22/17)
       
    1400. Aging / HIV -USA - Time For Integrated Care / Beyond Viral Suppression / Payer Analysis - (12/15/17)
       
    1401. Social stress induces neurovascular pathology promoting depression - (12/14/17)
       
    1402. EACS: Characterization of the Aging Population Living with HIV in Portugal: a multicentre, observational study to evaluate comorbidities in patients above 50 years of age - AGING POSITIVE - (12/14/17)
       
    1403. apoB vs LDL/cholesterol - To help save the heart, is it time to retire cholesterol tests? - (12/13/17)
       
    1404. The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue - (12/13/17)
       
    1405. EACS: BESIDE - FIRST NATIONWIDE ANALYSIS OF RECREATIONAL/ILLICIT DRUG USE IN HIV-INFECTED INDIVIDUALS IN GERMANY SHOWS HIGH PREVALENCE OF SUBSTANCE ABUSE WITH A POTENTIAL FOR DRUG-DRUG INTERACTIONS WITH ANTIRETROVIRAL THERAPY - (12/13/17)
       
    1406. EACS: BESIDE - HIGH PREVALENCE OF COMORBIDITIES AND CONCOMITANT MEDICATION IN HIV-INFECTED PATIENTS IN GERMANY CARRIES A HIGH POTENTIAL FOR DRUG-DRUG INTERACTIONS WITH ANTIRETROVIRAL THERAPY - (12/13/17)
       
    1407. EACS: Safety and Efficacy of DTG+RPV in the Phase III SWORD-1 and SWORD-2 Studies: 48 Week Subgroup Analysis by Baseline Third Agent Class and Geographic Location - (12/13/17)
       
    1408. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders - (12/11/17)
       
    1409. Cancer rates Higher in HIV+ vs HIV- for many but not for all cancers - (12/08/17)
       
    1410. County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States - (12/08/17)
       
    1411. EACS: Aging in Portugal: The number of PLHIV aged 50+ will double in the next 20 years, representing 80% of the estimated overall prevalence in 2037. The proportion over 70 will increase 4.3 times going from 6% to 26%. - (12/06/17)
       
    1412. HIV Stigma / Women /Aging / Relationships / Isolation / Depression-Mental Health / CVD - (12/02/17)
       
    1413. Does Social Isolation Predict Hospitalization and Mortality Among HIV+ and Uninfected Older Veterans? [yes] - (12/02/17)
       
    1414. European Researchers/Advocates Present HIV/Aging Recommendations/EATG to European Parliament - (12/02/17)
       
    1415. Stigma in HIV: 53% Report Social Stigma & 60% Report Self-Stigma.....high levels of depression, anxiety particularly for >50 Years Old - 63% Report 3 or more Comorbidities - (11/20/17)
       
    1416. Cardiovascular Disease & Risk Assessment in HIV - Editorial & New Study: "Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV" - (11/20/17)
       
    1417. New Hypertension Guidelines say systolic BP 120-129 & diastolic less than 80 are ELEVATED ! - (11/16/17)
       
    1418. EACS: Treated people living with HIV show poorer cognitive performance at baseline but similar longitudinal changes over two years compared to appropriately chosen controls - (11/08/17)
       
    1419. Reducing Blood Pressure / Hypertension Targets - Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and MortalityA Systematic Review and Network Meta-analysis - (11/08/17)
       
    1420. CVD / Hypertension Targets in USA - "Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the Targets" - (11/08/17)
       
    1421. IDWeek: HIV in the Brain - MANAGING COMORBIDITIES IN PATIENTS WITH HIV (10/16/17)
       
    1422. IDWeek: Similar Frequency of New HIV in US Group 45 or Older vs Younger - (10/11/17)
       
    1423. AGE: Aging and Antiretroviral Neurotoxicity - - (10/11/17)
       
    1424. AGE: Adherence to Recommendations from Comprehensive Geriatric Assessment in an HIV+ Population - written by Mark Mascolini - (10/04/17)
       
    1425. AGE: Cognitive Impairment in Symptomatic HIV over age 60 - written by Mark Mascolini - (10/04/17)
       
    1426. AGE: Limited evidence of biological aging in early-treated HIV-infected children - written by Mark Mascolini - (10/04/17)
       
    1427. AGE: Lean Mass Declines Consistently Over 10 Years in HIV-Infected Adults on Antiretroviral Therapy, with Patterns Differing by Sex - written by Mark Mascolini - (10/04/16)
       
    1428. AGE: Metformin suppresses human CMV infection - written by Mark Mascolini - (09/27/17)
       
    1429. AGE: Antiretroviral Therapy Does Not Dial Back Advanced Epigenetic Age With HIV - written by Mark Mascolini - (10/03/17)
       
    1430. HIV Prematurely Ages the Brain: "Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study" - (10/02/17)
       
    1431. Sclerostin Inhibition for Osteoporosis [Romosozumab]- A New Approach - Editorial - (10/02/17)
       
    1432. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - (10/02/17)
       
    1433. New Bone Drug: Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY™ (Romosozumab) In Postmenopausal Women With Osteoporosis - (10/02/17)
       
    1434. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (10/02/17)
       
    1435. ECLAIR Study of Cabotegravir (CAB) LA Injections: Characterization of Safety and PK During the "PK Tail" Phase - (10/02/17)
       
    1436. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (09/29/17)
       
    1437. 2008-2011 / HIV 13 Year Gap Life Expectancy Projected HIV+ vs HIV-Neg: 11 years for Whites; 13 yrs for Blacks; Hispanic 16 yrs. - (09/29/17)
       
    1438. Reyataz Reduced CVD Risk - (09/25/17)
       
    1439. Mitochondrial energetics in the kidney.... "Hyperglycaemia is the main factor that contributes to the development of diabetic nephropathy" - (09/19/17)
       
    1440. Outdated HIV HealthCare Models - high need, aging ignored - (09/18/17)
       
    1441. ARTs Brain Penetration: - do we need it? risks? / Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV - (09/15/17)
       
    1442. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (09/15/17)
       
    1443. Aging with HIV: Redesigning healthcare models - (09/13/17)
       
    1444. HIV & Sleep Disorders: 100% of HIV+ with cognitive impairment have sleep disorder study reports - (09/11/17)
       
    1445. Stigma in HIV+ : 60% experience self-stigma....going along with this is 63% of older HIV+ have 3+ comorbidities which can only worsen stigma & self-stigma - (09/11/17)
       
    1446. Aging With HIV: Expert Insights on Complications and Challenges - (09/11/17)
       
    1447. Fats/Carbohydrates PURE Study Refuted by AHA - (09/11/17)
       
    1448. Fruits, vegetables, and legumes: sound prevention tools Comment questioning PURE study results - (09/11/17)
       
    1449. Fruits, vegetables, and legumes: sound prevention tools - Comment - (09/11/17)
       
    1450. Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease and Lung Cancer- CANTOS Study - (09/11/17)
       
    1451. Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease and Lung Cancer- CANTOS Study - (09/11/17)
       
    1452. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial - (09/09/17)
       
    1453. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease - (09/09/17)
       
    1454. A5336: Ruxolitinib to Reduce Inflammation - (09/09/17)
       
    1455. extra virgin olive oil might be a good food additive to help preserve our 'repairing cells', the EPC: Dark chocolate with olive oil associated with improved cardiovascular risk profile - (09/09/17)
       
    1456. Poor sleep is associated with ischaemic heart disease and stroke - (09/09/17)
       
    1457. Long acting injectable Cabotegravir for PrEP is in Phase 3 [every 4 or 8 weeks] - (09/09/17)
       
    1458. EASL: DNA Methylation Signatures in Blood Show Accelerated Epigenetic Aging in Patients with Nonalcoholic Steatohepatitis Compared to Healthy Controls - (07/07/17)
       
    1459. Men With HIV Age Faster According to DNA Methylation Study: "5-year age advancement in HIV/cART individuals....increasing expected mortality risk by 19%" - (07/13/16)
       
    1460. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study - (09/01/17)
       
    1461. Reassessing the benefits of plant-based eating (PURE) - fruit, vegetables, legumes - CVD risk, mortality - (09/01/17)
       
    1462. Stressed brain, stressed heart?..... Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study - (09/01/17)
       
    1463. CVD-PCSK9 Repatha Outcomes Study FOURIER - (09/01/17)
       
    1464. 3 studies report Hearing Loss in HIV is Worse and Suggests that Aging Worsens Hearing - (09/01/17)
       
    1465. Aging with HIV in U.S. Trans NIH Research Themes - (09/01/17)
       
    1466. Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients - (09/01/17)
       
    1467. HIV & Value Based Healthcare? .....Incorporating Geriatric Consultation Into HIV Care / Employers Plans for Value Based healthcare' - (09/01/17)
       
    1468. From One Syndrome to Many: Incorporating Geriatric Consultation Into HIV Care - (09/01/17)
       
    1469. Geriatric-HIV Medicine Is Born - Commentary - (09/01/17)
       
    1470. Fatty Liver in HIV+ / Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease - (09/01/17)
       
    1471. Senescence, Telomerase, Aging HIV - (08/14/17)
       
    1472. IAS: Bone Mineral Density at the Hip Declines Twice as Quickly Among HIV-Infected Women than Men - (08/14/17)
       
    1473. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy - (08/08/17)
       
    1474. HIV - The Brain, Exercise, Diet, Comorbidities, BBB, CNS Penetration, Cure, Interruptions - (08/08/17)
       
    1475. Diet/Brain-Heart Connection - (08/08/17)
       
    1476. IWCADRH: Clinical Implications of Nonalcoholic Fatty Liver Disease in Patients with HIV Infection - (06/23/17)
       
    1477. IAS: Switch to Dolutegravir Noninferior to Continued PI in Older Group With Heart Risk - Mark Mascolini - (08/04/17)
       
    1478. IAS: Zoledronic Acid Boosts Bone Density More Than Switch From TDF - Mark Mascolini - (08/03/17)
       
    1479. Reyataz Reduced CVD Risk Compared with other ART Regimens - Cardiovascular outcomes among HIV-infected veterans receiving atazanavir: a US national historical cohort study - (07/21/17)
       
    1480. IAS: Sub-Study 202094 of SWORD-1 and SWORD-2: Switch From TDF-Containing Regimen to DTG + RPV Improves Bone Mineral Density and Bone Turnover Markers Over 48 Weeks - (07/26/17)
       
    1481. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review - (07/22/17)
       
    1482. Healthy Plant-Based Diet What Does it Really Mean? Editorial - Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults - (07/22/17)
       
    1483. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada - low CD4 at ART initiation reduced life expectancy 20 years - (07/22/17)
       
    1484. Life Expectancy in HIV / Reyataz Reduced CVD Risk vs PIs/NNRTIs/Integrase - (07/22/17)
       
    1485. CROI: CURE at CROI 2017 - (07/22/17)
       
    1486. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60 - (07/19/17)
       
    1487. Life Expectancy reduced 20 years If ART Started at < 350 CD4s - Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada - (07/19/17)
       
    1488. PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia - (07/19/17)
       
    1489. HIV prematurely ages the brain - new study & Commentary - (07/19/17)
       
    1490. Repatha Lipodystrophy - (07/19/17)
       
    1491. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer - (07/19/17)
       
    1492. Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV - (07/19/17)
       
    1493. Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy: socioeconomic, neurocognitive impairment, Medicaid/Medicare - exercise, diet, smoking, obesity - (07/19/17)
       
    1494. Mental Health in Aging with HIV - Suicide Ideation Will Increase in Aging Older HIV+ - Successful aging and the epidemiology of HIV - (07/19/17)
       
    1495. IL-17 Treatment, Anti-Inflammatory in Diabetes/Oral Microbiome - Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity - (07/19/17)
       
    1496. AGING CRISIS: Comorbidities Shorten Life & HALE: Healthy Years of Life Expectancy - (05/02/17)
       
    1497. "HIV and diabetes may have an additive effect on CKD risk " - HIV & the Aging Kidney - (07/11/17)
       
    1498. 2 New HIV CVD/Heart Disease Drugs: PCSK9 inhibitor & 1st CVD Anti-Inflammatory Canakinumab - (07/10/17)
       
    1499. HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan - Editorial - (07/10/17)
       
    1500. HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms - (07/10/17)
       
    1501. HIV & Heart Disease, Cognitive/Neurologic Disease, Bone Disease - (07/10/17)
       
    1502. Cancers Now in HIV..."cancer mortality much higher in HIV+" - Cancer-Attributable Mortality Among People With Treated HIV in North America - (07/10/17)
       
    1503. Merck to Present New Data from Clinical Trials Evaluating ISENTRESS® HD (raltegravir) and Investigational HIV Therapies Doravirine and MK-8591 at IAS 2017 - (07/10/17)
       
    1504. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease / Amgen Offers Refund / 'Value-Pricing' Contract Deals for PCKS9 Cholesterol Drug - (03/22/17)
       
    1505. Evolocumab - FOURIER Further cardiovascular Outcomes Research with PCSK9 Inhibition in subjects with Elevated Risk - (05/02/17)
       
    1506. Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US - "HIV should be considered a major risk factor for CVD....risk similar to diabetes risk for CVD" - (07/06/17)
       
    1507. CVD & Renal Disease Risk in HIV+ / Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults - (07/06/17)
       
    1508. Aging / HIV / Latinos - Report Released Illuminating The Needs Of The Forgotten - "Olvidados": A National Health Assessment Of Latinos Growing Older With HIV - (07/06/17)
       
    1509. Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection / ACTG HAILO Study - (06/29/17)
       
    1510. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial - (06/28/17)
       
    1511. IWCADRH: Fat in and around the muscle: metabolism and pathophysiology - (06/26/17)
       
    1512. 1st CVD Anti-InflammatoryCanakinumab with Positive Phase 3 Results Announced - Studied in HIV at CROI - (06/26/17)
       
    1513. 1st CVD Anti-Inflammatory - Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack - (06/26/17)
       
    1514. IWCADRH: Regulation of muscle function and mass by the bone-derived hormone osteocalcin - Brain/Bones/Muscle Exercise Connection/Mortality Too/Comorbidities Workshop-NY 9/16 - (06/23/17)
       
    1515. IWCADRH: Clinical Implications of Nonalcoholic Fatty Liver Disease in Patients with HIV Infection - (06/23/17)
       
    1516. Aging with HIV in U.S. Trans NIH Research Themes - (06/22/17)
       
    1517. Using Imaging to Understand the Role of Epicardial Adipose Tissue in HIV-Related Atherosclerosis - (06/22/17)
       
    1518. Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection (13%) - (06/22/17)
       
    1519. Types of Myocardial Infarctions in HIV+ - Type 2 vs Type 1 MIs - (06/22/17)
       
    1520. Aging & Diabetes - Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010 - YES - (06/21/17)
       
    1521. Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine - (06/21/17)
       
    1522. Strokes in HIV+ - (06/09/17)
       
    1523. Aging/Healthcare Costs-Europe & USA - (06/15/17)
       
    1524. CROI: Types of ischemic strokes among HIV-infected individuals across the United States - (06/07/17)
       
    1525. Key Select Aging & HIV Reports 2 An entire section on the NATAP website devoted to Aging & HIV. - (06/07/17)
       
    1526. Key Aging / HIV Reports 1 of 2 NATAP website devoted to Aging & HIV - (06/07/17)
       
    1527. Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome - (06/07/17)
       
    1528. Cost of noninfectious comorbidities in patients with HIV - Cost of HIV CARE Increases 5 fold Due to Cost for Comorbidities from <40 to >60 - (03/23/17)
       
    1529. Cost of Care in Older Aging patients with Increased Comorbidities......Non-HIV care provider....Aging, Worse Still to Come? - (12/09/16)
       
    1530. TREND IN MULTIMORBIDITY AMONG HIV+ ADULTS IN CLINICAL CARE IN THE US - (03/29/17)
       
    1531. Aging & HIV - an unaddressed timebomb waiting to explode - slide presentation by Jules Levin, NATAP - (03/14/17)
       
    1532. Coronary Aging in HIV-Infected Patients: "Increased vascular age was observed in 162 patients (40.5%), with an average increase of 15 years"...."you are 50 years old but your heart's age is 65"
       
    1533. CROI: BIOMARKERS OF AGEING IN HIV-POSITIVE INDIVIDUALS AND MATCHED CONTROLS: 8 years greater biologic age in HIV+ - (02/24/17)
       
    1534. IAC: Aging & Inflammation: 10 yrs decreased life expectancy/T-cell activation remind high despite viral suppression/inflammation markers predict disease & death- "Pathophysiology of Non-Communicable Diseases in Treated HIV Infection: Is there a common path?" talk by Peter Hunt - (07/22/16)
       
    1535. Biologic aging, frailty, and age-related disease in chronic HIV infection
       
    1536. Future challenges for clinical care of an ageing population infected with HIV: a "geriatric-HIV" modelling study - [Healthcare Costs].... Very Sobering Analysis on Aging in HIV+....60% frail
       
    1537. Future challenges for clinical care of an ageing population infected with HIV: a ''geriatric HIV'' modeling study
       
    1538. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...the proportion of patients aged 60 years or older will increase from 8% to 39%....The ageing HIV-infected population will put new demands on the health-care systems
       
    1539. The First HIV/AIDS Generation Reaches Retirement Age
       
    1540. Veterans Aging Cohort Study (VACS) Index, Functional Status, and Other Patient Reported Outcomes in Older HIV-positive (HIV+) Adults in SF.....Poor Outcomes in HIV+ Aging age 53-61 - (10/23/14)
       
    1541. Geriatric Syndromes in Older HIV-Infected Adults...at 57 age...Participants had a median of 4 (IQR: 3-6) comorbidities & were taking a median of 9 (6-12) nonantiretroviral medications & (53.6%) had 2 or more geriatric syndromes.....http://www.natap.org/2015/HIV/052015_04.htm
       
    1542. Decreased Life Expectancy in HIV+
       
    1543. Comorbidities & Life Expectancy: the affect of comorbidities on Life Expectancy - (03/15/17)
       
    1544. Alarmingly High Comorbidity Rates Among HIV+ - (09/24/15)
       
    1545. HIV Infection Prematurely Ages People by an Average of Five Years - (05/12/16)
       
    1546. Neurodegeneration and Ageing in the HAART Era... - (05/10/16)
       
    1547. CROI: Neurocognitive Disorders - Neurologic, Brain, Cognitive Impairment - (04/10/17) 20 relevant brain studies at CROI
       
    1548. HIV Remodels Brain Function Study Suggests - also: illicit drug use history, comorbidities
       
    1549. Aging/HIV IGNORED....The aging survivors left behind by AIDS - (03/09/16)
       
    1550. CROI: Cognitive Trajectories in Suppressed HIV Infection Indicate Evolving Disease Activity - (02/24/17)
       
    1551. CROI: Frailty Stronger Than Neurocognitive Impairment in Predicting Falls-Disability-Death - (02/26/17)
       
    1552. Cancer risk among the HIV-infected elderly in the United States - (06/07/16)
       
    1553. CROI: Cognitive Complaints and Development of Falls among HIV-Infected and Uninfected Women - (03/06/17)
       
    1554. CROI: CEREBRAL SMALL VESSEL DISEASE IN CART WELL-CONTROLLED HIV-INFECTED PATIENTS ANRS EP51 MICROBREAK - (02/28/17)
       
    1555. "aging implicated - body composition, involving both abdominal obesity and stavudine-induced peripheral lipoatrophy, might contribute to the higher prevalence of hypertension in HIV-1-infected patients.....Our results suggest a role for both abdominal fat accumulation and peripheral lipoatrophy in the pathophysiology of hypertension in the context of HIV." - Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure - (06/08/16)
       
    1556. SVR Reduces Comorbidities; IDUs Have Greater Immune Activation & Thus are at Greater Risk for Comorbidities & All-Cause Death, and of course HCV & HIV+ are at double the risk - (06/16/16)
       
    1557. GLASGOW: COMORBITY IN CHRONIC HIV INFECTION A CASE-CONTROL STUDY IN GERMANY USING HEALTH INSURANCE CLAIMS DATA [Examines 70-80+ Year Olds. Higher Prevalence of Comorbidities in HIV+ vs HIV-neg] - (11/08/16)
       
    1558. GLASGOW: HEALTH-RELATED COSTS IN CHRONIC HIV INFECTION: A CASE-CONTROL STUDY VS. GENERAL POPULATION USING A CLAIMS-BASED APPROACH IN GERMANY....healthcare/drug costs soar for HIV+ aging compared to HIV-neg. - (11/08/16)
       
    1559. GLASGOW: Changes in the Prevalence of Cardiovascular, Renal and Bone Co-Morbidities and Related Risk Factor in HIV-Infected Patients in The Spanish VACH Cohort: A Cross-Sectional Study in 2010 and 2014.... - (11/09/16)
       
    1560. IAC: Neurocognitive Assessment in Nigeria The ICON Cohort - (08/04/16)
       
    1561. HIV infection and vascular stiffness among older-adults taking antiretroviral therapy in rural Uganda.... arterial stiffness occurs more often in HIV+ .....aging/HIV in Africa
       
    1562. Premature Aging and Immune Senescence in HIV-1-Infected Children
       
    1563. Statins effects in Older Adults Risks/Benefits - Primary Prevention / ALLHAT-LLT Study "patients without atherosclerotic cardiovascular disease" - (05/25/17)
       
    1564. Statin Treatment for Older Adults: The Impact of the 2013 ACC/AHA Cholesterol Guidelines - new analysis: "the evidence is lacking for older adults without major cardiovascular risk aside from age" - (05/25/17)
       
    1565. Statin (JUPITER study) in Elderly with Relatively Low Risk Factors - (05/25/17)
       
    1566. Study Casts Doubt on Need for Statins in the 'Healthy Old' - But specialists cite research flaws, limitations - (05/25/17)
       
    1567. Analysis of Efficacy and Safety in Patients Aged 65-75 Years at Randomization [from Jules: relatively low risk] - (05/25/17)
       
    1568. Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia - higher mortality, health-care utilization, worse quality of life, more comorbidities/geriatric conditions matched to uninfected - (05/22/17)
       
    1569. Marijuana use impacts midlife cardiovascular events in HIV-infected men - (05/17/17)
       
    1570. Another statin option in HIV - Comment - (05/17/17)
       
    1571. LDL Debate - Role in CVD / Exercise, Diet Inflammation, Mortality - (05/12/17)
       
    1572. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects - (05/02/17)
       
    1573. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis / CROI: Higher Carnitine Levels Almost quadrupled MI Risk in HIV+ - (05/02/17)
       
    1574. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease - A Science Advisory From the American Heart Association - (05/02/17)
       
    1575. AGING CRISIS: Comorbidities Shorten Life & HALE: Healthy Years of Life Expectancy - (05/02/17)
       
    1576. FOURIER Further cardiovascular Outcomes Research with PCSK9 Inhibition in subjects with Elevated Risk - (05/02/17)
       
    1577. Disability among Middle-Aged and Older Persons with HIV Infection - (04/11/17)
       
    1578. An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS) - (04/11/17)
       
    1579. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients - (04/11/17)
       
    1580. From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care - (04/11/17)
       
    1581. Grey and white matter abnormalities in treated HIV- disease and their relationship to cognitive function - (04/11/17)
       
    1582. Cholesterol Lowering [statins] in Intermediate-Risk Persons without Cardiovascular Disease - (04/11/17)
       
    1583. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients - (04/11/17)
       
    1584. Aging of HIV-Infected: a explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too - Commentary by Jules Levin - (04/04/17)
       
    1585. Lipodystrophy Not Forgotten - Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection - in causing heart disease - (03/29/17)
       
    1586. Lipoatrophy, Lipodystrophy - Let's Not Forget their Contribution to Heart Disease in HIV - (03/29/17)
       
    1587. Eradication of HCV and non-liver-related non-AIDS-related events (CVD/diabetes/kidney/cancers) in HIV/HCV coinfection - (02/01/17)
       
    1588. Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors - (01/30/17)
       
    1589. 80% of HIV+ Are Over 45 / 20% over 60 /50% Over 50 in NY, SF, Boston, Florida - (01/27/17)
       
    1590. IBALIZUMAB 24-WEEK PIVOTAL PHASE III STUDY RESULTS ACCEPTED AS A LATE BREAKER WILL BE PRESENTED AT CROI 2017 - (01/25/17)
       
    1591. TLR9, TLR7 HIV Cure Research - (01/24/17)
       
    1592. 2 New Cure HIV Antibodies Studies Reported, Combination 3 Antibodies, Two-Pronged Antibody - (01/24/17)
       
    1593. Aging & HIV : "A Call to Action - Uncharted Territory A report into the first generation growing older with HIV" UK Patient Survey Report - (01/24/17)
       
    1594. 2 New HIV Antibodies Studies Reported, combining 3 antibodies - (01/24/17)
       
    1595. Aging - Death Rates of HIV+ Increase Only in those Over 60 Years Old, in Younger Groups Death Rates Decrease - (01/31/17)
       
    1596. 2 New Cure HIV Antibodies Studies Reported, Combination 3 Antibodies, Two-Pronged Antibody - (01/24/17)
       
    1597. Aging & HIV : "A Call to Action - Uncharted Territory A report into the first generation growing older with HIV" UK Patient Survey Report - (01/24/17)
       
    1598. 2 New HIV Antibodies Studies Reported, combining 3 antibodies - (01/24/17)
       
    1599. Darunavir + Genvoya [elvitegravir/cobi/FTC/TAF] in Treatment-Experienced Patients with HIV Drug Resistance - (01/24/17)
       
    1600. Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging - (01/20/17)
       
    1601. Darunavir + Genvoya [elvitegravir/cobi/FTC/TAF] in Treatment-Experienced Patients with HIV Drug Resistance - (01/18/17)
       
    1602. Brisk Walking & Strength Training Reduced Inflammation (CRP) & LDL/total Cholesterol - (01/18/17)
       
    1603. HIV Remodels Brain Function Study Suggests - also: illicit drug use history, comorbidities - (01/18/17)
       
    1604. Questioned - Statin Recommendations / Risk Calculator / American College of Cardiology/American Heart Association (ACC/AHA) guidelines on assessment of cardiovascular risk1 and on treatment of blood cholesterol - (01/13/17)
       
    1605. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults - (01/13/17)
       
    1606. CVD Prediction- Diabetes/Lipids/Hypertension - (01/11/17)
       
    1607. Diabetes / CVD in HIV+ / Inaccuracy of A1C - (01/11/17)
       
    1608. Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network - (01/11/17)
       
    1609. Predicting HIV-Life Expectancy, Comorbidities - Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population - (01/11/17)
       
    1610. Health & AIDS Spending USA - (01/11/17)
       
    1611. CVD Prediction- Diabetes/Lipids/Hypertension - (01/10/17)
       
    1612. Medical error-the third leading cause of death in the US - (01/10/17)
       
    1613. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/10/17)
       
    1614. The Management of Dyslipidemia in CKD: New Analyses of an Expanding Dataset - (01/10/17)
       
    1615. Interpretation of the evidence for the efficacy and safety of statin therapy - (01/10/17)
       
    1616. Under Estimating HIV Cardiovascular Disease Risk / Association Between HIV and Cardiovascular Diseases - Finding a Solution to Double Jeopardy - (01/10/17)
       
    1617. 2014 Statin Safety Task Force - (01/04/16)
       
    1618. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/04/16)
       
    1619. An assessment by the Statin Muscle Safety Task Force: 2014 update - (01/04/16)
       
    1620. Statin Benefit vs Harm - OPINION - (01/04/16)
       
    1621. Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) - (01/04/16)
       
    1622. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients - The GLAGOV Randomized Clinical Trial - (01/04/16)
       
    1623. Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsUS Preventive Services Task Force Recommendation Statement - (01/04/16)
       
    1624. Anti-PCSK9 Monoclonal Antibodies: The Future Lipid-Lowering Agent of Choice? - (01/04/16)
       
    1625. The Management of Dyslipidemia in CKD: New Analyses of an Expanding Dataset - (01/03/16)
       
    1626. Medical error-the third leading cause of death in the US - (01/03/16)
       
    1627. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis - (01/03/16)
       
    1628. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/03/16)
       
    1629. Pitavastatin: an overview of the LIVES study - (01/03/16)
       
    1630. Pitavastatin: a distinctive lipid-lowering drug - (01/03/16)
       
    1631. Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study - (01/03/16)
       
    1632. Changes in markers of T cell senescence and exhaustion with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s - (07/08/16)
       
    1633. After 52 Weeks, Pitavastatin is Superior to Pravastatin for LDL-C Lowering in Patients with HIV - (12/22/16)
       
    1634. HIV-Increased Stroke Rates/50% Higher - (12/22/16)
       
    1635. Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post-Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor for Age / Inflammation / Heart Disease Problem in HIV - (12/22/16)
       
    1636. Statins Safety - pitavastatin [LIVALO] Product Insert - (12/22/16)
       
    1637. Aging in US - Worse Still To Come - polypharmacy, multiple comorbidities, decreased survival, impaired daily activities functioning - (12/21/16)
       
    1638. The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin - (12/21/16)
       
    1639. HIV cure strategists: ignore the central nervous system at your patients' peril - (12/21/16)
       
    1640. ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention - (12/21/16)
       
    1641. Aging & Addiction / Substance Abuse - (12/21/16)
       
    1642. GLASGOW: Hepatic Steatosis is Highly Prevalent in HIV and Significantly Associated with Diabetes Risk - (12/15/16)
       
    1643. PD-1 New Cancer immunotherapy Drugs Success - Adverse Events, HIV - (12/07/16)
       
    1644. Nivolumab shows promise in first-ever trial for patients with refractory, metastatic anal cancer - (12/07/16)
       
    1645. Efavirenz-Induced Nitric Oxide Affects Mitochondrial Function in Glial Cells - (12/05/16)
       
    1646. AASLD: A Prospective Study of The Association of Body Morphometry With Hepatic Steatosis and Fibrosis in HIV-HCV Coinfected Patients - (11/30/16)
       
    1647. Aerobic exercise and vascular cognitive impairment - 74 Year Olds with Vascular Cognitive Impairment - (11/11/16)
       
    1648. Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults - (11/11/16)
       
    1649. Infection-related and -unrelated malignancies, HIV and the aging population....older age, low CD4, viral load, smoking, HBV, [HCV].....Non-HIV Cancers Predicted to Increase - (11/11/16)
       
    1650. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy - (11/11/16)
       
    1651. Anti-Inflammation New Drug Research / Cure May Not Reverse Inflammation Damage - (11/11/16)
       
    1652. IDSA: Long-term Effects of [Omega-3] Ω:-3 Fatty Acids in HIV: a RCT - (11/09/16)
       
    1653. GLASGOW: HIV PATIENTS TODAY AND 10 YEARS AGO: DO THEY HAVE THE SAME NEEDS? RESULTS FROM CROSS SECTIONAL ANALYSIS OF ANRS CO3 AQUITAINE COHORT - (11/05/16)
       
    1654. GLASGOW: Uncontrolled HIV Tied to NHL But Not Hodgkins in Large D:A:D Study - Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma: The D:A:D study - Mark Mascolini - (11/05/16)
       
    1655. Infection-related and -unrelated malignancies, HIV and the aging population....older age, low CD4, viral load, smoking, HBV, [HCV].....Non-HIV Cancers Predicted to Increase - (11/05/16)
       
    1656. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy - (11/05/16)
       
    1657. GLASGOW: Quantifying the future clinical burden of an ageing HIV-positive population in Italy: a mathematical modelling study - (11/02/16)
       
    1658. GLASGOW: Quantifying the future clinical burden of an ageing HIV-positive population in the USA:a mathematical modelling study - (11/02/16)
       
    1659. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...... - (11/02/16)
       
    1660. IDSA: [35% Taking 12 Comedications !] - Polypharmacy in HIV+ 50 or Older Linked to Lower CD4s, Higher CVD Rate - Evaluating the Effect of Polypharmacy on Outcomes in HIV-Infected Patients Age 50 and Older - Mark Mascolini - (10/31/16)
       
    1661. IDSA: Low Endothelial Progenitors Tied to CVD Risk, Activation in Older HIV+ Men - Endothelial Progenitor Cell Production is Suppressed and Associated with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men - Mark Mascolini - (10/31/16)
       
    1662. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...... - (10/26/16)
       
    1663. GLASGOW: Smoking, Nadir CD4s, and PI Use Tied to Bone Quality in Irish Group - The relative impact of antiretroviral drugs and baseline immune status on bone quality in HIV-positive subjects: results from the HIV UPBEAT cohort - Mark Mascolini - (10/27/16)
       
    1664. GLASGOW: Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir - (10/27/16)
       
    1665. GLASGOW: Improved kidney function in patients who switch their protease inhibitor from atazanaviror lopinavir to darunavir - (10/27/16)
       
    1666. GLASGOW: Kidney Function Improves After Switch From LPV or ATV to DRV - Mark Mascolini (10/27/16)
       
    1667. GLASGOW: Third ARV Does Not Affect Safety Gains in Switch From TDF/FTC to TAF/FTC - Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by 3rd Agent - (10/27/16) - Mark Mascolini
       
    1668. Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen - (10/18/16)
       
    1669. Associations of CSF Iron Biomarkers with Neurocognitive Function Over Time in HIV+ Adults - (10/18/16)
       
    1670. Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation - (10/18/16)
       
    1671. Raltegravir treatment outcomes among older patients and those with comorbidities: A sub-analysis of the CRICKET study (PN-807) - (10/12/16)
       
    1672. Exercise Reduces Cancers / Physical Activity and Digestive System Cancer Risk Still Chasing the Promise - (10/12/16)
       
    1673. T-cell Reactivity to Cytomegalovirus, Inflammation, and Frailty in HIV+ and HIV- Men Who Have Sex With Men (MACS) - (10/10/16)
       
    1674. Higher CMV Antibody Concentrations are Associated with Older Age and Worse Neurocognitive Performance in Adults Living with HIV Disease - (10/08/16)
       
    1675. Mitochondrial DNA damage in brain associated with HIV infection - (10/08/16)
       
    1676. Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study - (10/08/16)
       
    1677. Caring for Older Adults [aging] with the Human Immunodeficiency Virus....."advance care planning is essential in older adults with HIV" - (10/08/16)
       
    1678. HIV+ >65 on Medicare Have 2 Times More Comorbidities vs HIV-neg AND Blacks & Latinos Have 4-Fold Increased Risk for the 5 Comorbidities Examined vs Whites - CDC Report Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection. - (10/08/16)
       
    1679. Blood-Brain Barrier Permeability and Neurocognitive Performance in HIV+ Adults.... - (10/07/16)
       
    1680. Caring for Older Adults [aging] with the Human Immunodeficiency Virus....."advance care planning is essential in older adults with HIV" - (10/07/16)
       
    1681. HIV+ >65 on Medicare Have 2 Times More Comorbidities vs HIV-neg AND Blacks & Latinos Have 4-Fold Increased Risk for the 5 Comorbidities Examined vs Whites - CDC Report Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection. - (10/07/16)
       
    1682. Mitochondrial DNA damage in brain associated with HIV infection - (10/07/16)
       
    1683. CROI: Unexpectedly High Rate of Intolerance for Dolutegravir in Real Life Setting - (10/08/16)
       
    1684. Frailty / Aging Projections in Italy - Future challenges for clinical care of an ageing population infected with HIV: a "geriatric -HIV" modelling study - (10/07/16)
       
    1685. AGE: Atherosclerotic CVD Risk Profile of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate - (09/30/16)
       
    1686. AGE: Similar E/C/F/TAF Safety and Efficacy in Old vs Younger With Renal Impairment - Geriatric patients - Mark Mascolini - (09/29/16)
       
    1687. AGE: Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF) in Older HIV-Infected Virologically-Suppressed Adults - eGFR ≥50 - (09/29/16)
       
    1688. AGE: Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF) in Older, HIV-Infected Treatment-Naïve Adults - (09/29/16)
       
    1689. AGE: Non-HIV care provider....Aging, Worse Still to Come?....Aging Clinic at Weill-Cornell, NYC; aging $costs in HIV skyrocket - (09/29/16)
       
    1690. AGE: People 60 or Older Gain Fewer CD4s on ART Through 48 Months - Mark Mascolini (09/29/16)
       
    1691. AGE: Non-HIV care provider....Aging, Worse Still to Come?....Aging Clinic at Weill-Cornell, NYC; aging $costs in HIV skyrocket - (09/29/16)
       
    1692. AGE: People 60 or Older Gain Fewer CD4s on ART Through 48 Months - Mark Mascolini (09/29/16)
       
    1693. IWCADRH: CT Signals of Chronic Lung Disease in HIV Patients Who Never Smoked - Mark Mascolini - (09/28/16)
       
    1694. IWCADRH: Impact of initiation of protease inhibitor/ritonavir on PCSK9 levels in HIV-infected antiretroviral-naïve patients from the ANRS C09 COPANA cohort - Mark Mascolini - (09/27/16)
       
    1695. IWCADRH: New Therapies for LDL Management - Mark Mascolini - (09/27/16)
       
    1696. IWCADRH: The impact of HIV and smoking status on bone quality: results from HIV-UPBEAT; a prospective cohort study - Mark Mascolini - (09/27/16)
       
    1697. IWCADRH: Smoking Activates Neutrophils, Possibly Boosting CVD and Cancer Risk - Mark Mascolini - (09/26/16)
       
    1698. IWCADRH: Renal outcomes with EFV + TDF/FTC versus other TDF-containing antiretroviral regimens among HIV-infected Veterans: A national study - (09/26/16)
       
    1699. IWCADRH: Tenofovir disoproxil fumarate associated Fanconi syndrome in an HIV uninfected man receiving HIV pre-exposure prophylaxis - (09/26/16)
       
    1700. IWCADRH: Renal outcomes with EFV + TDF/FTC versus other TDF-containing antiretroviral regimens among HIV-infected Veterans: A national study - (09/26/16)
       
    1701. IWCADRH: Hyperbilirubinemia During ATV/r Initiation May Slow the Progression of Carotid Wall Thickening Through its Effects on Glucose and Lipid Metabolism: - (09/22/16)
       
    1702. IWCADRH: (1) Association between bilirubin and cardiovascular and cerebrovascular disease events among persons living with HIV across the US - (2) Association between initial antiretroviral therapy regimen and cardiovascular disease events among persons living with HIV in the US - (09/22/16)
       
    1703. IWCADRH: One Third Lower MI Risk With Atazanavir Than Other ARVs in US Veterans - Mark Mascolini - (09/22/16)
       
    1704. IWCADRH: Regulation of muscle function and mass by the bone-derived hormone osteocalcin - "Exercise is the only way to preserve muscle function" - (09/22/16)
       
    1705. IWCADRH: Three-Day per Week Atripla Maintains Viral Suppression and Decreases Sub-clinical Toxicity: a Pilot Study Three-Times-a-Week Atripla Maintains Viral Suppression in 24-Week Pilot Study - Mark Mascolini - (09/22/16)
       
    1706. IWCADRH: Tolerability of integrase inhibitors in a real-life setting - Barcelona - Mark Mascolini - (09/22/16)
       
    1707. IWCADRH: Less Inflammation in Metabolically Healthy vs Unhealthy Men With HIV - Associations Between Systemic Inflammatory Perturbations and Metabolic Health Vary by HIV Serostatus and BMI - (09/19/16)
       
    1708. IWCADRH: Raltegravir is Associated with Greater Abdominal Fat Increases after Antiretroviral Therapy Initiation Compared to Protease Inhibitors - (09/19/16)
       
    1709. IWCADRH: Comparison of CD4+ and CD8+ T Cell Subsets in Blood and Adipose Tissue from HIV-infected Persons on Long-term ART..... "Compared with blood, adipose tissue from HIV+ adults is enriched for activated CD4+ & CD8+ T-cells" - (09/16/16)
       
    1710. IWCADRH: HIV duration of 20 Years in 75 year olds Doubles Multimorbidities & Polypharmacy Rates & This Causes Using HAART with Less Drugs in the Regimen - Silver champions from the GEPPO cohort (GEriatricPatients living with HIV/AIDS): a case control study of people above 75 years of age addressing Multimorbidity Polypharmacy and Antiretrovirals' Prescription in old HIV patients. - (09/16/16)
       
    1711. IWCADRH: Future challenges for clinical care of an ageing population infected with HIV: a "geriatric-HIV" modelling study - [Healthcare Costs].... Very Sobering Analysis go Aging in HIV+....60% frail - (09/15/16)
       
    1712. IWCADRH: Ischemic strokes among HIV-infected individuals in the CNICS cohort: the role of traditional and HIV-related risk factors and the impact of events secondary to other causes - Diabetes, HCV, Lipids, Low CD4s Predict Ischemic Stroke With HIV - (09/15/16)
       
    1713. IWCADRH: HIV Boosts Risk of Persistently High ALT After HCV Clearance - "Persistent Aminotransferase Elevation following HCV clearance in Adults with and without HIV" - (09/15/16)
       
    1714. IWCADRH: Exercise Reduced Comorbidities Risk A Lot / "the detrimental consequences of inactivity are exacerbated by excess visceral adiposity" - Physical Activity Consistently Linked to Comorbidity in US HIV Group - (09/15/16)
       
    1715. IWCADRH: Coronary Endothelial Dysfunction is Present in HIV+ Patients Despite a Zero Coronary Artery Calcium Score and is Related to the Degree of Inflammation and Local Epicardial Fat (heart) - (09/15/16)
       
    1716. IWCADRH: Coronary Endothelial Dysfunction is Present in HIV+ Patients Despite a Zero Coronary Artery Calcium Score and is Related to the Degree of Inflammation and Local Epicardial Fat (heart) - (09/14/16)
       
    1717. IWCADRH: Heart Disease Prevention Inadequate in Large Older HIV Cohort - Mark Mascolini - (09/14/16)
       
    1718. IWCADRH: Australian Study of BMD Changes for Men on PrEP Who Are Adherent to Daily TDF/FTC PrEP - Mark Mascolini - (09/14/16)
       
    1719. IWCADRH: BMD and Bone Markers Improve Over 18 Years in Perinatally HIV Infected - Mark Mascolini - (09/14/16)
       
    1720. IWCADRH: Slower Bone Growth May Be Risk for Young Men on TDF/FTC PrEP - (09/13/16)
       
    1721. IWCADRH: Bone Microarchitecture, Not Just BMD, Worse in Women With Than Without HIV - (09/13/16)
       
    1722. IWCADRH: Slower Bone Growth May Be Risk for Young Men on TDF/FTC PrEP - (09/13/16)
       
    1723. IWCADRH: More Than 5% BMD Loss With 1 Year of TDF/FTC PrEP in Half of Australian Group - (09/13/16)
       
    1724. AGE: Excess Mitochondrial DNA Damage in Brain of People With HIV - written by Mark Mascolini - (09/28/16)
       
    1725. AGE: Frailty and the Risk of Falls in HIV-Infected Older Adults in the ACTG A5322 Study - (09/28/16)
       
    1726. AGE: Longitudinal Study of Falls among HIV-infected and Uninfected Women: Results from the Women's Interagency HIV Study - (09/28/16)
       
    1727. AGE: Worse Neurocognitive Score Tied to Higher CMV, Longer HIV, Lower BP - written by Mark Mascolini - (09/28/16)
       
    1728. AGE: Transitions from Disability to Ability: A Qualitative Study to Understand Exercise Barriers in Older, HIV-Infected Adults - (09/28/16)
       
    1729. AGE: Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults....HIV+ have 2-4 times higher rates of impaired ability to perform daily functioning activities vs HIV-negatives - written by Mark Mascolini (10/05/16)
       
    1730. AGE: Cognition, Depression, Neuropathy Predict Falls in WIHS Women With or Without HIV - written by Mark Mascolini (10/05/16)
       
    1731. AGE: Eliminating Smoking and Hypertension Could Cut MI Rate 20% to 40% in HIV Group - [lack of prevention by providers for HIV+] - written by Mark Mascolini (10/05/16)
       
    1732. AGE: Less Physical Activity, Less Education Tied to Daily Living Impairments [Disabilities] in Older HIV Group - ACTG5322 - written by Mark Mascolini (10/05/16)
       
    1733. AGE: Up to Half in Older DC Cohort Not Treated for Metabolic Comorbidities - High Burden of Comorbidities in Inner City Washington DC - written by Mark Mascolini (10/05/16)
       
    1734. AGE: Resting Metabolic Rate Higher in Older Men With Than Without HIV - written by Mark Mascolini (10/05/16)
       
    1735. Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication - (09/23/16)
       
    1736. A Novel Perspective on the Biology of Bilirubin in Health and Disease....."Unconjugated bilirubin (UCB) is known to be one of the most potent endogenousantioxidant substances....to ameliorate atherosclerosis, cancer, autoimmunity, and/or neurodegenerative conditions.....BLB has also potent anti-inflammatory activities in brain tissue" - (09/23/16)
       
    1737. Impact of Strength Training on Bone Mineral Density in Patients Infected With HIV Exhibiting Lipodystrophy - (09/23/16)
       
    1738. Bone & The Brain: osteocalcin predicts brain function - (09/23/16)
       
    1739. Brain Growth with Exercise - (09/23/16)
       
    1740. Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication - (09/23/16)
       
    1741. "Exercise is the only way to preserve muscle function"- Exercise/Brain/Bone/Muscle Connection - (09/23/16)
       
    1742. Aging - New drugs - (01/08/16)
       
    1743. HIV & HCV & Parkinsons Disease: is there an increased risk - undecided yet with mixed opinions and suggestive data - (01/06/16)
       
    1744. EASL: EACS aging-related presentations - (12/18/15)
       
    1745. AGE: 6th 2015 Aging Workshop Reports (12/11/15)
       
    1746. Aging/Comorbidities Update: New Studies-Publications / Conference Aging Studies: EACS / IDSA / ICAAC / IAS / CROI - (12/10/15)
       
    1747. CROI: CROI 2015 - Metabolics / Aging, Senescence / Comorbidities / Inflammation - 3 Exercise Studies / Heart Disease / Statins / Cancers / The Kidney / Bone / TAF / The Brain - neurologic function
       
    1748. IDSA: Influence of Age on Outcomes in HIV-Infected Adults Initiating Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate With Elvitegravir, Cobicistat, and Emtricitabine (10/15/15)
       
    1749. AGE: Neurocognitive Performance Falls Faster With Age in HIV-Positive People - written by Mark Mascolini (10/09/15)
       
    1750. AGE: Depression Tied to Worse Cognitive Function in MACS Men With or Without HIV - written by Mark Mascolini (10/09/15)
       
    1751. AGE: Are frailty, precariousness and comorbidity related in HIV-infected aging patient? YES, 65% Frail/Prefrail in French Study/Mean age 57.....at the Aging Workshop Oct 2015 (10/09/15)
       
    1752. AGE: Noninfectious Conditions May Drive Neurocognitive Problems With HIV - written by Mark Mascolini (10/09/15)
       
    1753. AGE: Older Adults With HIV Spend Most Time Home, Alone, and Passive - written by Mark Mascolini (10/09/15)
       
    1754. AGE: Frailty Tied to Cardiometabolic Disorders and Death in Large HIV Cohort - written by Mark Mascolini (10/09/15)
       
    1755. AGE: Emphysema Progression Similar With HIV and in Older HIV-Negative Heavy Smokers - written by Mark Mascolini (10/07/15)
       
    1756. AGE: CD4/CD8 Ratio Better in HIV+ Women Than Men, But Survival Similar - written by Mark Mascolini (10/07/15)
       
    1757. AGE: Rapid Rise in Frailty in First 3 Years of Menopause in HIV+ Women, Then Stable - written by Mark Mascolini (10/07/15)
       
    1758. AGE: Frailty Doubles Death/MACS) A frailty-related phenotype and death: Investigating inflammatory markers as potential mediators among men with HIV in the modern HAART era - [Interleukin 6 (IL-6), C-reactive protein (CRP), Tumor necrosis factor-receptor 2 (TNFαR2)] (10/05/15)
       
    1759. AGE: Higher Non-AIDS Cancer Rate in Men With HIV: 30-Year MACS Study - written by Mark Mascolini (10/05/15)
       
    1760. AGE: Frailty, "Precarious" Status, and Comorbidities Linked in Large French Cohort - written by Mark Mascolini (10/05/15)
       
    1761. AGE: Grip Strength Fades Faster With Age in Men With Than Without HIV - written by Mark Mascolini (10/05/15)
       
    1762. AGE: Frailty Doubles Death Risk in HIV+ Men, With Only Modest Impact of Inflammation - written by Mark Mascolini (10/05/15)
       
    1763. Aging & Comorbidities at ICAAC 2015 & IAS 2015 - (10/02/15)
       
    1764. Parkinson Disease in HIV.....Does HIV Infection Alter Parkinson Disease? - (09/24/15)
       
    1765. Aging/Comorbities at IAS - (08/18/15)
       
    1766. IAS: Aging, Hospitalization Rates for Liver/GI - Rates Increased for Cardiovascular Disease & Non-AIDS Cancers in Italy - Mark Mascolini - (07/29/15)
       
    1767. IAS: Age, IDU, Viral Load Testing Rate Predict HIV Control and Rebound in Canadian MSM - written by Mark Mascolini - (07/21/15)
       
    1768. HIV in the Older Adult, Aging/Comorbidities & Death in HIV... "Will You Still Treat Me When I'm 64? Care of the Older Adult With HIV Infection" - (07/17/15)
       
    1769. HIV & Aging Accelerated?: .....HIV-infection and comorbidities: a complex mix...... Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study - (07/10/15)
       
    1770. HIV & Aging: Psychosocial, mental health, and behavioral issues/services/mental health policy - (07/09/15)
       
    1771. Mediterranean Diet/Nuts/Olive Oil Improve Brain Function - (07/08/15)
       
    1772. Enhancing Cognitive Aging: Clinical Highlights of a Report From the Institute of Medicine - (07/02/15)
       
    1773. Aging, Frailty African-American Women and in IDUs (managing aging & HIV) - (06/19/15)
       
    1774. Aging/HIV in Europe - Predictions - (06/11/15)
       
    1775. Is HIV a Model of Accelerated or Accentuated Aging? - (06/01/15)
       
    1776. AGE: Inflammation/Morbidity/Mortality - Coagulation and Morbidity in Treated HIV Infection - (10/27/14)
       
    1777. AGE: The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging - (10/27/14)
       
    1778. AGE: HIV, Aging, and Statins: Pros vs. Cons... - (10/27/14)
       
    1779. AGE: HCV in Australia "it is the Dallas Buyers Club scenario"...HCV therapy is much less expensive than HIV HAART...... "Australia is on the verge of a catastrophic death spiral from Hepatitis C" - Mark Mascolini (10/24/14)
       
    1780. AGE: Health Deficits Accumulate Faster With HIV Than Without in Older Adults - Mark Mascolini - (10/24/14)
       
    1781. AGE: Higher Frailty Index Tied to Lower Odds of Successful Cognitive Aging in HIV+ Over 50 - Mark Mascolini - (10/24/14)
       
    1782. AGE: Gait Speed Slows More With Age in MACS Men With Than Without HIV - Mark Mascolini - (10/24/14)
       
    1783. AGE: Kidney Disease Key Cofactor in Coronary Artery Disease Risk With HIV at 60 and Older - Mark Mascolini - (10/24/14)
       
    1784. AGE: Switch From PI or NNRTI to Stribild in People 50 or Older Effective and Safe in Trials - Mark Mascolini - (10/24/14)
       
    1785. AGE: PIs and Raltegravir Favored Over NNRTIs for Frail and Older People - Mark Mascolini - (10/24/14)
       
    1786. AGE: Testosterone Lower in AM But Not PM in MACS Men With vs Without HIV - (10/23/14)
       
    1787. AGE: Diastolic Dysfunction Tied to Impaired Exercise Capacity in Older Men With HIV - (10/23/14)
       
      1788. HIV & Aging: Failure to Normalize Immunity Despite Decade of Successful HAART - (06/16/14) 
       
      HIV & Aging: HIV and the aging kidney - (06/16/14) 
       
      HIV & Aging: Biologic aging, frailty, and age-related disease in chronic HIV infection - (06/16/14) 
       
      HIV & Aging: Immunosenescence and aging in HIV - (06/16/14) 
       
      HIV & Aging: Update on metabolic issues in HIV patients - (06/16/14) 
       
      HIV & Aging: Coping styles and illicit drug use in older adults with HIV/AIDS - (06/16/14) 
       
      HIV & Aging: Psychosocial, mental health, and behavioral issues of aging with HIV - (06/16/14) 
       
      HIV & Aging: Demographics of HIV and aging - (06/16/14) 
       
      HIV & Aging: African Americans, Hispanics, Caucasians (2 MACS Studies) - (06/09/14) 
       
    1788. CROI: Metabolics and Aging at CROI 2014 - David Alain Wohl, MD - The University of North Carolina - (04/06/14)
       
    1789. CROI: Abdominal Obesity, Inflammation, Immune Activation and Neurocognitive Impairment - (03/19/14)
       
    1790. Decline in locomotor functions over time in HIV-infected patients - (02/26/14)
       
    1791. AGE: Poor Physical Function in Older Women on ART Tied to Comorbidities, Inflammation - Written by Mark Mascolini - (11/14/13)
       
    1792. AGE: Prescriptions Rise With Age in Ontario HIV+, But Drug-Related Problems Don't - Written by Mark Mascolini - (11/14/13)
       
    1793. AGE: Cardiovascular Risk Linked to Poor Memory Independently of Age in HIV+ - Written by Mark Mascolini - (11/14/13)
       
    1794. AGE: Carotid Plaques Develop More Often With vs Without HIV in Metabolic Syndrome Patients - Written by Mark Mascolini - (10/31/13)
       
    1795. AGE: "Successful Cognitive Aging" in Only One Fifth of US HIV Group 50 or Older - Written by Mark Mascolini - (10/31/13)
       
    1796. EACS: Twice-Higher Latest Vitamin D Almost Halves Odds of Death in EuroSIDA - Written by Mark Mascolini - (10/21/13)
       
    1797. High sensitive CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study - (07/20/13)
       
    1798. CROI: CMV and HIV Infections Have Opposite Effects on CD8+ T Cell Differentiation and Proliferation - (06/23/13)
       
    1799. CROI: Phenotypic CD8+ T cell Defects in Treated HIV Infection are Distinct from Those of Aging, Predict Mortality, and May Be Prevented by Earlier ART - (06/23/13)
       
    1800. People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010 - (05/29/13)
       
    1801. Autonomic Nervous System Dysfunction & Inflammation: Autonomic-mediated immunomodulation and potential clinical relevance - (05/29/13)
       
    1802. CROI: CROI 2013: Comorbidities- Aging/Kidney/Heart/Belly Fat/HCV/Bone/Statins/Frailty - (05/27/13)
       
    1803. Association of kidney disease measures with poor outcomes - (10/09/12)
       
    1804. CROI: Metabolics, Inflammation, Complications, and Aging at CROI - written by David Alain Wohl, MD - The University of North Carolina - (04/03/11)
       
    1805. The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus - (03/23/12)
       
    1806. CROI: Impact of HAART Initiation on Immune Regulation (activation/senescence) in Aging HIV-infected Women -Women's Interagency HIV Study - (03/16/11)
       
    1807. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence - Review - (02/07/12)
       
    1808. Coping with HIV/Aging: managing health & psychological factors & HCV - (01/15/12)
       
    1809. AntiAging Cancer Drug - Ageing: A midlife longevity drug? - (01/02/12)
       
    1810. A New Link Between Aging Cells and Aging People - (01/02/12)
       
    1811. HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated With Increased Multimorbidity Among Aging Injection Drug Users (ALIVE Study): unrecognized high rates of of multucomordibities - (11/28/11)
       
    1812. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders - (11/04/11)
       
    1813. 4 Aging Published Reports This Week: - (10/27/11)
       
    1814. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy - (10/05/11)
       
    1815. Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients - (09/29/11)
       
    1816. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women - (09/19/11)
       
    1817. Immune Activation Impairs CD4 Recovery & Increases Mortality - (09/07/11)
       
    1818. Even Short Workout (15 minutes) Could Extend Life Expectancy - (08/19/11)
       
    1819. Minimum amount (15 minutes) of physical activity for reduced mortality and extended life expectancy: a prospective cohort study - (08/19/11)
       
    1820. Editorial - Survival benefit associated with low-level physical activity: "the direct health benefits of exercise are irrefutable. Exercise can reduce cardiovascular mortality and, in particular, coronary mortality by many mechanisms, including improvements in endothelial function, autonomic tone, inflammation, and risk-factor control" - (08/19/11)
       
    1821. The Stanford HIV Aging Cohort Recruiting - (08/02/11)
       
    1822. IAS: Biomarkers Predict Hepatic Flares and Death in Hepatitis-Coinfected People Starting ART - written by Mark Mascolini - (07/26/11)
       
    1823. A Frailty-Related Phenotype Before HAART Initiation as an Independent Risk Factor for AIDS or Death After HAART Among HIV-Infected Men - pdf attached - (07/05/11)
       
    1824. Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism - (07/05/11)
       
    1825. Senescent phenotypes and telomere lengths of peripheral blood T-cells mobilized by acute exercise in humans - (07/05/11)
       
    1826. Aging, Persistent Viral Infections, and Immunosenescence: Can Exercise ''Make Space''? - (07/05/11)
       
    1827. Updated HRSA Guide for HIV/AIDS Clinical Care/Comorbidities now Available Online - see excerpted highlights on comorbidities below - (06/13/11)
       
    1828. Vitamin D Ups Bisphosphonate Response (from Jules: and calcium levels too perhaps) - (06/13/11)
       
    1829. AIDS survivors suffer premature aging, Needs/NIH Response - (06/13/11)
       
    1830. Growing Older With H.I.V. - (06/13/11)
       
    1831. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study: Vit D levels associated with HIV progression & mortality - (06/13/11)
       
    1832. Premature aging seen as issue for AIDS survivors - (06/13/11)
       
    1833. Exercise and inflammation - (05/26/11)
       
    1834. Fighting Inflammation - diet & exercise - (05/26/11)
       
    1835. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals: 'and to CD4 change after starting ART' - pdf attached - (05/19/11)
       
    1836. Low Vitamin D Levels Seen in Parkinson's Patients - full text of study below - - (05/19/11)
       
    1837. Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality: "Women in the highest vitamin D quintile had a 42% lower risk of all-cause mortality, compared to the lowest quintile. Vitamin D status had a protective association with HIV disease progression, all-cause mortality" - (05/19/11)
       
    1838. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment - - (04/23/11)
       
    1839. CROI: Risk of Stage 1 AIDS Dementia 12% Over 2 Years in Asymptomatic People - written by Mark Mascolini - (03/22/11)
       
    1840. CROI: Carotid Atherosclerosis Is Related to HIV Duration and Anti-inflammatory Profile and Not to ARV Exposure: The CHIC Controlled Study - (03/17/11)
       
    1841. CROI: D-dimer Levels Correlate with Inflammatory and Endothelial Activation Markers in HIV-infected Adults - (03/17/11)
       
    1842. CROI: Coronary Artery Plaque Linked to Low Fat in MACS Men With HIV - written by Mark Mascolini - (03/15/11)
       
    1843. CROI: Chronic Inflammation and HIV: CROI 2011 - David H. Shepp, MD Associate Professor of Medicine Hofstra North Shore-LIJ School of Medicine (03/11/11)
       
    1844. HIV and Cancer in Germany - pdf attached - (03/10/11)
       
    1845. CROI: Higher Fracture Rate With HIV + HCV Than With Either Virus Alone written by Mark Mascolini - (03/1/11)
       
    1846. High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial - pdf attached - (02/26/11)
       
    1847. Statins as Anti-inflammatory Therapy in HIV Disease? Editorial - pdf attached - (02/26/11)
       
    1848. The Dual Impact of HIV-1 Infection and Aging on Naïve CD4+ T-Cells: Additive and Distinct Patterns of Impairment - From the Multicenter AIDS Cohort - (02/26/11)
       
    1849. Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial - pdf attached - (02/18/11)
       
    1850. Testosterone Treatment of Older Men-Why Are Controversies Created? Editorial - (02/18/11)
       
    1851. Do the Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, And Quality of Life Persist Six Months after Treatment in Intermediate-Frail and Frail Elderly Men? - pdf attached - (02/18/11)
       
    1852. Why Is Androgen Replacement in Males Controversial? - CLINICAL REVIEW- pdf attached - (02/18/11)
       
    1853. Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis - pdf attached - (02/06/11)
       
    1854. HIV Infection, Inflammation, Immunosenescence, and Aging - pdf attached - (02/06/11)
       
    1855. 1st Int. Workshop on HIV & Aging Published REPORT pdf attached. 4 -5 October 2010, Baltimore, USA - (01/27/11)
       
    1856. Increasing incidence of ischemic stroke in patients with HIV infection: HIV, HAART, metabolics, median age 50, absolute numbers small - pdf attached - (01/20/11)
       
    1857. Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence among Adults in the US General Population - pdf attached (this was presented in poster at CROI) - (01/14/11)
       
    1858. The Effect of Antiretrovirals on Vitamin D - pdf attached - (01/14/11)
       
    1859. HIV & Aging Slide Talk CME - (01/12/11)
       
    1860. Fractures In Aging >50 Yrs Old: associated with antiepileptic drugs, comorbidities, hypertension osteoprotective - pdf attached - (01/12/11)
       
    1861. Aging with HIV: As HIV population grows older, diseases of aging are a new dilemma New Aging Study/Clinic at SFGH - (01/08/11)
       
    1862. Inflammation (lipodystrophy) Associated with Physical Performance Decline - (01/05/11)
       
    1863. Gait speed was associated with survival in older adults - (01/05/11)
       
    1864. Aging HIV, Diabetes and Kidney Disease - (12/22/10)
       
    1865. Higher HDL-C levels may curb Alzheimer's disease risk - (12/22/10)
       
    1866. Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease - pdf attached - (12/22/10)
       
    1867. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health (vit D insufficiently defined)- publication pdf attached - (12/22/10)
       
    1868. Marijuana Component Eases Diabetic Heart Woes - pdf publication attached - (12/13/10)
       
    1869. Insulin metabolism and the risk of Alzheimer disease - full txt from Neurology below pdf attached - (12/05/10)
       
    1870. 10th Congress Drug Therapy HIV: Nevirapine Versus Ritonavir-Boosted Atazanavir CombinedWith Tenofovir/ Emtricitabine in First-LineTherapy: NEWART 48-Week Data - (12/05/10)
       
    1871. Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection - published pdf attached - (11/29/10)
       
    1872. The Lesser-Known Complications (Bone) of HIV/AIDS (aging, complications) - (11/29/10)
       
    1873. Telomerase reverses ageing process (full text; published pdf attached) - (11/29/10)
       
    1874. White House Meeting on HIV/Aging - (11/01/10)
       
    1875. Cancer and viral infections in immunocompromised individuals - pdf attached - (10/26/10)
       
    1876. Cancer incidence and risk factors after solid organ transplantation - pdf attached - (10/26/10)
       
    1877. Immunosenescence & Aging in HIV - (10/22/10)
       
    1878. "initiating HAART at higher CD4 cell counts for older individuals may be useful- NA-ACCORD Study" - pdf attached - (10/18/10)
       
    1879. Symposium: Optimizing Vitamin D Intake for Populations with Special Needs: Barriers to Effective Food Fortification and Supplementation - (10/16/10)
       
    1880. Biomarkers of impaired renal function - pdf attached - (10/16/10)
       
    1881. Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort - pdf attached - (10/16/10)
       
    1882. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey - pdf attached - (10/16/10)
       
    1883. Aging Wrkshp: CD4 Counts Lower on Entry Into Care Among People 50 and Older: NA-ACCORD - (10/13/10)
       
    1884. Aging Wrkshp: Low Vitamin D Not Linked to Bone Density or Liver Fibrosis in HIV/HCV Group - Written by Mark Mascolini - (10/08/10)
       
    1885. Aging Wrkshp: Multiple non-AIDS Diseases More Frequent in Aging IDUs With Versus Without HIV - Written by Mark Mascolini - (10/08/10)
       
    1886. Aging Wrkshp: Family History of Dementia Predicts Worse Neuropsych Function With HIV (dementia defined below) - Written by Mark Mascolini - (10/08/10)
       
    1887. Aging Wrkshp: Aging HIV+ Hospitalized More Often: Non-AIDS Infections, Heart and GI Disease Explain Most Hospitalizations in Over-50 People With HIV - Written by Mark Mascolini - (10/04/10)
       
    1888. Aging Wrkshp: HIV-Infected in 40s Have Multiple Non-HIV Illnesses as Often as HIV-Negatives in 50s - Written by Mark Mascolini - (10/04/10)
       
    1889. Aging Wrkshp: Comorbidity Rates Higher in Over-49 HIV Group Than in Matched HIV Negatives - Written by Mark Mascolini - (10/04/10)
       
    1890. HIV and Premature Aging: A Field Still in Its Infancy - Editorial: "Age at Cancer Diagnosis Among Persons With AIDS in the United States" (pdf of published study attached) - (10/06/10)
       
    1891. Aging Wrkshp: Sexual Function Worse With HIV Than Diabetes or No Chronic Illness in Older Men - Written by Mark Mascolini - (10/06/10)
       
    1892. Aging Wrkshp: Older Age, HIV, and Antiretrovirals Linked to Neurodegenerative Marker - Written by Mark Mascolini - (10/06/10)
       
    1893. Aging Wrkshp: More Non-HIV Illnesses With HIV Than Without, But Less Treatment; New HCV therapy will add to burden - Written by Mark Mascolini - (10/06/10)
       
    1894. Aging Wrkshp: Older Women With HIV Report "Premature Aging" Strikingly More Often Than Men - Written by Mark Mascolini - (10/06/10)
       
    1895. Aging Wrkshp: Higher Risk of Potential Drug-Drug Interactions in Toronto HIV Patients Over 60 - Written by Mark Mascolini - (10/05/10)
       
    1896. Aging Wrkshp: Lipoatrophy and Efavirenz Tied to Vitamin D Deficiency in Ontario - Written by Mark Mascolini - (10/05/10)
       
    1897. Aging Wrkshp: Pretreatment CD4s and CD4/CD8 Ratio Lower in Trial Participants Over 50 - Written by Mark Mascolini - (10/05/10)
       
    1898. Aging Wrshp: Age Raises Fracture Risk More in People With Than Without HIV - Written by Mark Mascolini - (10/05/10)
       
    1899. Coronary Aging in HIV-Infected Patients - (09/23/10)
       
    1900. Coronary Aging in HIV-Infected Patients: "Increased vascular age was observed in 162 patients (40.5%), with an average increase of 15 years"...."you are 50 years old but your heart's age is 65" - pdf attached - (09/23/10)
       
    1901. Immune senescence in aged nonhuman primates Review - (09/23/10)
       
    1902. Prevalence and Correlates of Sexual Behavior and Risk Management Among HIV-Positive Adults Over 50 - pdf attached - (09/23/10)
       
    1903. Persistence of Racial Differences in Attitudes Toward Homosexuality in the United States.....may help to explain disparities in HIV-infection rates between black & white MSM - pdf attached - (09/23/10)
       
    1904. Ageing and HIV/AIDS (Aging/HIV Clinic in London): A dedicated clinical service for HIV-infected individuals over 50 years of age (09/16/10)
       
    1905. NIH statement on National HIV/AIDS and Aging Awareness Day Sept. 18, 2010 - not good enough - (09/15/10)
       
    1906. Aging Exacerbates Extrapyramidal Motor Signs in the Era of HAART - (09/13/10)
       
    1907. PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY - (09/13/10)
       
    1908. New UCSF Anal Cancer Information Website - (09/09/10)
       
    1909. Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice - (09/09/10)
       
    1910. Oral bisphosphonates and oesophageal cancer - 'evidence inconclusive' Editorial - (09/09/10)
       
    1911. Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer - 2nd study 'no difference in risk' - (09/09/10)
       
    1912. Here is a booklet out of the UK from Mike Youle's group on Aging with helpful information on aging with or without HIV. - (08/29/10)
       
    1913. Diabetes, Insulin Resistance Linked to Alzheimer's - (08/29/10)
       
    1914. High Rates of Asymptomatic Neurocognitive Impairment in Vertically Acquired HIV-1-Infected Adolescents Surviving to Adulthood - (08/29/10)
       
    1915. Older Patients' Share of Office Visits Grows: Care Services for Aging Increased Demand - (08/15/10)
       
    1916. Cognitive Decline Biomarkers-HIV Studies Needed !!!! - (08/13/10)
       
    1917. C-Reactive Protein Levels Increase During HIV-1 Disease Progression in Rakai, Uganda, Despite the Absence of Microbial Translocation - publication pdf attached - (08/07/10)
       
    1918. Alzheimer disease and HIV A tangled story - Editorial - (07/15/10)
       
    1919. HIV & Alzheimers: are HIV+ At Greater Risk for Alzheimers - pdf full text attached - (07/14/10)
       
    1920. HIV/Aging & Antiaging Therapy - (07/12/10)
       
    1921. Inflammation Predicts Mortality in FRAM - (07/08/10)
       
    1922. Depression doubles risk of dementia - (07/07/10)
       
    1923. Telomere Length and Risk of Incident Cancer and Cancer Mortality - (07/08/10)
       
    1924. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment - (07/07/10)
       
    1925. Depressive symptoms and risk of dementia - The Framingham Heart Study - (07/07/10)
       
    1926. New Gene Therapy Zinc Fingers Research Published: 'doctors may someday control HIV virus using stem cells without using anti-retroviral drugs' - (07/07/10)
       
    1927. Immunosenescence and Vaccination - Commentary - (06/29/10)
       
    1928. Mechanisms of immunosenescence Short report - (06/29/10)
       
    1929. Immunosenescence comes of age. Symposium on Aging Research in Immunology: The Impact of Genomics - (06/23/10)
       
    1930. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes' - (06/23/10)
       
    1931. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation - (06/23/10)
       
    1932. HIV-associated lipodystrophy: from fat injury to premature aging - Review - pdf of article attached - (06/22/10)
       
    1933. Mitochondrial Dysfunction in HIV+ CNS/Muscular Organ Systems Disorders in HIV+ Children, and perhaps related to accelerated aging in older HIV+ adults - (06/20/10)
       
    1934. Beyond Hemoglobin A1c-Need for Additional Markers of Risk for Diabetic Microvascular Complications - commentary - (06/08/10)
       
    1935. Circulating mitochondrial DAMPs cause inflammatory responses to injury - (06/07/10)
       
    1936. "mitochondria.....might initiate inflammation....mitochondria are probably released in patients with infectious disease" - (06/07/10)
       
    1937. Immunology & Mitochondria - Clinical immunology: Culprits with evolutionary ties - (06/07/10)
       
    1938. The Mitochondrion - A Trojan Horse That Kicks Off Inflammation? - (06/07/10)
       
    1939. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model - (05/12/10)
       
    1940. Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection - (05/07/10)
       
    1941. Inflammation and Complications of HIV Disease - EDITORIAL COMMENTARY - (05/07/10)
       
    1942. Pre-HAART Immune Activation Associated with Developing Cancers & Death - (05/07/10)
       
    1943. CROI: T cell Senescence and Proliferation Defects Persist in Treated HIV-infected Individuals Maintaining Viral Suppression and Are Associated with Poor CD4+ T Cell Recovery - (03/01/10)
       
    1944. CROI: Impact of CD8+ T Cell Activation on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating Antiretroviral Therapy - (03/01/10)
       
    1945. CROI: Valganciclovir Reduces CD8+ T Cell Activation among HIV-infected Patients with Suboptimal CD4+ T cell Recovery During Antiretroviral Therapy - (03/01/10)
       
    1946. Early Immune Senescence in HIV Disease - (02/15/10)
       
    1947. Immunosupportive therapies in aging - pdf attached - (02/05/10)
       
    1948. Protein in Urine Presages More Severe Problems - free full text link below - (02/04/10)
       
    1949. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women (and men) - (01/29/09)
       
    1950. HIV Infection and Aging Independently Affect Brain Function as Measured by Functional Magnetic Resonance Imaging - BRIEF REPORT - (01/25/09)
       
    1951. Quality-Of-Life Predicts Survival in HIV: HIV & aging - (01/17/09)
       
    1952. Aerobic Exercise Improved Cognitive Function in Older Adults with Mild Cognitive Impairment - (01/17/09)
       
    1953. Moderate Mid-Life Exercise Prevents Mild Cognitive Impairment - (01/17/09)
       
    1954. Testosterone: More Is Not Always Better - EDITORIAL - (12/21/09)
       
    1955. Thyroid Function and Longevity: New Insights into an Old Dilemma - EDITORIAL - (12/21/09)
       
    1956. Mediterranean Diet and Late-Life Cognitive Impairment -Editorial - (12/09/09)
       
    1957. Physical Activity, Diet, and Risk of Alzheimer Disease: In this study, both higher Mediterranean-type diet adherence and higher physical activity were independently associated with reduced risk for AD. - (12/09/09)
       
    1958. Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall - (12/01/09)
       
    1959. Cardiovascular Diseases and Risk of Hip Fracture - (10/27/09)
       
    1960. Diabetes Can Impair Exercise Capacity: Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus - (10/07/09)
       
    1961. Subcutaneous (lipoatrophy) Rather than Visceral Adipose Tissue Is Associated with Adiponectin Levels and Insulin Resistance in Young Men - (10/07/09)
       
    1962. Sex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) Study - (10/07/09)
       
    1963. Frontostriatal fiber bundle compromise in HIV infection without dementia - (10/06/09)
       
    1964. Lipoatrophy & Mortality, CVD - (09/30/09)
       
    1965. Diabetes 2 Caused Brain Atrophy in Older Individuals - (09/30/09)
       
    1966. HIV and Aging: The Long-term Consequences of Successful Antiretroviral Therapy - (09/11/09)
       
    1967. HIV, HAART & Brain Damage & Repair - (09/11/09)
       
    1968. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people - (08/29/09)
       
    1969. Neurological Impairment Persists Despite HAART: "adjunctive therapies needed" - (08/29/09)
       
    1970. Insulin Resistance Is Associated With Cognition Among HIV-1-Infected Patients: The Hawaii Aging With HIV Cohort - (08/29/09)
       
    1971. HCV Coinfection & Neurologic Impairment - (08/29/09)
       
    1972. 5th IAS: Prevalence of HIV-1-Associated Neurocognitive Disorders in Argentina - (08/27/09)
       
    1973. Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss - pdf attached - (08/27/09)
       
    1974. The clot thickens-oxidized lipids and thrombosis - (08/26/09)
       
    1975. Oxidized lipids: a key to heart disease? - (08/26/09)
       
    1976. Aging/HIV Clinical Care & Research - New IDSA Guidelines - (08/26/09)
       
    1977. Thyroid Dysfunction, Hypogonadism, Testosterone, Bone, Prostate Cancer, HIV & HAART - (08/26/09)
       
    1978. Aging & HIV Recognized as a Serious Concern But No Real Discussion, Still Ignored. 2007 NIH Workshop recommendations - (08/26/09)
       
    1979. NIH Workshop on HIV in Older Adults Oct 20 2007 - (08/18/09)
       
    1980. A serum 25-hydroxyvitamin D level below 50 nmol/l has been associated with increased body sway and a level below 30 nmol/l with decreased muscle strength. - (08/18/09)
       
    1981. Vitamin D deficiency, muscle function, and falls in elderly people1,2 Review Article - (08/18/09)
       
    1982. 5th IAS: One Third With Undetectable HIV RNA Have Asymptomatic Neurocognitive Impairment - written by Mark Mascolini - (07/20/09)
       
    1983. 5th IAS: Thinking Through the CNS: The Importance of Considering the Blood-Brain Barrier. Slide talk by Scott Letende, GSK satellite meeting at IAS 2009 - (07/19/09)
       
    1984. 5th IAS: European Researchers Issuing Guidelines on Bone Disease - (07/19/09)
       
    1985. HIV-1 Infection Is Associated With an Earlier Occurrence of Frailty....in MACS - (07/18/09)
       
    1986. Growth Hormone and Sex Steroid Effects on Serum Glucose, Insulin, and Lipid Concentrations in Healthy Older Women and Men - (07/16/09)
       
    1987. MRI Findings May Track Risk of Cognitive Impairment in Healthy Seniors - (07/16/09)
       
    1988. Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men - (07/16/09)
       
    1989. Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men - (07/16/09)
       
    1990. Nitrates May Be Environmental Trigger For Alzheimer's, Diabetes And Parkinson's Disease - (07/08/09)
       
    1991. Global Consequences of the Future of Aging with HIV - (07/08/09)
       
    1992. A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection - full text pdf attached - (07/07/09)
       
    1993. IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection - pdf full text attached - (07/07/09)
       
    1994. IL-21 Is Required to Control Chronic Viral Infection - pdf full text attached - (07/07/09)
       
    1995. Immunology Controlling Chronic Viral Infections, EDITORS' CHOICE - (07/07/09)
       
    1996. A Chronic Need for IL-21 EDITORIAL - (07/07/09)
       
    1997. Metabolic bone disease in HIV infection: HIV, ART Implicated EDITORIAL - (07/02/09)
       
    1998. First line AZT/3TC/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir - (07/02/09)
       
    1999. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (07/02/09)
       
    2000. Inflammation Marker hsCRP & CVD- Cause or Effect: Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease - (07/02/09)
       
    2001. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community: "Minimal Benefit In Predicting CVD Compared To Traditional Risk Factors" - (07/02/09)
       
    2002. Biomarkers and Cardiovascular Disease: Determining Causality and Quantifying Contribution to Risk Assessment - Editorial - (07/02/09)
       
    2003. CRP, other biomarkers, not clinically useful to predict CVD risk - (07/02/09)
       
    2004. New meta-analysis: Statins of benefit in primary prevention: improved survival & CVD risk in patients with only risk factors - (07/02/09)
       
    2005. Monitoring bone mineral density during antiresorptive treatment for osteoporosis - Editorial - (06/27/09)
       
    2006. Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data - (06/27/09)
       
    2007. The Value of Bone Density Testing - (06/27/09)
       
    2008. Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys - (06/19/09)
       
    2009. Study in Neurology journal (Aug 2008) Reports Alzheimers Appears to Precede Frailty and Study in Jnl of Geronotology (2007) in the MACS Cohort Reports Risk of Frailty Higher in HIV+ vs HIV-; is early onset of Alzheimers or some other brain or cognitive dysfunction related to early onset and higher rates of frailty among HIV+? - (06/08/09)
       
    2010. Antiaging Therapy with TAT2: Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes - (06/02/09)
       
    2011. Modulation of T Lymphocyte Replicative Senescence via TNF-{alpha} Inhibition: Role of Caspase-31 - (06/01/09)
       
    2012. Does HIV Increase Prostate Cancer Risk? - (05/21/09)
       
    2013. Effects of Oxidation and Inflammation, Cancer, Prostate Cancer - (05/21/09)
       
    2014. Predicting risk of dementia in older adults. The late-life dementia risk index - Aging !!!! - (05/15/09)
       
    2015. RNA Testing for HIV Instead of Antibody Testing Could Detect Early Stage of HIV Infection And Would Likely Improve Prevention AND Allow for Early HAART' Could it Prevent Accelerated Aging? - (05/13/09)
       
    2016. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS (case study) - (05/13/09)
       
    2017. Cancers in HIV Review in AIDS May 15 2009 - (05/13/09)
       
    2018. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial - (05/13/09)
       
    2019. Glucocorticoid-induced osteoporosis: hope on the HORIZON-COMMENT - (04/20/09)
       
    2020. Reversing HIV T-Cell Aging - (04/20/09)
       
    2021. HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty: HIV+ men in MACS 10-Times More Likely to Exhibit Frailty than HIV-negative Men. - (04/20/09)
       
    2022. MACS Frailty/HIV/CD4 Study Misses The Point - (04/20/09)
       
    2023. Midlife Patients With HIV or AIDS Require Care for Chronic Conditions: "HIV simulates aging" - (03/27/09)
       
    2024. ISHLVD: Developing HBV/HCV Associated Liver Cancer At A Young Age < 40 Yrs Old - (03/25/09)
       
    2025. How Inflammatory Disease Causes Fatigue: chronic inflammation infiltrates the brain but can be blocked - (03/10/09)
       
    2026. WHO | The unexplored story of HIV and ageing - (03/05/09)
       
    2027. CROI: Effects of Aging on HIV-1 Pathogenesis: HIV causes inflammation & T-cell activation, reported here to be more in postmenopausal women - (03/04/09)
       
    2028. CROI: Immune Senescence, Activation and Abnormal T cell Homeostasis Despite Effective HAART, A Hallmark of Early Aging in HIV Disease - (03/03/09)
       
    2029. Kidney Disease in Patients with HIV Infection and AIDS - (03/02/09)
       
    2030. HAART Does Not Reverse Premature T-Cell Aging Caused by HIV - (02/27/09)
       
    2031. Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment - (02/27/09)
       
    2032. CROI: Aging with HIV - Lessons from CROI 2009 - Victor Valcour MD - (02/27/09)
       
    2033. CROI: HIV Infection May Make the Brain 15 to 20 Years Older: HIV slows cerebral blood flow and stimulus response in MRI study - written by Mark Mascolini - (02/23/09)
       
    2034. CROI: Effects of Aging on HIV Pathogenesis: aging is associated with higher t-cell activation in women than men, effects of menopause on inflammation and immune activation...." (02/23/09)
       
    2035. CROI: Immune Senescence, Activation, and Abnormal T Cell Homeostasis despite Effective HAART, a Hallmark of Early Aging in HIV Disease: "HIV-infected subjects (median 56 years) with good immune reconstitution and viral suppression had immune changes comparable to older (median 88 years) HIV-negative subjects" - (02/20/09)
       
    2036. CROI: HIV-1 INFECTION IS ASSOCIATED WITH ACCELERATED VASCULAR AGING (02/18/09)
       
    2037. CROI: Neurocognitive (and neuropathy) Impairment Rate Remains High in Diverse US Cohort - written by Mark Mascolini - (02/18/09)
       
    2038. Causes of Accelerated Aging in HIV: HIV Induces Aging of T-Cells - (02/10/09)
       
    2039. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity: review by Steve Deeks and Andrew Phillips - (01/28/09)
       
    2040. Aerobic + Strength Exercise is Optimal for Insulin Resistance and Improved Health & Frailty in Study of Obese and Older, Average Age 67 Yrs - (01/28/09)
       
    2041. HIV Prematurely Accelerates Aging - (01/22/09)
       
    2042. AGING AND INFECTIOUS DISEASES: effects of aging; Immunosenescence and Vaccination in Nursing Home Residents - (01/22/09)
       
    2043. Our results suggest that HIV-1 infection induces an accelerated aging of T lymphocytes, which is associated with the clinical progression to AIDS and death - (01/13/09)
       
    2044. C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study - (01/14/09)
       
    2045. Cardiovascular Complications in HIV Management: Past, Present, and Future [Critical Review: Clinical Science] - (01/12/09)
       
    2046. Increased Melanoma Rates in USA Are Real and Aging/HIV - (01/09/09)
       
    2047. Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women - (01/07/09)
       
    2048. Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy - (01/02/09)
       
    2049. Keeping Blood Sugar Low May Help Stem Geriatric Memory Loss - (01/02/09)
       
    2050. Central obesity and increased risk of dementia more than three decades later - (12/22/08)
       
    2051. Visceral Fat & Neurotoins, Insulin Resistance & Alzheimer Disease/Dementia EDITORIAL - (12/22/08)
       
    2052. Impaired insulin secretion increases the risk of Alzheimer disease - (12/22/08)
       
    2053. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes - (12/22/08)
       
    2054. Associations between Male Anogenital Human Papillomavirus Infection and Circumcision by Anatomic Site Sampled and Lifetime Number of Female Sex Partners - (12/22/08)
       
    2055. Federal Government NIAID Aging Funding Opportunities - (12/16/08)
       
    2056. Neurological/Cognitive Impairment on HAART: 50% on HAART have cognitive impairment - (12/10/08)
       
    2057. 10th Intl Workshp Adverse Drug Reactions & Lipo: A Comparison of Cardiac Function Between HIV-Infected and HIV-Seronegative People With and Without the Metabolic Syndrome. - (12/10/08)
       
    2058. 10th Intl Workshp Adverse Drug Reactions & Lipo: COMPARISON OF THE EFFECTS OF NEVIRAPINE RESPECT TO EFAVIRENZ ON DIFFERENTIATING AND MATURE HUMAN ADIPOCYTES IN CULTURE - (12/10/08)
       
    2059. Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy - (12/09/08)
       
    2060. "elevations in inflammatory markers seen in insulin resistance, metabolic syndrome, and diabetes are not causative but a consequence of these abnormalities." - (12/02/08)
       
    2061. Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes - (12/02/08)
       
    2062. Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and Lipoatrophy - (12/02/08)
       
    2063. Inflammation May Be Associated with AIDS Progression - (12/02/08)
       
    2064. Uric Acid Levels Increase Risk for New-Onset Kidney Disease - Editorial - (12/02/08)
       
    2065. HIV TAT Protein Infects Brain Shortly After HIV-Infection and Disrupts Brain Normal Activity, Affects Mitochondria-- Pretreatment with the RyR antagonist, dantrolene mediated these pathologic effects.....dantrolene has side effects but these findings could lead to research for therapy to block this mechanism of action "RyR may be a crucial target for neuroprotection in HIV-associated neurologic disease" - (11/19/08)
       
    2066. ICAAC: Continuous Antiretroviral Therapy Decreases Bone Mineral Density: Results from the SMART Study (11/24/08)
       
    2067. ICAAC: Bone Loss in SMART Study - Written by Mark Mascolini - (10/30/08)
       
    2068. Statin induced myopathy - (11/21/08)
       
    2069. 10th Intl Workshp Adverse Drug Reactions & Lipo: Effect of HAART on insulin sensitivity, autonomic nervous system function and beta-adrenergic mediated lipolysis (11/20/08)
       
    2070. Statin (Crestor) Prevents Heart Disease, Lowers LDL and Inflammation in Healthy with Normal Lipids - (11/18/08)
       
    2071. Statin Therapy for Prevention? EDITORIAL Expanding the Orbit of Primary Prevention - Moving beyond JUPITER - (11/18/08)
       
    2072. JUPITER hits New Orleans: Landmark study shows statins benefit healthy individuals with high CRP levels - (11/18/08)
       
    2073. Crestor Study Will Boost Statin Demand - (11/18/08)
       
    2074. The role of HIV in serious diseases (non-AIDS diseases) other than AIDS - (11/18/08)
       
    2075. Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies - (11/18/08)
       
    2076. Higher frequency of dementia in older HIV-1 individuals The Hawaii Aging with HIV-1 Cohort - (11/18/08)
       
    2077. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis - (11/18/08)
       
    2078. Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection - (11/18/08)
       
    2079. 9th Interntl Drug Thrpy HIV: Cardiovascular disease; HIV, ART, immunodeficiency, pro-inflammation and other factors - (11/13/08)
       
    2080. ICAAC: Unremitting Kaposi Sarcoma in HIV infected patients with viral suppression on antiretrovirals - (10/31/08)
       
    2081. Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia - (10/24/08)
       
    2082. The CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study - (10/23/08)
       
    2083. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients - (10/23/08)
       
    2084. Neurotoxic effect of HIV: HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people - (10/23/08)
       
    2085. The prevalence and incidence of neurocognitive impairment in the HAART era (08/30/07)
       
    2086. More Alzheimer's Risk for Hispanics, Studies Suggest - (10/21/08)
       
    2087. Diabetes in D.A.D. Study - (10/21/08)
       
    2088. Non-AIDS Deaths In HIV Positive Patients Linked To Inflammation And Coagulation Markers...and ART interruption - (10/21/08)
       
    2089. Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients - (10/21/08)
       
    2090. Association of White Blood Cell Subfraction Concentration with Fitness and Fatness - (10/17/08)
       
    2091. Aging with HIV Increases Risk for Comorbidities: Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity? - (10/14/08)
       
    2092. CROI: HIV and Aging at CROI 2008 - epidemiology of aging with HIV - (02/22/08)
       
    2093. Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes - (10/10/08)
       
    2094. Mitochondria and Aging - (10/09/08)
       
    2095. New Genetic Model For Parkinson's Disease: mitochondrial damage - (10/09/08)
       
    2096. Mitochondria Damage & Aging - (10/09/08)
       
    2097. Reports of KS in Aging SF Patients - (10/06/08)
       
    2098. Can We Cure Aging? - (10/06/08)
       
    2099. Central obesity and increased risk of dementia more than three decades later - (10/03/08)
       
    2100. Impaired insulin secretion increases the risk of Alzheimer disease - (10/03/08)
       
    2101. Visceral Adiposity & Insulin Impairment & Dementia/Alzheimer's - (10/03/08)
       
    2102. Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study - (09/2/08)
       
    2103. Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America - (05/13/05)
       
    2104. Cancers in HIV: immunity/ART - (09/26/08)
       
    2105. Estimating GFR Using Cystatin Alone & in Combination with Creatinine: analysis of 3,418 with CKD - (09/26/08)
       
    2106. Chronic Kidney Disease Prevalence Higher in the USA: related to hypertension, diabetes, aging - (09/26/08)
       
    2107. CKD in the Elderly-Old Questions and New Challenges: CKD in the elderly as a new challenge for research, clinical practice, and public health. - (09/26/08)
       
    2108. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis - (09/26/08)
       
    2109. CROI: Incidence Anal Squamous Intraepithelial Lesions (SIL) and Predictors of in the SUN Study after One Year of Follow-up - (02/22/08)
       
    2110. CROI: Immunodeficiency and Risk of AIDS-defining and Non-AIDS-defining Cancers: ANRS CO3 Aquitaine Cohort, 1998 to 2006 - (02/25/08)
       
    2111. CROI: Insufficient Virus Suppression during HAART Is a Strong Predictor for the Development of AIDS-related Lymphoma: German CLINSURV Cohort - (02/25/08)
       
    2112. CROI: Fat Changes Boost Heart Disease and Diabetes Risk in HIV-Infected Men - Written by Mark Mascolini (02/19/08)
       
    2113. CROI: Cardiovascular Risk Markers Greatly Inflate Death Risk in People With HIV; interruptions increase risk - Written by Mark Mascolini (02/12/08)
       
    2114. CROI: Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis - (03/07/08)
       
    2115. CROI: Prevalence and Risk Factors in HIV-infected Persons for Echocardiographic Abnormalities in the Era of Modern HAART - (03/05/08)
       
    2116. CROI: Inflammatory Markers Correlate with Carotid Intima-Media Thickness and Endothelial Activation in HIV-infected Patients (03/12/08)
       
    2117. Subclinical Glucose Abnormalities & Undiagnosed Diabetes Noted in HCV+ - (09/18/08)
       
    2118. Vitamin B12 & Brain Atrophy - (09/18/08)
       
    2119. Alzheimer's Disease Risk Factors: metabolics-diabetes, cholesterol--, genetics, lifesyle - (09/18/08)
       
    2120. Mediterranean Diet Improves Health & Mortality - (09/18/08)
       
    2121. HIV, Dementia & HAART - (09/18/08)
       
    2122. Intensive Blood Glucose Control Has Positive Outcomes in ADVANCE Study - (09/12/08)
       
    2123. Aging with HIV; Early Cognitive Decline - (08/28/08)
       
    2124. Depression in the United States Household Population, 2005-2006 - (09/16/08)
       
    2125. HIV-associated Alzheimer's disease in the Future? - (09/16/08)
       
    2126. Statins for Slowing Kidney Disease Progression: An as yet Unproven Indication - (09/16/08)
       
    2127. Frailty Defined in Older Adults Evidence for a Phenotype - (09/16/08)
       
    2128. Physical Frailty Could Predict Alzheimer's Disease - (09/16/08)
       
    2129. Alzheimer's Disease Risk Factors: exercise, metabolics, lifestyle, genetics - (09/16/08)
       
    2130. ACTG Bone Study Group Established; More Bone Issues Need Attention - (09/18/08)
       
    2131. Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy: Results of an Observational Multicenter Study - (09/18/08)
       
    2132. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis - (09/12/08)
       
    2133. Approach to the Patient with Prediabetes - (09/08/08)
       
    2134. HCV Coinfection Increases Risk for HIV-Related Kidney Disease - (09/18/08)
       
    2135. The Inflammatory Debate: Is it the Virus, the Drugs, or the Host? - (09/18/08)
       
    2136. Highly-sensitive C-reactive protein (hsCRP) is associated with body mass index (BMI) and serum lipids in HIV-infected patients with low cardiovascular disease (CVD) risk and virologic suppression on antiretroviral therapy (ART) - (09/18/08)
       
    2137. Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The Mortalite 2000 and 2005 Surveys (ANRS EN19 and Mortavic) [Epidemiology and Social Science] - (08/27/08)
       
    2138. Running slows the aging clock, Stanford researchers find - (09/02/08)
       
    2139. Earlier HAART Suggested for African-Americans At-Risk for Kidney Disease - (08/27/08)
       
    2140. HIV, HAART & Brain Damage - (09/18/08)
       
    2141. Intensive Blood Glucose Control Has Positive Outcomes in ADVANCE Study - (09/18/08)
       
    2142. Subclinical Glucose Abnormalities & Undiagnosed Diabetes Noted in HCV+ - (09/18/08)
       
    2143. HIV Infection and Dementia in Older Adults: should we be concerned? - (04/25/06)
       
    2144. HIV, HAART & Brain Damage - (11/28/05)